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Abstract 
Carbohydrates are among the most abundant biomolecules on earth and can be 
found in all living things. Their role in nature ranges from structural components 
such as cellulose in plants and chitin in the exoskeletons of arthropods, to 
fundamental building blocks of DNA and RNA, to the most important energy 
storage molecules in organisms in the form of starch and glycogen. 
The practically unlimited ways in which individual monosaccharides can be 
connected make the information storage potential of this class of compounds 
exponentially greater than that of DNA or proteins. This property does, however, 
also result in some complications as, while the potential for storing information 
in carbohydrate structures is great, the process of doing so and reading the 
information back is complicated by this exact same phenomenon. A majority of 
the early carbohydrate investigations focused on the elucidation of the structures 
of carbohydrates and the pioneering work in this field was done by Emil Fischer 
at the end of the 19
th
 century. Later the focus shifted towards creating glycosidic 
linkages, and over the years, countless methods have been developed allowing 
for the preparation of complex structures. The advances in the field have enabled 
the investigation of the biological roles of this class of compounds. 
This thesis explores the world of carbohydrates starting from small 
oligosaccharides, expanding towards multivalent structures and finally into 
modification of polysaccharides for preparing well-defined mimics of natural 
polysaccharides. Potential biological applicability is always a consideration 
when designing the compound and a recurring theme throughout the thesis are β-
(1→2) linked mannosides which are an interesting class of compounds due to 
their biological impact, their unique structure and problems associated with their 
synthesis. Particular attention has been paid to the analysis of products by NMR 
spectroscopy and complete assignment of the spectra. Where feasible, the 
spectra were simulated by NMR simulation software PERCH to allow a more 
complete interpretation. 
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Abstrakt 
Kolhydrater tillhör en av de största grupperna av naturligt förekommande 
biomolekyler. Deras förekomst i naturen sträcker sig från strukturella 
komponenter såsom cellulosa i växter och chitin i exoskeletten av artropoder, till 
fundamentala byggnadsblock av DNA och RNA, till stärkelse och glykogen som 
är de viktigaste molekylerna för energiförvaring. 
De praktist taget oändliga sätten att kombinera enskilda monosackarider medför 
en informationslagringspotential som är exponentiellt större än den hos DNA 
och proteiner. Denna egenskap leder dock också till vissa komplikationer, 
emedan potentialen för lagring av information är stor, kompliceras de praktiska 
aspekten av att göra så av detta exakta fenomen. Majoriteten av de tidiga 
undersökningarna av kolhydrater var fokuserade på utredning av deras strukturer 
och de fundamentala grunderna för detta arbete utfördes av Emil Fischer i slutet 
av 1800-talet. Senare har forskningen skiftat mot skapandet av glykosidiska 
bindningar och genom åren har otaliga metoder utvecklats vilket har möjliggjort 
framställning av komplexa strukturer för undersökning av de biologiska rollerna 
hos denna klass av föreningar. 
Denna avhandling utforskar kolhydratlandskapet med början från små 
oligosackarider varifrån forskningen expanderar mot multivalenta strukturer och 
senare mot modifiering av polysackarider för att framställa väldefinierade 
molekyler som imiterar naturliga polysackarider. De potentiella biologiska 
tillämpningarna hos de framställda molekylerna hålls alltid i tankarna och ett 
genomgående tema i avhandlingen är β-(1→2) kopplade mannosider som är en 
intressant klass av föreningar på grund av sina biologiska egenskaper, unika 
struktur och problemen associerade med deras syntes. Särskild uppmärksamhet 
har ägnats åt analys och karakterisering av de framställda molekylerna med hjälp 
av NMR spektroskopi och NMR spektra har i mån av möjlighet simulerats med 
NMR-simuleringsprogrammet PERCH för att erhålla så mycket information som 
möjligt. 
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1 Introduction 
Carbohydrates are among the most abundant biomolecules on earth and 
comprise one of the three types of biopolymers, polysaccharides, the other two 
being polynucleotides (DNA and RNA) and polypeptides. The functions of 
carbohydrates in nature are many, for example, components for structural 
integrity such as cellulose in plant cell walls and chitin in the exoskeletons 
arthropods. Furthermore, ribose and deoxyribose (2-deoxy-D-erythro-
pentofuranose) are vital parts of the fundamental building blocks of life itself 
and glucose is the most important molecule for energy storage in living 
organisms. 
The widespread use of carbohydrates in nature, and one of the major differences 
between polysaccharides and other biopolymers, stems from the large variation 
of monosaccharide units and ways in which they can be connected. 
Both polynucleotides and polypeptides form linear structures with no 
stereochemistry involved in the linkages between the monomers (technically a 
stereocenter is involved in the linkage between polypeptides, but only the L 
enantiomer occurs in nature). Carbohydrates, however, typically have several 
positions where another carbohydrate unit can be attached which can lead to 
branching. Furthermore, most of the hydroxyl groups involved in the linkages 
between two monosaccharides are connected to a stereocenter.  A simple 
disaccharide consisting of two D-glucose units can be constructed in 19 different 
ways. If the disaccharide consists of two different monosaccharides, such as D-
glucose and D-mannose, the total number of molecules that can be constructed is 
36. 
1.1 Structure and nomenclature of carbohydrates 
Early elemental analysis showed that carbohydrates consist of carbon and water 
in a ratio Cn(H2O)m (n ≥ m) which means that they are hydrates of carbon. The 
term carbohydrate is derived from the Latin word carbo and the ancient Greek 
word for water (ὕδωρ, húdōr).1 
Generally, carbohydrates are divided into three groups: monosaccharides 
consisting of a single carbohydrate unit, oligosaccharides consisting of between 
two to ten monosaccharide units, and polysaccharides consisting of more than 10 
monosaccharide units. The exact definitions of how many monosaccharide units 
constitute an oligosaccharide or polysaccharide vary between sources though. 
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Monosaccharides are the simplest carbohydrate structures and even though they 
are rather small molecules, they offer great structural variation due typically to 
having several stereocenters. Monosaccharides can further be divided into 
aldoses that contain an aldehyde functionality and ketoses that contain a ketone. 
One of the earliest pioneers in carbohydrate chemistry was Hermann Emil 
Fischer who, in 1902, was awarded the Nobel Prize in chemistry “in recognition 
of the extraordinary services he has rendered by his work on sugar and purine 
syntheses”. His most famous achievements are the determination of the absolute 
stereochemical configuration of all the sugars known at the time as well as the 
first total synthesis of D-glucose.
2–4
 What makes his discoveries even more 
remarkable is that he, did not have access to modern analytical methods and had 
to rely heavily on more primitive methods such as measuring the optical rotation 
and derivatization with phenylhydrazine to form osazones. He also laid the 
foundations for the nomenclature of sugars
2
 and developed the Fischer 
projection which is still commonly used for visualizing monosaccharides. 
OH
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OH
OH OH
HO
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O
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OH
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HO
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OH
OH
O
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OH
O O
 
Figure 1.1. Fischer projections of selected monosaccharides. 
In the Fischer projection, the monosaccharides are drawn in such a way that the 
carbon atoms are arranged in a vertical line placing the carbon atom with the 
lowest number at the top. The hydroxyl groups are drawn out horizontally to the 
left or to the right. The horizontal bonds come out of the plane of the paper and 
the vertical bonds go into the plane. This is visualized in Figure 1.1, which 
shows the Fischer projections of selected monosaccharides. 
Monosaccharides are given trivial names by grouping the carbon atoms in 
groups of a maximum of four, starting from the lowest numbered center of 
chirality. The first one to three carbon atoms determine the trivial name for that 
segment, for example gluco, manno, galacto etc. and the fourth determines 
whether the segment is D or L. If the substituent at that position is on the right 
side in the Fischer projection, it is denoted D and if it is on the left, it is denoted 
L.
5
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Monosaccharides can, be named in a systematic way like any other molecules 
and β-D-glucopyranose could be called (2R, 3R, 4S, 5S, 6R)-6-
(hydroxymethyl)oxane-2,3,4,5-tetraol. This is obviously not practical and thus 
trivial names are almost exclusively used. 
1.1.1 The cyclic structures of monosaccharides 
Fischer incorrectly assumed that the monosaccharides occur as linear molecules. 
Today, we know that monosaccharides prefer to form cyclic structures in the 
form of hemiacetals (in the case of aldoses) or hemiketals (in the case of 
ketoses). In an aqueous solution, the linear form typically makes up less than 1% 
of the total amount. Monosaccharides typically form six-membered pyranose 
rings or five-membered furanose rings that are in equilibrium with the linear 
form. This happens when one of the hydroxyl groups attacks the carbonyl carbon 
to form a hemiacetal or hemiketal. Because the carbonyl carbon has a planar 
structure, the attack can happen from either side and a new stereocenter is 
formed. The ring-opening and closing is called mutarotation and is visualized in 
Scheme 1.1. The configuration of the new stereocenter in the cyclic structure is 
denoted with α or β and the IUPAC definition for this is as follows (Figure 1.2):5 
The anomeric reference atom is the configurational atom of the parent, 
unless multiple configurational prefixes are used. If multiple 
configurational prefixes are used, the anomeric reference atom is the 
highest-numbered atom of the group of chiral centres next to the 
anomeric centre that is involved in the heterocyclic ring and specified by 
a single configurational prefix. In the α anomer, the exocyclic oxygen 
atom at the anomeric centre is formally cis, in the Fischer projection, to 
the oxygen attached to the anomeric reference atom; in the β anomer 
these oxygen atoms are formally trans. 
 
Figure 1.2. Visualization of the IUPAC definition of anomeric configuration. 
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Here, the configurational atom refers to the chiral center that has the highest 
location number, i.e. the atom that is used to determine whether the 
monosaccharide has D or L configuration. The anomeric reference atom is that 
used for determining whether the anomeric configuration is α or β. In the 
molecules discussed in depth in this thesis, the configurational atom and 
reference atom will always be the same. Monosaccharides with more than six 
carbon atoms can have several configurational atoms and in these, the 
configurational atom and the anomeric reference atom are not necessarily the 
same, but these do not appear in this thesis. 
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Scheme 1.1. Mutarotation in D-glucose. 
In addition to different stereochemical configurations of monosaccharides, the 
same monosaccharide can exist in a number of different conformations. 
Technically, a monosaccharide in a furanose or pyranose form can exist in 
similar conformations as other five- or six-membered structures consisting of sp
3
 
hybridized atoms (Figure 1.3). 
A six-membered ring can be twisted into several different conformations, some 
more stable than the others. Pyranoses can exist in four different types of ring 
conformations or variations of these: chair (C), boat (B), skew (S) and half-chair 
(H). Additionally, when describing a conformation, the atom that is above the 
plane is indicated with a superscript before the notation and the atom below the 
plane is indicated with a subscript after the conformation. There are a total of 26 
pyranose conformations (two chair, six boat, six skew and twelve half-chair 
conformations). The furanose forms of monosaccharides can adopt two general 
ring conformations: envelope (E) and twist (T) with ten variations of each. 
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Figure 1.3. Examples of the different conformations of the pyranose (top) and furanose 
(bottom) conformations. 
The preferred conformation of monosaccharides in pyranose form is 
4
C1 for D-
sugars and 
1
C4 for L-sugars as these conformations minimize the steric 
interactions between the substituents on the ring (Figure 1.4). 
OHO
HO
HO
OH
OH
O
OH
HO
OH
OH
OH
O OH
HO
HO
OH
HO
4C1
1C4
1C4
-D-glucopyranose -L-glucopyranose 
Figure 1.4. Chair conformations of β-D-glucopyranose (left) with steric interactions 
indicated in the 
1
C4 conformation and β-L-glucopyranose (right). 
In general, monosaccharides that can form a pyranose will prefer that over a 
furanose form as the ring strain is lower in a six-membered ring than it is in a 
five-membered ring. Monosaccharides that have several axial substituents 
regardless of the conformation, however, such as altrose (Figure 1.5) or idose, 
also exist to a significant degree in the furanose form.
6
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Figure 1.5. The ratios of the different pyranose and furanose forms of D-altropyranose in 
water at 31 °C. 
While the cyclic structures are the dominant ones in aqueous solution, the small 
amount of aldehyde or ketone present can be used for chemical modifications. 
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Emil Fischer used the aldehyde for chain extensions by first reacting it with 
NaCN followed by hydrolysis and finally reduction of the formed lactone with 
sodium amalgam to create a new monosaccharide with one more carbon atom. 
This method for extending monosaccharides is known as the Kiliani–Fischer 
synthesis.
7,8
 
1.2 Anomeric effect 
In cyclic structures, the preferred conformation can often be explained by steric 
factors and a common rule is that large substituents prefer an equatorial 
orientation to minimize steric interactions. An electronegative atom, e.g. oxygen 
or nitrogen, in the ring can, however, have a significant effect on the stability of 
the orientations of the substituents on the neighboring atoms. Electronegative 
substituents at the anomeric position have a preference for axial orientation, 
instead of an equatorial orientation that would be preferred from a sterical point 
of view. This phenomenon was first described by J. T. Edward in 1955
9
 and R. 
U. Lemieux later coined the term anomeric effect.
10
 The effect is also sometimes 
called the Edward-Lemieux effect, and is one of the key factors for determining 
the conformations of monosaccharides.
9,11
 Without the anomeric effect, one 
would expect that D-glucose exists almost solely in the β-configuration in a 
solution. In reality, the α:β-ratio is 36:64, and the effect is even more 
pronounced in D-mannose due to the axial substituent at on C-2, resulting in an 
α:β-ratio of 69:31.6 
Some of the most extreme cases, where the anomeric effect drastically changes 
the low-energy conformation of a monosaccharide are acetylated aldopyranosyl 
halides. In the case of 2,3,4-tri-O-acetyl-α-D-xylopyranosyl chloride, the only 
conformation found is the expected 
4
C1 whereas in the corresponding β-anomer, 
there is an equilibrium between the 
4
C1 and the 
1
C4 conformations, with 
preference for the latter (~80%), even though this results in all the acetyl groups 
being axial (Figure 1.6).
12,13
 
OAcO
AcO
AcO
Br
O Br
OAc
OAc
OAc
OAcO
AcO
AcO
Br O
Br
OAc
OAc
OAc
4C1
1C4
4C1
1C4
~100% ~0% ~20% ~80%
   
Figure 1.6. Comparison of the preferred conformations of the α and β anomers of 
acetylated xylopyranosyl bromide. 
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There are two main reasons for the anomeric effect: hyperconjugation between 
the axial free electron pair of the ring oxygen and the antibonding orbital of the 
anomeric C-X bond, and dipolar interaction. Hyperconjugation allows one 
electron pair from the endocyclic oxygen to be shifted towards the antibonding 
orbital of the C-X bond at the anomeric center, resulting in a lower energy 
conformation. Dipolar interaction between the dipoles caused by the endocyclic 
oxygen and the C-X bond is repulsive if the anomeric substituent is equatorial 
(Figure 1.7). 
O
X
O
X
+
O
X
O
X
Stabilization Nonrepulsive dipole interaction
No stabilization Repulsive dipole interaction  
Figure 1.7. Top: Stabilization of the axial substituent by electronic effects. Bottom: An 
equatorial substituent is not stabilized. 
1.3 Reactivity of carbohydrates 
Carbohydrates have many reactive sites that can be targeted for modification. 
These sites are typically hydroxyl groups with very similar reactivities, and 
require special methods for specific modifications. There are generally three 
types of functional groups on a monosaccharide: the anomeric center which is a 
(hemi)acetal or –ketal, secondary hydroxyl groups and primary hydroxyl groups 
(Figure 1.8). The hydroxyl group at the anomeric center has different reactivity 
than the rest, and can be selectively manipulated under acidic conditions. 
Primary hydroxyl groups are more nucleophilic than secondary ones, and 
typically also less sterically hindered. Under basic conditions, the least hindered 
primary hydroxyl group can typically be manipulated selectively. Of the 
secondary hydroxyls, the equatorial ones tend to be more reactive than the axial. 
The reactivity of the hydroxyl groups can, however, be modified by appropriate 
selection of protecting groups. 
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Figure 1.8. The different types of hydroxyl groups in D-glucose. 
While manipulations not involving protecting group chemistry would often be 
preferred, from an atom economical point of view, it is typically not possible due 
to the very similar reactivities of the hydroxyl groups, which would lead to a 
complex mixture of products. Because of this, the hydroxyl groups not targeted 
for the modification typically have to be blocked with protecting groups. 
Traditionally, synthetic carbohydrate chemistry relies heavily on protecting 
groups, and there are several factors that have to be taken into consideration 
when designing a synthetic strategy, such as stability, order of introduction, and 
orthogonality. The protecting groups should be stable enough to remain intact 
during subsequent transformations, but possible to remove without affecting the 
other protecting groups present. 
Protecting groups are generally divided into two categories, permanent and 
temporary protecting groups. Permanent protecting groups stay on the molecule 
until the end, when they are preferentially all removed in one single step. 
Temporary protecting groups are groups that can be removed selectively, 
without affecting the other protecting groups. 
1.4 Creating glycosidic linkages 
The perhaps most important aspect of carbohydrate chemistry, is the creation of 
new glycosidic linkages between carbohydrates, or between a carbohydrate and 
some other molecule, commonly referred to as an aglycon. There are several 
ways of preparing these types of linkages, and the earliest example of chemical 
glycosylation is by Arthur Michael who reacted potassium phenolate with 
2,3,4,6-tetra-O-acetyl-D-glucopyranosyl chloride to form phenyl D-
glucopyranoside.
14
 
 
 
Introduction 
9 
 
1.4.1 Enzymatic methods 
In nature, glycosidic bonds are created by enzymes, so-called 
glycosyltransferases, which attach carbohydrates to various other structures, 
including proteins and other carbohydrates. These enzymes, are highly selective 
and do not require protecting groups, but each type of linkage requires its own 
enzyme. During recent years, enzymatic oligosaccharide synthesis has received 
considerable attention, and a multitude of complex structures have been 
prepared. A more detailed view of the use of enzymes in synthetic carbohydrate 
chemistry is beyond the scope of this thesis, but an overview can be found in the 
reviews by Liang et. al.
15
 and Lairson et. al.
16
 
Enzymatic methods are useful, but do suffer from some drawbacks, such as high 
cost of enzymes and difficult scale up of the synthesis. Because of this, the most 
reliable method for preparing oligosaccharides for biological purposes is 
typically traditional carbohydrate synthesis. 
1.4.2 Chemical glycosylation 
While numerous ways of creating glycosidic linkages have been developed, 
most of them are based on the same principle. One molecule, called the glycosyl 
donor, has a good leaving group at the anomeric position. The other molecule 
involved in the glycosylation, called glycosyl acceptor, has a nucleophilic 
functionality, such as an alcohol or thiol. The donor is activated by a promotor, 
typically a Lewis acid, which forms an oxocarbenium ion that is attacked by the 
nucleophile (Scheme 1.2). One of the most simple examples of chemical 
glycosylation is the so-called Fischer glycosylation,
17–19
 originally reported by 
Emil Fischer in the 1890s, where an unprotected sugar is dissolved or suspended 
in a solvent that can also act as the acceptor, such as methanol, in the presence of 
an acid catalyst. This leads to the formation of a mixture of α and β anomers, 
where the ratio depends on the thermodynamic stability of the anomers, the α 
anomer typically being the predominant one. 
Later, in 1901, Wilhelm Koenigs and Eduard Knorr reported a new method for 
glycosylation, using glycosyl halides that could be activated towards 
glycosylation by heavy metal halophiles, such as silver carbonate.
20
 This 
method, which is still used today, became known as Koenigs-Knorr 
glycosylation. 
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Scheme 1.2. General scheme for a glycosylation reaction. 
While both Fischer glycosylations and Koenigs-Knorr glycosylations still find 
their use today, new methods are constantly being developed and there are a vast 
number of different reaction protocols suitable for different applications. The 
most commonly used methods still rely on the same donor/acceptor principles, 
however. Some selected glycosyl donors can be seen in Figure 1.9.
21
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Figure 1.9. Selected glycosyl donors. From left to right: glycosyl acetates, glycosyl 
halides, glycosyl trichloroacetimidates, thioglycosides, glycosyl phosphates. 
The oxocarbenium ion that is initially formed has a planar geometry, and thus 
the attack of the nucleophile can come from either side and the product can be 
either an α-glycoside or a β-glycoside. Typically, only one of the stereoisomers 
is the desired product, and because of this, stereoselective synthetic protocols are 
required to minimize the formation of unwanted products. Stereoselectivity in 
glycosylation reactions, has thus over the years been one of the major research 
areas of chemical glycosylation. 
Great care should be taken when designing a protecting group strategy for 
chemical glycosylation, as it is one of the most powerful ways of controlling the 
stereochemical outcome of the reaction. Using participating protecting groups, is 
the simplest way of controlling the anomeric configuration of the final product. 
A participating group, such as an ester group, on the carbon atom next to the 
anomeric center can greatly enhance the stereoselectivity of the reaction. The 
carbonyl functionality of the ester can act as a temporary nucleophile and form a 
five-membered ring that blocks a nucleophilic attack from one side of the ring 
(Scheme 1.3). 
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Scheme 1.3. Neighboring group participation used for controlling the stereochemical 
outcome of a glycosylation reaction. 
In some cases, depending on the reaction conditions, the intermediate can form 
stable orthoesters, in particular when secondary alcohols are used as acceptors.
22
 
This inevitably leads to some loss of yield. 
The use of ester protecting group on C-2 allows for simple preparation of so-
called 1,2-trans glycosides (although there are some reports
23,24
 where they have 
been used for preparing 1,2-cis glycosides as well), where the substituents on 
carbon atoms 1 and 2 are on opposite sides of the ring. There are, in general, no 
equally simple methods for preparing 1,2-cis glycosides, where the substituents 
on carbon atoms 1 and 2 are on the same side of the ring. Developing new 
methods for such reactions is one of the driving forces of progress in synthetic 
carbohydrate chemistry. 
While 1,2-cis glycosides are generally considered difficult to prepare, over the 
years a number of different methodologies have been developed. One of the 
most important aspects of 1,2-cis glycosylation is the glycosyl donor and the 
intermediate it forms.  
Neighboring group participation can also be used for preparing 1,2-cis 
glycosides, as demonstrated by Boons et. al.
25,26
 who used a particular 
participating group at carbon two, (S)-phenyl-thiomethylbenzyl ether. Upon 
activation of the donor, the protecting group forms a six-membered ring that 
blocks the β-face of the activated glucopyranosyl donor, resulting in high 
selectivity towards α-glucosides. 
In addition to neighboring group participation, protecting groups further away 
from the anomeric center can also have an effect on the glycosylation reaction. 
Particularly the substituents at C-3 and C-6 have been shown to be able to 
significantly alter the α:β ratio of the products.27,28 
The solvent used in the reaction also plays a part in the stereochemical outcome 
of the reaction.  In general, ethereal solvents have been shown to direct the 
reaction towards the α-glycoside, whereas nitrile solvents favor the formation of 
β-glycosides. While the effect is typically not very strong,29,30 it has in some 
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cases been shown to have a significant effect on stereochemical outcome of the 
reaction.
31
 
A large part of the published research about 1,2-cis glycosylations focus on 
making α-glycosides. In these cases, the anomeric effect helps by making the 
target product thermodynamically favorable. Making β-linked 1,2-cis 
glycosides, such as β-mannosides,  is typically even more difficult. A specific 
case of such 1,2-cis glycosides, β-(1→2) linked mannosides, will be a recurring 
theme throughout this thesis, and the synthesis will be discussed in more detail 
in the next chapter. 
This has been a short, and in no way complete, overview of some of the methods 
available for preparing 1,2-cis glycosides. For a more comprehensive overview 
the reader is referred to for example the reviews by S. S. Nigudkar and A. V. 
Demchenko.
32,33
 
1.4.3  Automated synthesis 
Automated synthesis of peptides has been available since the 1960s,
34,35
 and the 
first automatic oligonucleotide synthesizer was built in the late 1970s. The 
linearity, and limited structural variation of these classes of molecules, makes 
them optimal for an automated process. In essence, one would only need one 
variation of each building block to make any sequence of peptides or 
nucleotides. The possibility of branching, and stereochemical variations of 
carbohydrates, makes oligosaccharides exponentially more complicated. While it 
is true, that a particular linear oligosaccharide could be made using only single 
building block, such structures are not always of high biological relevance. 
Any polypeptide or polynucleotide can be constructed from 20 or four building 
blocks respectively. A hexapeptide could thus be constructed in 20
6
 (=64 
million) different ways, and a hexanucleotide in 4
6
 (=4096) different ways. It has 
been calculated, that a hexasaccharide based on the ten mammalian 
monosaccharides, however, could due to branching and stereochemical 
variation, theoretically be constructed in 192 000 000 000 different ways.
36
 The 
number of possible structures for oligosaccharides is, thus, more than three 
orders of magnitude greater than the number of polypeptides consisting of the 
same number of monomeric units. 
While each new peptide or nucleotide coupling can be made under more or less 
identical conditions, the creation of different types of glycosidic linkages often 
requires very different conditions in terms of solvent, temperature and reagent 
Introduction 
13 
 
systems.
37
 Contrary to oligopeptides and oligonucleotides, one single variation 
of a specific monosaccharide is not sufficient for creating all oligosaccharides 
containing such a monomer unit.
38
 One of the largest obstacles in 
oligosaccharide synthesis is the requirement for a vast library of glycosyl 
donors, with carefully designed protecting group strategies. It has been 
estimated, that 36 monosaccharide building blocks would be required for 
preparing 75% of the mammalian polysaccharides, and to create 90% of the 
polysaccharides, 65 different monosaccharide building blocks would be 
required.
36
 
The general principle of automated synthesis is that the polysaccharide to be 
constructed is attached to a support that can be used to easily separate the 
reaction product from the reaction mixture. Typically, this support is attached to 
the reducing end of the sugar. The activated donors are highly reactive 
molecules, and thus more susceptible to undesired side reactions. By attaching 
the acceptor to the support, the byproducts can more easily be separated from the 
product. The supports can be divided into soluble
39
 and insoluble, of which the 
insoluble ones have by far been more utilized. Regardless of whether one uses 
soluble or insoluble tags, the principle for the synthesis is the same, and can be 
divided into five distinct steps (Scheme 1.4): 
1) a) Attachment of a solid or fluorous tag for easy purification. 
b) Selective deprotection of one or more hydroxyl groups for further 
modifications. 
2) Chain growth by addition of glycosyl donor and promotor. 
3) Selective deprotection of one or more hydroxyl groups for further 
modifications. 
4) Purification of the intermediate by filtration or FSPE. 
 
Steps 2 – 4 are repeated until the oligosaccharide has been assembled. 
 
5) The oligosaccharide is detached from the support, the remaining 
protecting groups are removed, and the final product is purified, 
typically by HPLC methods. 
Even though the synthesis of oligosaccharides in this manner simplifies the 
purification of the intermediates, the automated synthesis introduces some new 
problems regarding the analysis of intermediates, and purification of final 
products. Typically, all intermediates in oligosaccharide synthesis would as a 
minimum be analyzed by HRMS and fully characterized by NMR spectroscopic 
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methods. Insoluble compounds are difficult, if not impossible, to analyze in this 
manner, which means that an aliquot of reasonable amount of the growing 
oligosaccharide is typically cleaved from the support and characterized.
40
 
Furthermore, as very few glycosylation reactions are fully stereoselective, each 
addition of a new monosaccharide unit will generate two diastereomers. For 
creating a hexasaccharide as in the previous example, five glycosidic bonds need 
to be created (excluding the step where the first monosaccharide is attached to 
the support). As each step creates two compounds, the number of compounds 
after the final deprotection is 2
5
 (=32) of which typically only one is the target 
compound. In traditional synthesis, the overall number of diastereomers 
produced would be 2 × 5 (=10), and these would be separated two at a time after 
each glycosylation reaction, whereas on solid support the unwanted anomers 
(and other side products, including deletion sequences) accumulate throughout 
the synthesis. 
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Scheme 1.4. Automated oligosaccharide synthesis. 
Automated synthesis has been used to prepare some rather impressive structures, 
such as for example the fully protected Le
y
-Le
x
 nonasaccharide depicted in 
Figure 1.10.
41
 Many of the challenges with traditional synthesis remain, 
however. The requirement for a large number of building blocks required for 
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preparing arbitrary oligosaccharides is an intrinsic one that is not easily 
overcome. 
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Figure 1.10. Fully protected Le
y
-Le
x
 nonasaccharide prepared by automated synthesis. 
1.5 Biological importance of carbohydrates 
Carbohydrates are one of the four major classes of biomolecules, the other three 
being nucleotides, peptides and lipids. While this is the classification that is 
typically used, the distinction is not always so straightforward. In nature, 
carbohydrates are often found as glycoconjugates; glycosides covalently bound 
to other types of molecules, such as proteins or peptides (glycopeptides, 
glycoproteins and peptidoglycans) and lipids (glycolipids and 
lipopolysaccharides). 
The most abundant biomolecule on earth is cellulose, an important structural 
component of the cell wall of green plants, consisting of β-(1→4) linked glucose 
units. A very similar polysaccharide, consisting of N-acetylglucosamine linked 
in the same fashion, chitin, makes up the exoskeletons of arthropods. 
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Figure 1.11. Structures of cellulose and chitin. 
Carbohydrates mediate and regulate a wide range of critical biological processes, 
such as cell communication, cell adhesion, inflammation, protein function, 
fertilization,
42
 and many others. Typically, a cell expresses a multitude of 
different carbohydrates on its surface. Diseases or disorders can cause changes 
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in the carbohydrates expressed on a cell, which makes carbohydrates excellent 
biomarkers for tracking changes in living systems. 
1.5.1 Carbohydrates as diagnostic tools 
The distinction of native and foreign cells in our bodies is largely based on the 
carbohydrate biomarkers on the surface of cells. One of the most commonly 
used examples of this, is the ABO blood group system. In a very simplified 
manner, our blood types can be separated into four categories, (A, B, AB and O) 
based on the glycans on the surface of our blood cells. Individuals with blood 
group A, express A antigens on the surface of their blood cells, individuals with 
blood group B, express B antigens and individuals with blood group AB express 
both A and B antigens. Individuals with blood group O, express an H antigen on 
the surface of their blood cells. This H antigen is a disaccharide precursor to the 
A and B antigens (Figure 1.12). 
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Figure 1.12. ABO blood group antigens. 
The existence of different blood groups, was originally discovered in the 
beginning of the 20
th
 century by Karl Landsteiner, who discovered blood groups 
A, B and O in 1900
43–45
 followed by Alfred von Decastello and Adriano Sturli, 
who discovered the AB blood type in 1902.
46
 A few years later, in 1907 Jan 
Jaský,
47
 and in 1910 William Lorenzo Moss, 
48
 published similar findings. The 
discoveries showed that humans could be divided into different categories 
depending on whether their blood serum contained components that would 
agglutinate red blood cells from other humans. At the time, it was not known 
that the antigens were glycans, however, and it was not until the work of Morgan 
and Watkins in the 1940s and 1950s, that the actual structures were 
determined.
49–51
 Since the discovery of different blood types, the complications 
associated with blood transfusions have diminished significantly and countless 
lives are saved on yearly basis. While the ABO classification of blood types is 
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the most common one, there are, in fact, over 30 different human blood group 
systems, the majority of which involve carbohydrates. 
One of the most active areas of research involving carbohydrate biomarkers is in 
cancer research. Cancer is a group of diseases associated with abnormal and 
uncontrolled growth of cells. It is one of the biggest medical problems of the 
modern world, and according to a report by the World Health Organization there 
were 14.1 million new cancer cases, and 8.2 million deaths due to cancer in the 
year 2012.
52
 It is the second most common cause of death after cardiovascular 
and circulatory diseases.
53
 
Upon transforming into a cancerous cell, the expression of carbohydrates on the 
cell surface changes, typically towards overexpression of certain carbohydrates. 
These carbohydrates, which can stay on the cell surface, or be shed into 
circulation, are commonly referred to as tumor-associated carbohydrate antigens 
(TACA). Over the years a number of TACAs have been identified,
54
 and the 
most common of these is the Tn  antigen.
55
 The Tn antigen was reported as a 
TACA in the late 1970s,
56
 and has since then been the focus of numerous 
investigations.
55,57,58
 Structurally, it is a GalNac moiety α-linked to a serine or 
threonine residue of a polypeptide, and it has been reported to be found on the 
cell surface of 90% of solid tumors.
56
 The Tn antigen also acts as a precursor for 
a number of other carbohydrate TACAs, such as sTn, TF, sTF and di-sTF which, 
in addition to the Tn structural, unit also contain additional galactose and sialic 
acid residues. 
In addition to the Tn-based TACAs, there are a number of others that have been 
studied extensively, such as Globo H, the Lewis blood group antigens and their 
sialylated analogues; sLe
a
, sLe
x
, and Le
y
, as well as the ganglioside based 
structures GM2, GD2, and GD3.
59
 Examples of the structures of some TACAs 
can be seen in Figure 1.13. 
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Figure 1.13. Examples of TACAs. 
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The search for new carbohydrate biomarkers is an ongoing process, and while 
the majority of research in carbohydrate biomarkers is  focused specifically on 
biomarkers for cancer, there are several promising applications in various 
metabolic disorders,
60–62
 infectious diseases,
55
 inflammation etc. The immense 
effect of minute differences in carbohydrate structures, as exemplified by the 
violent reaction of our bodies towards foreign blood groups, shows the great 
potential of carbohydrate biomarkers as diagnostic tools.  
Throughout history, bodily fluids have been used for diagnosis of diseases.
63
 
Even though it was not known at the time, carbohydrates have been used for 
diagnosing type I diabetes for 3.5 millennia. Urine from persons with diabetes 
was found to attract ants and flies, which caused Indian physicists to name it 
madhumeha or “honey urine”. In 1670 Thomas Willis, an English doctor, found 
that the urine from diabetes patients tastes sweet, and in 1776 it was shown, by 
the British physiologist Matthew Dobson, that the sweet taste was caused by 
sugar.
64
 Nowadays measuring the glucose content in urine is not considered 
reliable, and thus blood is used instead. 
Since ancient times the analytical methods have, of course, evolved and today 
we have access to powerful methods, such as proteomics, antibody screening, 
mass spectrometry and nuclear magnetic resonance.
65–68
 Interdisciplinary 
collaborations have enabled the detection of smaller amounts, a wider range of 
different carbohydrate-based biomarkers, as well as accurate structural 
determination of them.  
1.5.2 Pharmaceutical applications and immunological aspects 
With carbohydrates being involved in a wide range of biological processes, it is 
a very logical step to try to take advantage of these properties for treatment of 
various conditions as well. Carbohydrates do, however, suffer from some severe 
inherent draw-backs that limit their applicability as pharmaceuticals. The major 
problem is their high polarity, which limits their uptake due to their inability to 
passively cross the enterocyte layer of the small intestine. This makes oral 
administration difficult, if not impossible, in many cases. While the problems 
with uptake can be circumvented by parenteral administration, the high polarity 
remains a problem as it leads to fast renal excretion and, consequently, short 
biological half-lives.
69
 
Despite the problems with uptake and pharmacokinetics, carbohydrates and 
carbohydrate-based structures have, over the years, found widespread clinical 
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use as antithrombotics, anticoagulants, antibotics, antiviral drugs as well as for 
treatment of diabetes, epilepsy, osteoarthritis and several other conditions.
70
 In 
this section, a few selected examples of carbohydrate-based pharmaceuticals will 
be presented. 
It is not possible to discuss carbohydrate-based pharmaceuticals without 
mentioning glycosaminoglycans (GAG). GAGs were first described, almost two 
centuries ago, by J. Müller who isolated chondrin, (later renamed chondroitic 
acid) from cartilage. Almost a century later, heparin (Figure 1.14), a highly 
sulfated GAG consting of alternating glucosamine and uronic acid (iduronic acid 
and glucuronic acid) units connected via (1→4) linkages, was discovered. The 
actual discovery is somewhat debated, but typically Jay McLean, working under 
William Howell at John Hopkins University, is credited. Heparin was found to 
have significant anticoagulant properties, and became commercially available in 
the 1920s, making it the oldest carbohydrate-based drug. The original 
preparation had some significant side-effects, such as headache, fever and 
nausea and even after development of better isolation procedures, which allowed 
for a more pure product, problems with a short biological half-life, and side-
effects in the form of bleeding and thrombocytopenia remained. Heparin with 
lower molecular weight, produced by enzymatic fragmentation, was shown to 
cause significantly fewer side-effects, and after the active component of heparin, 
a pentasaccharide fragment, was determined the first total syntheses of the 
fragment were developed in the 1980s.
71,72
 In 2002, a fully synthetic heparin 
pentasaccharide, fondaparinux, marketed under the name Arixtra, entered the 
market and since then a number of analogues have been developed.
73
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Figure 1.14. The active pentasaccharide fragment of heparin. 
Antibiotics are generally defined as a class of compounds of fungal or bacterial 
origin, which inhibit the growth of other microorganisms.
74
 The definition has 
come to include also semisynthetic and synthetic products.
75
 Generally, the 
carbohydrate-based antibiotics can be divided into two groups: so-called 
aminoglycoside antibiotics (e.g. streptomycin and neomycins),
76
 where the 
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carbohydrates are glycosidically linked to cyclitols or aminocyclitols, and 
orthosomycins,
77
 which consist of polysaccharides where, in addition to normal 
glycosidic linkages, the monosaccharide units can also be connected via 
orthoester linkages (e.g. flambamycin). In addition to these two main classes of 
carbohydrate-based antibiotics, this class of compounds contains molecules 
where carbohydrates are glycosidically linked to non-carbohydrate antibiotics, 
such as macrolides (e.g. erythromycin).
74
 
In addition to carbohydrates being used as pharmaceuticals as such, there a many 
cases where carbohydrates are used as starting points, and selectively modified 
to eliminate the problems commonly associated with carbohydrate-based 
pharmaceuticals. One particular example of such glycomimetic drugs, is 
oseltamivir (Tamiflu), which is based on the structure of Zanamivir, which in 
turn was developed from N-acetylneuraminic acid.
78
 While the design of the 
compound is based on a carbohydrate precursor, the final molecule no longer fits 
the definition of carbohydrates. Some selected examples of carbohydrate-based 
and carbohydrate-derived pharmaceuticals can be seen in Figure 1.15 below. 
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Figure 1.15. Examples of carbohydrate-based and carbohydrate-derived 
pharmaceuticals. 
Most diseases are treated directly by pharmaceuticals and this practice has, over 
the years, led to serious problems. At least partially due to excessive use of 
antibiotics, some diseases are becoming increasingly more difficult to treat due 
to mutations and gene exchange, which has made some bacteria resistant to 
antibiotics. The development of new antibiotics has not been able to keep up 
with the speed at which bacteria develop resistance, and there are several strains 
of life-threatening diseases that are resistant to most, if not all, known 
antibiotics, for example, Enterococcus faecalis,
79
 Mycobacterium tuberculosis
80
 
and Pseudomonas aerudinosa.
81
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Our immune system is an effective weapon against foreign cells, and is able to 
eventually defeat most common pathogens. The first time our bodies encounter a 
specific pathogen, the immune response is a complicated cascade of reactions. A 
detailed description is beyond the scope of this thesis, but this complex 
mechanism, while ultimately effective, is rather slow compared to the rate at 
which the pathogen can multiply, and thus our bodies do not have enough time 
to defeat certain infections before they become a serious threat to our health. 
Furthermore, there are pathogens that do not cause a significant immune 
response, even if present in dangerous amounts. One example is the anaerobic 
bacterium Clostridium tetani that releases tetanospasmin, a potent neurotoxin. 
The toxin is so potent that even a lethal dose is insufficient to trigger an immune 
response.
82
 
As mentioned earlier, the surface of cells is covered with glycan structures, 
herein referred to as antigens. The antigens on foreign cells are different than 
those of native cells. These structures are recognized by the immune system, 
which produces specific antibodies, also known as immunoglobulins, to target 
the antigens. These antibodies, bind to the pathogen, deactivating it and marking 
it for disposal. Some of the cells that produce the specific antibodies develop 
into so-called memory cells, which can be rapidly activated upon subsequent 
infection. 
One of the most important breakthroughs in medicine throughout history is the 
invention of vaccines. Vaccines are used to trigger an immune response, in order 
to teach the immune system to combat a pathogen. This can, in general, be 
achieved in two ways: using whole cells that have been weakened or killed, or 
using only the antigenic polysaccharide or protein fragments from the cell 
surface.
83,84
  
The easiest way of preparing vaccines is to use killed or attenuated pathogens. 
Live microorganisms are typically more efficient than killed ones, due to a 
stronger immune response as a result of more sustained dose of antigen. There 
are, however, some problems and risks associated with using whole pathogens as 
vaccines. The attenuated pathogen might revert back to the virulent form and 
cause an infection. Furthermore, an entire pathogen will contain more than just 
the antigens required for the protective response. These additional components 
might suppress the immune response towards the protective antigens, or in the 
worst case they might cause side reactions in the form of hypersensitivity.
83
 
Furthermore, while growing viruses and bacteria in bulk quantities, is in general 
not very difficult, the same is not true for pathogens such as parasitic worms. 
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Antigenic fragments, associated with certain pathogens, can be acquired via 
either purification of samples of biological origin, or by synthetic methods. The 
glycans on the surface of cells are, however, inherently highly heterogenic, 
which can cause problems due to the high specificity of antibodies. If an 
antibody only binds to a specific part of a glycan, heterogeneity will inevitably 
dilute the response. Furthermore, high heterogeneity induces problems with 
purification and batch-to-batch variations. Synthetic approaches bypass these 
problems, and although the synthetic procedures might be laborious, they at least 
technically allow for large-scale production of highly pure compounds. There 
are some inherent problems associated with the use of carbohydrate fragments as 
vaccines, besides those related to the heterogeneity of native polysaccharides. 
Polysaccharides are typically poorly immunogenic, especially among young 
children, and have to be conjugated to an immunogenic carrier protein. The 
interactions between carbohydrates and proteins are generally quite weak, and 
achieving binding at physiological concentrations is difficult.
83
 This problem 
can, however, often be solved by multivalency, where several antigens are 
attached to a scaffold, which has been shown to enhance binding to a larger 
extent than a simple increase in the concentration of the ligand.
85,86
 
There are a number of carbohydrate-based vaccines available that offer 
protection against various pathogens, e.g. Salmonella typhi, several strains of 
Streptococcus pneumoniae and Haemophilus influenzae type b (hib). In addition, 
there are a number of carbohydrate-based vaccines in different stages of clinical 
trials.
87
 Of these vaccines, hib vaccine is the most noteworthy as it is based on a 
fully synthetic carbohydrate antigen. 
The goal of this brief discussion about the biological importance of 
carbohydrates is not to be a comprehensive overview of current literature, but 
rather to show their importance with selected examples. From the examples 
presented here, it should be evident that for understanding the biological 
interactions, knowledge about the structure and behavior of the carbohydrates in 
a biological environment is crucial. A particular class of oligosaccharides, β-
(1→2) linked mannosides, and their biological importance and potential 
applications will be discussed in more detail in the following chapters. 
Modern analytical tools, particularly NMR spectroscopy, allow accurate 
determination of the structure of carbohydrate structures found in nature. The 
amount of material available by isolation from biological sources is, however, 
typically insufficient to be of use in comprehensive biological studies. The 
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synthetic methods developed over the years, allow chemists to prepare well-
defined, pure, compounds for biological studies. 
1.6 Outline of this thesis 
This thesis is based on the work done by the author at the Laboratory of Organic 
Chemistry, at Åbo Akademi University from 2013 – 2017. The thesis features all 
the most common aspects of carbohydrate chemistry: Synthesis, 
characterization, and biological applications, and tackles the challenges 
associated with each of these. 
Chapter 2 explores in detail the synthesis of β-(1→2) linked mannosides, which 
are a recurring theme throughout the thesis. Different methods for creating the 
cis-glycosidic linkage from mannose are discussed, and a versatile synthetic 
protocol, the Crich β-mannosylation reaction, is selected. Key features of the 
building blocks required for the synthesis are discussed, and different methods 
for introducing a phosphate group are explored. The methods are then applied 
for preparation of a β-(1→2) mannotriose and tetraose, with a phosphate group 
at the reducing end, which are then used for investigating how the phosphate 
group might affect the unique conformation of this class of compounds. 
Application of NMR spectroscopy for structural verification and conformational 
analysis is emphasized. 
Chapter 3 applies the concepts of chapter 2 for preparing multivalent structures 
featuring β-(1→2) linked mannosides, using click chemistry. The compounds 
are based on a previously discovered biologically active lead molecule, and two 
new trivalent glycoclusters with varying linker length are prepared, and their 
biological activity is evaluated to investigate the impact of the linker length. A 
brief overview of allergic inflammation is provided, and the potential of using 
the prepared glycoclusters as adjuvants for specific allergen immunotherapy is 
evaluated. The behavior of the compounds in solution is investigated with NMR 
spectroscopic and molecular modelling techniques. 
Chapter 4 further expands the concept of multivalency by grafting various 
disaccharide fragments onto a polysaccharide-based backbone, using techniques 
discussed in chapter 3. The interactions between the modified polysaccharides 
and a protein, human Galectin-3, are evaluated by NMR spectroscopic 
techniques. The aim here is to investigate the claims of Gal-3 binding to β-
(1→2) linked mannosides, and the general potential of using polysaccharides as 
scaffolds for carbohydrate-based ligands. An investigation of the applicability of 
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the click reaction for controlled depolymerization of polysaccharides, prompted 
by an unexpected decrease in size of the polymers during the reaction, is carried 
out using three naturally occurring polysaccharides 
NMR spectroscopy, which is a particularly powerful analytical tool in 
carbohydrate chemistry, is heavily featured throughout the thesis. Accurate 
chemical shifts and coupling constants, are extracted from the spectra by 
quantum-mechanical simulations using the NMR simulation software PERCH. 
In addition to structural verification, NMR spectroscopy is used for investigating 
the conformational behavior of the target molecules, and interactions between 
polyvalent carbohydrate structures and proteins. 
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2 Oligosaccharides: The almighty mannose 
 
Candida albicans is one of the few organisms that express β-(1→2) linked 
mannosides on its cell surface. This class of compounds is known to be highly 
immunogenic, and considerable effort has been focused on developing vaccines 
against C. albicans based on these structures. This chapter explores the synthesis 
of β-(1→2) linked mannotriose and tetraose with a phosphate group at the 
reducing end, analogous to the acid-labile mannan portion of the C. albicans cell 
wall polysaccharide. The conformations of the prepared compounds in solution 
are investigated, and the impact of the charged phosphate group on the 
conformation is evaluated. 
 
 
 
 
 
This chapter is based on the previously published paper: Synthesis and 
conformational analysis of β-(1→2)-linked phosphorylated mannosides, J. 
Rahkila, F. S. Ekholm, R. Panchadhayee, A. Ardá, F. J. Cañada, J. Jiménez-
Barbero, R. Leino, Carbohydr. Res. 2014, 383, 58 – 68.  
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2.1 Introduction 
Candida is a genus of fungi, with a large number of species that are responsible 
for an increasing number of invasive fungal infections. Most people carry these 
fungi, and they are considered part of the human microbial flora.
1
 While they 
can cause yeast infections in healthy people, these infections do not typically 
become invasive, or pose any serious threat. In immunocompromised individuals 
e.g. HIV patients,
2
 people undergoing prolonged antibiotic treatment, and organ 
transplant receivers treated with immunosuppressant drugs,
3
 however, they can 
cause serious infections. The infections caused by Candida are commonly called 
candidosis or candidiasis. 
During the last 30 years, there has been a significant increase in invasive fungal 
infections of which the vast majority, more than 95%, are caused by Candida 
spp. or Aspergillus spp.
4,5
 One contributing factor to the increased number of 
invasive infections, is the increasing resistance to antifungal drugs.  
The most common species of the Candida species is C. albicans, the cell wall of 
which contains a glycoprotein consisting of α-(1→6) linked mannopyranan with 
branches of α-(1→2), α-(1→3), and additional α-(1→6) linked mannopyranosyl 
units. What makes the cell wall especially interesting, is the fact that some of the 
branches terminate in β-(1→2) linked mannopyranosyl fragments (acid stable β-
mannan). Additionally, there are β-(1→2) linked mannans connected via a 
phosphodiester linkage to C-6 on the side chains (acid labile β-mannan). The 
entire polysaccharide is attached via N-linked glycan core to N-acetyl 
glucosamine, that is connected to an asparagine residue on the glycoprotein 
(Figure 2.1).
6–8
 
2.2 Immunochemistry of β-(1→2) linked mannosides 
The cell wall of C. albicans has been found to be highly immunogenic,
9,10
 and 
compelling evidence suggests that it is the β-(1→2) linked mannans that are the 
main source for the effect. Immunoglobulin M (IgM) monoclonal antibody 
(MAb) B6.1, has been shown to protect mice from disseminated candidiasis. 
Another antibody, IgM MAb B6, on the other hand, does not offer such 
protection.
11
 While the antibodies are of the same type and both bind to the cell 
wall of C. albicans, their epitope specificities differ. The protecting IgM MAb 
B6.1 antibody binds the acid labile fraction of the cell wall mannan, whereas 
IgM MAb B6 does not. Furthermore, another monoclonal antibody IgG3 MAb 
C3.1 also offers protection against candidiasis in mice.
12
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Figure 2.1. Structural representation of the C. albicans cell wall mannan. 
The immunogenic activity of the β-(1→2) linked mannans has prompted 
rigorous investigations towards potentially using them for treatment or 
prevention of candidiasis. Bundle et al. have determined that the affinities of the 
aforementioned antibodies is greatest towards disaccharides and trisaccharides, 
and decreases rapidly for larger fragments.
13
 This is due to the unique 
conformation of β-(1→2) linked mannosides, which will be discussed in more 
detail below. Binding of larger fragments would require energetically 
unfavorable conformational adjustments of the oligosaccharides. Molecular 
modelling of a tetrasaccharide fragment (Figure 2.2) spanning the 
phosphodiester linkage found in the native C. albicans mannan suggests that, 
while the phosphate group is not crucial for the binding, the α-linkage to the 
phosphate allows the tetrasaccharide to make greater contact with the antibody. 
Synthesis of the fragment and binding studies indicated, however, that this does 
not increase the binding affinity.
14
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Figure 2.2. Mannotetraose derived from the C. albicans cell wall, prepared and 
investigated by Bundle et. al. 
The immunochemical properties of β-(1→2) linked mannosides have been 
studied in detail, and the potential applications of this class of compounds as 
vaccines have been investigated. As mentioned in the previous chapter, 
carbohydrates alone are typically not highly immunogenic. Therefore the 
vaccines have been based on glycoconjugates where the carbohydrate is 
covalently attached to a protein
12,15,16
 or a shorter glycopeptide chain.
17
 
Immunization with such vaccines has shown to protect mice and rabbits against 
candidiasis, but they have not yet entered clinical trials. 
2.3 Synthesis of β-(1→2) linked mannosides 
The preparation of β-mannosides was for long considered one of the greatest 
challenges in synthetic carbohydrate chemistry,, and still today it is far from 
trivial. There are several factors that contribute to the particular difficulties 
associated with the synthesis of this class of compounds. β-Mannosides are cis 
glycosides, which makes the use of neighboring group participation difficult. 
Furthermore, the stabilizing effect of the anomeric product makes the α-anomer 
more favorable from a thermodynamic point of view and, finally, the β-face of 
the oxocarbenium ion transition state is typically more hindered than the α-face, 
making the α-anomer kinetically favored as well.  
Over the years, a number of methods for creating such linkages have been 
developed.
18–20
 While many of these methods are highly creative, it is difficult to 
find one universal synthetic protocol for preparing these compounds. Many of 
the published methods are to be regarded with some caution, as they are 
developed having rather simple or very specific acceptors in mind. These are 
quite often unsuitable for bulkier and otherwise more complex acceptors, such as 
monosaccharides or larger carbohydrate structures. 
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One method that has found widespread use is the preparation of β-glucosides 
followed by stereochemical inversion of C2 via an oxidation-reduction 
sequence. This method, originally developed by Lichtenthaler et al.
21
 has been 
used extensively by Bundle et al. for preparation of β-(1→2) linked mannosides 
for developing a C. albicans vaccine.
22–24
 Using glucopyranosyl donors allows 
for taking advantage of neighboring group participation of an ester protecting 
group on C2. After the reaction the protecting group is hydrolyzed, and the 
alcohol is oxidized to a ketone, typically by Swern oxidation,
25
 followed by 
reduction with a bulky reduction agent, such as L-selectride, resulting in hydride 
addition from the least hindered side, yielding an axial hydroxyl group (Scheme 
2.1). 
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Scheme 2.1 The method for preparation of β-mannosides used by Bundle et al.24 
Reagents and conditions: i) 1. AgOTf, 4 Å MS, toluene, CH2Cl2, –40 °C (74%), 2.  
NaOMe, MeOH, rt, (96%); ii) DMSO, (COCl)2, Et3N; iii) L-selectride, THF (73%).  
Many of the modern strategies for preparing β-mannosides are based on 
modification of the transition state of the activated glycosyl donor. Generally 
SN1-like reactions will prefer the α-product, and a shift towards SN2-type 
reactions would thus be preferred. Destabilizing the oxocarbenium ion 
intermediate will favor SN2-type reactions. This destabilization can be achieved 
by electronic effects, or physical constraints that prevent the molecule from 
attaining the 
4
H3 conformation that is postulated as the preferred one of the 
oxocarbenium ion.
26
 Upon reaction with a nucleophile, the ring will twist into a 
favored 
4
C1 conformation or a disfavored 
1
S3 conformation, depending on if the 
nucleophile attacks from the α or β-face (Scheme 2.2).26,27 
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Scheme 2.2. Conformational changes of the oxocarbenium intermediate associated with 
the SN1 mechanism. 
A popular method, used by several groups, for preventing the intermediate from 
attaining a 
4
H3 conformation is to use a 4,6-tether, a second ring structure that 
fixes the geometry of O5-C5-C6-O6 in a trans-gauche (tg) conformation. This 
also maximizes the electron-withdrawing effect of O6. While the oxocarbenium 
ion is destabilized by the conformational restriction and the electron-deficiency 
in the ring, the mechanism of the reaction is shifted towards a synchronized 
reaction, but is never purely SN2. The additional benefit of a 4,6-tether is that the 
oxocarbenium ion that does form, is assumed to have a B2,5
28,29
 conformation, 
which makes a nucleophilic attack from the α-face less favored. 
Finally, the method selected for this work was the so-called Crich method,
18,30
 
where an α-triflate is used as the donor in combination with a 4,6-O-benzylidene 
acetal. The electron withdrawing effect of O6 destabilizes the oxocarbenium ion 
favoring a covalent or contact ion pair α-triflate that can undergo an SN2-type 
reaction instead of SN1. Originally, the method used glycosyl sulfoxides 
preactivated by triflic anhydride (Tf2O) to form the α-triflate before adding the 
acceptor.
31–34
 Later, the method was developed further, and thioglycosides are 
now typically used as donors.
35
 The activation protocol typically uses 1-
(phenylsulfinyl)-piperidine (BSP) and triflic anhydride, but other sulfoxides, 
such as diphenylsulfoxide, can be used to reduce the cost, as BSP is rather 
expensive. During the reaction, one equivalent of triflic acid is formed and to 
avoid anomerization, or other side reactions, a non-nucleophlic base, such as 
2,4,6-tri-tert-butylpyrimidine, is used to quench the acid. This method has 
successfully been used for preparation of various β-(1→2), β-(1→3) and β-
(1→4) linked oligomannosides.36–39 Mechanistic studies by suggest, that the 
reaction proceeds via a transition state where the α-triflate is in equilibrium with 
a transient contact ion pair, with the triflate ion in close proximity to the α-face 
of the oxocarbenium ion (Scheme 2.3).
40,41
 NMR spectroscopic studies show, 
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that the chemical shift of the anomeric carbon is 104.5 ppm instead of ~250 
ppm, as would be expected for an oxocarbenium ion. This indicates that the 
equilibrium is heavily shifted towards the covalent α-triflate.40 The small amount 
of α-product often obtained in the reaction, is likely to be due to the presence of 
a small fraction of a more loosely associated, maybe even solvent separated 
triflate anion. 
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Scheme 2.3. Proposed mechanism of the Crich β-mannosylation. 
The preparation of the monosaccharide building blocks used in this work has 
been described earlier,
39,42
 and will not be discussed in detail here but, in short, 
the synthesis started with acetylation of D-mannose with acetic anhydride in 
pyridine to afford 1 (Scheme 2.4). The peracetylated mannose was used in a 
thioglycosylation reaction, with thiophenol as the acceptor and BF3∙OEt2 as the 
activator. In theory, this reaction would only require a catalytic amount of the 
acid, but even with large excess the reaction typically takes overnight which is 
why five equivalents were used. The thioglycoside 2 was deprotected under 
Zemplén conditions,
43
 using sodium methoxide in methanol. The 4 and 6 
positions of 3 were protected with a benzylidene acetal by using benzaldehyde 
dimethyl acetal and catalytic p-toluenesulfonc acid to yield 4. At this point, the 
synthetic path splits in two to make the two final building blocks. The minute 
difference in reactivity between the axial 2-OH and equatorial 3-OH can be 
amplified by generating a stannylene acetal using dibutyltin oxide. This acetal 
could be selectively ring-opened and alkylated at the equatorial position by using 
a fluoride salt, tetrabutylammonium bromide and an alkyl halide (benzyl 
bromide in this case) to yield the monobenzylated compound 5. The last free 
hydroxyl group was protected by a traditional Williamson ether synthesis using 
sodium hydride to generate the alkoxide, followed by addition of 4-
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methoxybenzyl bromide to afford the finished building block 6. Finally, building 
block 7 was prepared in a similar manner by treating 4 with sodium hydride, 
followed by benzyl bromide (Scheme 2.4). 
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Scheme 2.4. Synthesis of monosaccharide building blocks. Reagents and conditions: i) 
Ac2O, pyridine, rt, 2 h (95%); ii) PhSH, BF3∙OEt2, CH2Cl2, rt, 20 h (90%); iii) NaOMe, 
MeOH, rt, 18 h (quant), iv) C6H5CH(OCH3)2, p-TSA, DMF, 60 °C, 200 mbar, 2 h 
(91%); v) 1. Bu2SnO, toluene, 120 °C, 2 h, 2. Bu4NBr, CsF, BnBr, 120 °C, 3 h (48%); 
vi) 1. NaH, DMF, 0 °C, 30 min, 2. PMBCl, rt, 1 h (95%); vii) 1. NaH, DMF, 0 °C, 30 
min, 2. BnBr, rt, 3 h (95%). 
The stability of thioglycosides under a wide range of conditions, and the 
utilization of a preactivation protocol made it possible to use building block 5 as 
the reducing end monosaccharide unit without further modification. This 
particular method was selected for this work due to the robustness of the 
reaction, and the fact that it allows for a convergent synthesis in the case of a 
tetrasaccharide. The linear synthesis of larger oligosaccharides is less efficient 
considering the number of synthetic steps.  While the stereoselectivity of the 
reaction is in general very high, it has been shown to decrease from practically 
fully selective, to an α:β ratio of approximately 1:4 for larger oligosaccharides.44 
With all the building blocks prepared, the focus was turned to the preparation of 
the target oligosaccharides. Using the Crich β-mannosylation protocol, building 
block 7 was converted to the corresponding α-triflate by Tf2O and BSP, in the 
presence of TTBP in freshly distilled CH2Cl2 at –60 °C under inert atmosphere. 
Typically, the activation was complete in less than 15 minutes, but the reaction 
was stirred at said temperature for 30 min to ensure complete activation. The 
reaction mixture containing the activated donor was cooled down to –78 °C, and 
the acceptor, building block 5, was added dropwise as a solution in freshly 
distilled CH2Cl2. The solution of the acceptor was at room temperature, so a 
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slow addition was important to avoid localized warmer areas in the reaction 
mixture. After two hours at –78 °C the reaction was complete according to TLC, 
and was quenched with triethylphosphine followed by conventional work-up, 
resulting in a 75% yield of disaccharide 8. This disaccharide was activated using 
the same protocol, and glycosylated one more time using acceptor 5 to afford a 
β-(1→2) linked mannotriose 9 with a thiophenol group at the reducing end in 
62% yield (Scheme 2.5). 
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Scheme 2.5. Synthesis of trisaccharide 9. Reagents and conditions: i) 1. BSP, TTBP, 
Tf2O, CH2Cl2, –60 °C, 30 min, 2. Acceptor 5, –78 °C, 2 h (75%); ii) BSP, TTBP, Tf2O, 
CH2Cl2, –60 °C, 30 min, 2. Acceptor 5, –78 °C, 2 h (62%). 
One could argue, that it would be better to design a synthesis so that the simplest 
possible molecule (typically a monosaccharide) would be used as a donor. The 
activated donor is highly reactive, and thus more likely to decompose or undergo 
side reactions. Because of this, the least valuable molecule should be used as an 
acceptor. This could have been achieved using building block 6 instead of 7 
when preparing the disaccharide. The yields of glycosylations using the more 
reactive donor 6 were, however, found to be somewhat lower than the yields of 
7. Furthermore, this methodology would have required an extra deprotection 
step before the second glycosylation. Overall, the benefits of using a 
disaccharide donor outweigh the disadvantages in this particular case. 
The helical conformation of β-(1→2) linked mannosides is already quite evident 
in a molecule as small as a trisaccharide, which would make the β-face of the 
activated donor 9 rather sterically hindered, and thus a similar strategy as was 
used for preparing trisaccharide 9, is not viable for preparation of an analogous 
tetrasaccharide. Because of this, a convergent synthetic strategy was selected, 
and another disaccharide (10) was prepared according to the same protocol as 
previously. The yield of this reaction was, however, slightly lower (57% vs 
75%) than when preparing disaccharide 8. As previously mentioned, this could 
be due to the somewhat higher reactivity of the donor, owing to the electron-
donating properties of the PMB protecting group on C2. After the glycosylation, 
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the PMB group was selectively cleaved under oxidative conditions using DDQ 
yielding disaccharide acceptor 11 in fair (50%) yield over two steps. 
Disaccharide 8 was again used as a donor, and reacted with acceptor 11 to afford 
tetrasaccharide 12 in 35% yield (Scheme 2.6). 
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Scheme 2.6. Synthesis of tetrasaccharide 12. Reagents and conditions: i) 1. BSP, TTBP, 
Tf2O, CH2Cl2, –60 °C, 30 min, 2. Acceptor 5, –78 °C, 2 h (57%); ii) DDQ, CH2Cl2:H2O 
1:1, 0 °C, 1 h (88%); iii) 1. BSP, TTBP, Tf2O, CH2Cl2, –60 °C, 30 min, 2. Acceptor 11, 
–78 °C, 2 h (35%). 
With the basic structures for the trisaccharide and tetrasaccharide completed, the 
next step was to add the phosphate functionality. Similar molecules have been 
prepared previously,
39
 and in the reported method, the thiophenyl group was 
hydrolyzed by N-bromosuccinimide in acetone/H2O, followed by reacting the 
anomeric hydroxyl group with dibenzyl(N,N-diisopropyl) phosphoramidite in 
the presence of 1H-tetrazole. The phosphite was then oxidized to the 
corresponding phosphate by m-chloroperbenzoic acid. Initially, the same 
procedure was employed for these molecules as well, but the yields of the 
hydrolysis of the thiophenyl groups were not satisfactory (28% for both 
trisaccharide 13 and tetrasaccharide 14). One reason for the low yield could be 
that the NBS is able to cleave the benzylidene acetals.
45,46
 Despite the low yield 
of the reaction, the products were phosphorylated with dibenzyl(N,N-
diisopropyl) phosphoramidite and 1H-tetrazole, and subsequently oxidized to the 
corresponding phosphates with m-CPBA (Scheme 2.7). The overall yield of this 
reaction was good but, rather surprisingly, there was almost no stereoselectivity 
(α:β = 1:1 for trisaccharide 15 and 2:1 for tetrasaccharide 16). The overall yields 
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of 11% and 17% over two steps for 15 and 16 respectively prompted to explore 
an alternative method for preparing these compounds. 
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Scheme 2.7. Synthesis of phosphorylated tri and tetrasaccharides 15 and 16. Reagents 
and conditions: i) NBS, acetone:H2O 50:1, 0 °C, 1.5 h (13, 14: 28%); ii) 1. 
Dibenzyl(N,N-diisopropyl) phosphoramidite, 1H-tetrazole, CH2Cl2, 0 °C, 22 h, m-
CPBA, –60 °C, 2 h (15: 41%, α:β ≈ 1:1, 16: 60%, α:β ≈ 2:1). 
Trisaccharide 9 and tetrasaccharide 12 both have a thioglycoside functionality, 
and can thus act as donors in a glycosylation reaction. Thioglycosides can 
typically not be activated by using simple Lewis acids like many other glycosyl 
donors. Stronger electrophiles are needed, and in this case iodonium ions, 
produced by a reagent system consisting of NIS and TMSOTf or TfOH, were 
used as promotor, and dibenzyl phosphate as acceptor.
47,48
 This makes the 
reaction proceed via the typical oxocarbenium ion, which should promote the 
formation of the α-product. It was found, however, that there was practically no 
stereoselectivity in this reaction either, and both α and β anomers were formed in 
an approximately 1:1 ratio. The overall yield was excellent, however, and the 
yields of the α-anomers of 15 and 16 were 42% and 47% respectively, which 
was a significant improvement over the previous method (Scheme 2.8). 
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Scheme 2.8. Direct phosphorylation of 9 and 12. Reagents and conditions: i) 
HOPO(OBn)2, NIS, TfOH (9) TMSOTf (12), CH2Cl2, –20 °C → 0 °C, 1 h (9), –50 °C 
→ –20 °C, 18 h (12), (15: 42%, 16: 47%) α:β ≈ 1:1. 
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Once the protected trisaccharide and tetrasaccharide had been prepared, the final 
step that remained was deprotection, which could be performed in a single step 
due to the protecting group strategy selected for these molecules. Deprotection 
of benzylic ethers is typically performed by hydrogenation over Pd/C, and this is 
the strategy that was applied here as well.
49
 The protected trisaccharide and 
tetrasaccharide were deprotected in an autoclave reactor over Pd/C under 2 bar 
H2 overnight, which yielded the target trisaccharide in excellent (97%) yield, and 
the target tetrasaccharide in fair (67%) yield. The only purification required in 
this step was filtration through celite to remove the Pd/C (Scheme 2.9). 
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Scheme 2.9. Deprotection of trisaccharide 15 and tetrasaccharide 16. Reagents and 
conditions: i) Pd/C, H2, MeOH, 2 bar, rt, 19 h (17: 97%, 18: 67%). 
2.4 Characterization by NMR spectroscopy 
All compounds were thoroughly characterized by NMR spectroscopy to ensure 
that the correct compounds were formed, and that the purity was acceptable. The 
compounds were analyzed by a standard set of spectra: 
1
H, 
13
C, and 
31
P NMR 
(for the phosphorylated compounds), COSY, HSQC (both coupled and 
decoupled) and HMBC. 
The analysis of NMR spectra of carbohydrates can often be rather complicated, 
as most of the protons are in rather similar chemical environments. In fact, most 
of the signals in the 
1
H NMR spectra appear in the range of 3 – 4.5 ppm 
(excluding anomeric signals). This causes severe overlapping in the spectra, 
making the analysis difficult. Fortunately the spectra can be simplified by using 
the selective 1D-TOCSY experiment, which reduces the complexity to a 
monosaccharide level. The 1D-TOCSY experiment requires only one signal 
from a spin system to be separated from others.  This signal can then be used to 
spread the magnetization to the entire spin system giving, in this case, separate 
1
H spectra for each of the monosaccharide units. 
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Determining the anomeric configuration of monosaccharides, is often achieved 
by measuring the coupling constant JH1-H2 between the anomeric proton and the 
proton on C2. In mannopyranosyl units, the difference between the coupling 
constants in the α and β-anomers is very small though, making this method 
inapplicable. In addition, the chemical shifts of H3 and H5 are typically 
somewhat affected by the anomeric configuration. In the α anomer, the protons 
are closer in space to the anomeric oxygen, and will thus typically appear at 
higher chemical shifts than those of the corresponding β anomer, where they are 
located further away from the anomeric oxygen.
37
 In the case of 18, the chemical 
shift of H5A was found to be 3.84 ppm, and the chemical shifts of H5B, H5C 
and H5D were found to be 3.42, 3.38 and 3.39 ppm respectively. The chemical 
shift of H3A was found to be 4.00 ppm, and the chemical shifts of H3B, H3C 
and H3D were found to be 3.73, 3.66 and 3.62 ppm respectively. These values 
are in accordance with the expected values for the anomeric configurations 
While the JH1,H2 coupling constant and chemical shifts of H3 and H5 might 
provide some indication of the anomeric configuration, they are not universally 
true (as will be seen in the following chapter). NOE and ROE experiments can 
be used for determining the anomeric configuration, but typically it is achieved 
by measuring the 
1
JC1-H1 between C1 and H1. A coupling constant of >170 Hz is 
considered indicative of α-configuration, and ~160 Hz or below is considered 
indicative of β.50 Measuring the coupling constants in a coupled 13C could prove 
to be difficult due to the anomeric signals being fairly close to each other. 
Because of this, coupled HSQC spectra, which show the coupling along the 
1
H 
axis, was used instead. In the case of 18, the coupling constants were found to be 
172.1, 159.9, 162.0 and 160.6 Hz for JC1A-H1A, JC1B-H1B, JC1C-H1C and JC1D-H1D 
respectively. From these values it can be concluded that the anomeric 
configurations in the molecule are as reported. 
The 
1
H NMR spectra were analyzed in detail by employing the NMR simulation 
software PERCH, which by iterative quantum mechanical calculations allows 
for determination of accurate chemical shifts and coupling constants which, in 
many cases, would be difficult to obtain by conventional, manual, spectral 
analysis. The spectral simulation showed, that the coupling constants JH2,H3, 
JH3,H4 and  JH4,H5 were 3.0 – 3.5 Hz, 9 – 10 Hz and 9 – 10 Hz respectively which 
suggested that the individual monosaccharide units are in 
4
C1 conformations as 
expected. Especially this information obtained from the coupling constants is 
important later for the conformational analysis of the molecules. Figure 2.3 
shows experimental and simulated spectra of tetrasaccharide 18. 
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Figure 2.3. 
1
H NMR spectrum of 18 (bottom) and simulated spectrum (top). The 
difference between the observed and simulated spectra is shown in green. 
2.5 Conformational studies 
The glycosidic bonds in oligosaccharides can rotate which allows the molecules 
to adopt a number of different conformations. Naturally, not all of these 
conformations are equally likely, as some will be more favored due to steric and 
electronic effects. The low-energy conformations of oligosaccharides can be 
important from a biological point of view, as they might affect how the 
oligosaccharide can interact with biological receptors. 
The conformation around a glycosidic linkage can be described by two 
parameters: The dihedral angle defined by H1B–C1B–O1B–C2A (ϕH1) and the 
dihedral angle defined by C1B–O1B–C2A–H2A (ψH1) (Figure 2.4). The lower 
index indicates which glycosidic bond the angle refers to (i.e. 1, 2, or 3 in the 
molecules discussed herein), and the upper index ‘H’ indicates that the angle 
includes a hydrogen atom. As all the angles discussed herein will include a 
hydrogen atom, the upper indices will be omitted for clarity. 
O
HO
HO
HO
O
H
O
HO
HO
HO O
O


H
H1B
C2B O5B
C2A

C1B
C3A
H2A
C1A

 
Figure 2.4. Definitions of the dihedral angles across glycosidic linkages. 
The conformations of β-(1→2) linked mannosides have been studied 
extensively, and already in the 1970s, calculations using empirically derived 
force fields were used to predict that this class of compounds would adopt folded 
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conformations.
51
 Further evidence for these types of structures has been obtained 
for oligomannosides capped at the reducing end by various alkyl chains, as well 
as for fully unprotected oligomannosides, and it has been shown that the 
molecules form a contorted helical structure with approximately 3 – 4 mannose 
residues per revolution.
13,37,52,53
 The focus of this work was, thus, to determine 
how a charged phosphate group at the reducing end would impact the 
conformation. It could be reasoned, that a phosphate group could affect the 
conformation due to its ability to form hydrogen bonds. 
When available, crystal structures obtained by X-ray crystallographic methods 
are valuable sources for conformational information as they, more or less, give a 
direct image of the molecule in question. In a crystal, the molecules are locked 
in a specific conformation. This, however, may or may not be of biological 
importance. In a solution, however, the molecules can switch between different 
conformations. Because of this, it is often more useful to investigate how the 
molecules behave in solution, instead of simply finding the conformation with 
the lowest energy. 
The behavior of a molecule in solution over time can be investigated by 
performing molecular dynamics (MD) simulations. Such simulations predict the 
conformational changes in a molecule based on a set of physical rules. 
Depending on the wanted result, and the amount of computing power available, 
different levels of detail can be applied. Typically MD simulations are carried 
out by solving Newton’s equations of motion for a system of particles, i.e. the 
molecule to be investigated. The other alternatives are quantum-mechanical or 
hybrid approaches, which are significantly more resource intensive in terms of 
computing power. These methods are not applied in this thesis, and will thus not 
be discussed in detail here. 
Newton’s equations of motion can typically not be solved analytically, except 
for trivial cases, which is why numerical methods are needed. This inevitably 
leads to cumulative errors, which can be minimized by using so-called force 
fields, i.e. parameter sets that describe the potentials of clusters of atoms. These 
force fields are derived from physical experiments or by quantum-mechanical 
calculations. 
One important aspect to consider in molecular modeling is how to treat the 
solvent. Basically there are three approaches: 1) no solvent, 2) a homogeneous 
medium described by electrical properties (implicit solvation, continuum 
solvation), and 3) explicit solvation where the molecule to be investigated is 
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surrounded by a large number of actual solvent molecules. It is easy to 
understand that the last alternative is the most demanding in terms of computing 
power. Here, an implicit solvation model based on the relative permittivity of 
water (ε = 80) was used. 
While the MD simulations can give good approximations of the conformational 
behavior of a molecule, verifying that the calculations give realistic results is 
recommended. In other words, the calculated result should be compared to 
experimentally obtained parameters. This can be done by applying NMR 
techniques such as NOESY (Nuclear Overhauser Effect SpectroscopY) and 
ROESY (Rotating-frame Overhauser Effect SpectroscopY). These experiments 
give information about the distance between atoms in three-dimensional space. 
Similar to most NMR techniques these two also give only relative information, 
which means that for quantitative results, a reference is needed.  The intensities 
of NOE/ROE correlations are proportional to 1/r
6
, which means that, if the 
distance between to protons A and B in the molecule is known, the intensity of 
that correlation can be used for calculating the distance between two other 
protons, C and D, according to equation 1 below. 
 
𝑁𝑂𝐸𝐴𝐵
𝑁𝑂𝐸𝐶𝐷
=
𝑟𝐶𝐷
6
𝑟𝐴𝐵
6 ⇒ 𝑟𝐶𝐷 = √
𝑁𝑂𝐸𝐴𝐵 ∙ 𝑟𝐴𝐵
6
𝑁𝑂𝐸𝐶𝐷
6
 
 
[1] 
The distance between 1,3-diaxial protons in a chair conformation of cyclohexane 
is known to be approximately 2.6 Å.
54
 Since the individual monosaccharide units 
in 17 and 18 were shown to be in 
4
C1 conformations, this means that the 
correlations between 1,3-diaxial protons H1, H3 and H5 can be used to calculate 
other distances in the molecules. 
For small molecules that tumble rapidly in solution, the NOE effect is positive, 
i.e. the intensity of a signal is increased by a nearby proton, whereas for large 
molecules that tumble more slowly, the NOE effect is negative which means that 
the signal intensity is decreased by a nearby proton. A consequence of this is, 
that for molecules of intermediate size, the signal intensity remains unaffected 
by nearby protons. What this means in practice is that no NOE effect is observed 
for molecules of this size. The region where this zero-crossing happens is 
approximately 400 – 1500 Da, which for oligosaccharides means approximately 
disaccharides to pentasaccharides. This is, however, also dependent on the 
specific molecule in question. In addition to the tumbling rate, the zero-crossing 
also depends on the spectrometer frequency. The tumbling rate can be somewhat 
affected by temperature, but changing the spectrometer frequency (i.e. moving to 
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a spectrometer with higher or lower field) is not always possible. Furthermore, 
NOESY can suffer from indirect NOE correlations where two protons far away 
from each other can appear to be close if they are both close to a third proton. 
These correlations are typically indistinguishable from direct NOE correlations. 
ROESY, another NMR technique that gives information about distances 
between atoms, does not suffer as severely from the drawbacks associated with 
NOESY. Indirect ROE correlations are not as common as indirect NOE 
correlations, and if they appear, they are distinguished by having opposite phase 
of direct ROE correlations. Since ROESY relies on a spin-lock pulse, TOCSY 
artifacts can occasionally be seen in the spectra. The spin-lock pulse in the 
ROESY experiment is, however, much weaker than in the TOCSY experiment, 
and because of this, such artifacts are not very common. If the artifacts appear, 
however, they can still be distinguished by having opposite phase of real ROE 
correlations. 
NOESY spectra of tetrasaccharide 18 were recorded at 5 °C on a 700 MHz 
instrument, which made the observed NOE signals enter the negative regime. 
For trisaccharide 17, however, the NOE correlations were very weak, which is in 
accordance with a smaller size, and therefore slightly faster tumbling. Because 
of this, the conformation of 17 was investigated using ROESY instead of 
NOESY. 
2.5.1 Conformation of trisaccharide 17 
The ROESY spectrum of trisaccharide 17 showed correlations across the 
glycosidic bonds (H2A–H1B and H2B–H1C), which further confirmed the 
correct sequential assignment. The important correlations for the conformational 
analysis, however, were the correlations between H4A and H1C as well as 
between H4A and H2C (Figure 2.5). These correlations between protons from 
non-contiguous residues indicate that the molecule prefers a well-defined, 
folded, conformation. Unfortunately, not all correlations could be properly 
quantified due to overlapping in the spectrum and disappearance of the signals in 
the direct dimension due to solvent suppression. The fact that a correlation is 
found, however, shows that the protons are within 4 Å, which is the approximate 
maximum range at which NOE/ROE correlations can be seen in molecules of 
this size. 
Oligosaccharides: The almighty mannose 
50 
 
 
Figure 2.5. ROESY spectrum of 17 (300 ms mixing time, 500 MHz, 298 K). Key inter-
residual cross peaks are labeled. 
During the MD simulation, the dihedral angles ϕ and ψ, as well as key inter-
molecular distances in 17 were monitored. The glycosidic ϕ angles remained 
mostly at around 60° (Figure 2.6) in accordance with the exo-anomeric effect, 
which states that the O5B-C1B-O1B-O2A dihedral angle prefers a gauche 
conformation, which minimizes the repulsive interaction of the dipoles created 
by the lone pairs of the two oxygen atoms, over the typically less sterically 
hindered trans (antiperiplanar) conformation. The ψ angles, however, seemed to 
prefer eclipsed syn-type conformations, with values between 0 and 30° (Figure 
2.6). While these values represent the majority of conformations over the course 
of the MD simulation, a number of minor conformations were observed. 
Although these conformations exist only for a short amount of time, they show 
that the molecule is not trapped in a local minimum, but able to find the global 
minimum energy conformation. Key intermolecular distances calculated from 
the MD simulation and the ROESY spectrum, are shown in Table 1, and the 
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most abundant conformational family, where ϕ1 = 58°, ψ1 = 41°, ϕ2 = 56° and ψ2 
= –1°, is represented in Figure 2.7. 
 
Figure 2.6. Populations of ϕ1/ψ1 and ϕ2/ψ2 angles for 17 during the MD simulation. 
Table 1. Key intramolecular distances for 17 calculated from the MD simulation 
(weighted) and from NMR data. 
Correlation MD (Å) NMR (Å) 
H2A,H1B 2.3 2.5 
H1A,H1B 2.3 2.8 
H2B,H1C 2.3 2.4 
H4A,H1C 2.7 2.8 
H4A,H2C 2.7 n.d. 
 
 
Figure 2.7. Stereoscopic representation of 17. 
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2.5.2 Conformation of tetrasaccharide 18 
The NOESY spectrum of 18 (Figure 2.8) shows similar trends as the ROESY 
spectrum of 17. Vicinal correlations across the glycosidic linkages can be seen, 
but quantification is impossible due to severe overlapping of the anomeric 
proton signals. Correlations between non-contiguous residues separated by one 
mannose unit, can again be seen from H4A to H1C and H2C, as well as from 
H4B to H2D. 
The ϕ and ψ again display similar behavior as in 17, and all ϕ angles are in good 
agreement with the exo-anomeric effect. The ψ1 and ψ3 angles strongly prefer a 
syn-type geometry like in 17, but the ψ2 angle has a somewhat significant 
population in the opposite direction as well (ca. –15°), which suggests that the 
helical conformation can be oriented in both directions (Figure 2.9). 
 
Figure 2.8. NOESY spectrum of 18 (250 ms mixing time, 700 MHz, 278 K) Key inter-
residual crosspeaks are labeled. 
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Table 2. Key intramolecular distances for 18 calculated from the MD simulation 
(weighted) and from NMR data. 
Correlation MD (Å) NMR (Å) 
H1A,H2B 3.0 3.3 
H1A,H1B 2.3 2.6 
H4A,H1C 2.7 n.d. 
H4A,H2C 2.6 3.0 
H4B,H2D 2.7 3.4 
 
 
Figure 2.9. Populations of ϕ1/ψ1, ϕ2/ψ2 and ϕ3/ψ3 angles for 17 during the MD 
simulation. 
The distances extracted from the MD simulation data, and those calculated from 
the intensities of the correlations in the NOESY spectrum are in good agreement 
(Table 2). This indicates that the MD simulation is a realistic representation of 
the behavior of the molecule. Nevertheless, for a large molecule like this, with 
several degrees of freedom in terms of rotation around the glycosidic bonds, a 
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large number of minor conformations, which differ significantly from the 
minimum-energy conformation, are possible. The most populated conformation, 
with ϕ1 = 58°, ψ1 = 17°, ϕ2 = 31°, ψ2 = 8°, ϕ3 = 51° and ψ3 = 16° is, however, 
depicted in Figure 2.10. 
 
Figure 2.10. Stereoscopic representation of 18. 
In addition to the behavior of individual molecules, the interactions between the 
molecules and their ability to form larger, structured, complexes in solution were 
investigated. Theoretically, this could be possible if several molecules were to 
form clusters with water molecules trapped inside them, or by interactions 
between the charged oxygen atoms of the phosphate group and hydroxyl groups 
at other positions in the molecules. The first alternative is not possible to study 
by NMR in D2O, due to the rapid association/dissociation and proton/deuterium 
exchange between the solvent and the hydroxyl groups of the molecule. This 
investigation, focused on the possibility of forming P–O–H–O bonds, was 
carried out by measuring 
1
H and 
31
P spectra of the molecules at different 
concentrations. If the interactions were sufficiently strong for the molecules to 
prefer larger structures, slight chemical shift perturbation should be expected of 
the signals involved in the interactions. No differences in the spectra recorded at 
different concentrations were observed for either the trisaccharide 17 or 
tetrasaccharide 18, which suggests that no larger aggregates are formed. This is 
not very surprising due to the large excess of water molecules compared to the 
carbohydrate molecules. Water likely causes any eventual interactions between 
the phosphate group and hydroxyl groups to be dominated by interactions with 
water, thus negating any ability to form larger aggregates. 
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2.6 Conclusions 
Phosphorylated β-(1→2) linked mannosides analogous to the C. albicans cell 
wall polysaccharide were prepared and thoroughly characterized by NMR 
spectroscopic methods. Their behavior in solution was investigated by MD 
simulations and NMR spectroscopic techniques, and the impact of a charged 
phosphate group was evaluated by comparing the obtained data to that of non-
phosphorylated analogues. The conformation of trisaccharide 17 and 
tetrasaccharide 18 are very similar, as expected, and no significant differences in 
the geometries of the phosphorylated mannosides compared to the non-
phosphorylated analogues were observed,
14,22,23,37,52
 i.e. the phosphate group does 
not significantly alter the conformation of the molecules. When inspecting the 
three-dimensional structures of the molecules, the reason for this is evident: The 
phosphate group in α-position is located outside of the helical structure, and is 
thus not sufficiently close to interact with, for example, hydroxyl groups within 
the molecule.  
2.7 Experimental section 
2.7.1 Instrumental and general details 
All reagents were purchased from Sigma-Aldrich and used without further 
purification. Dry solvents were either distilled (CH2Cl2 Over CaH2 and toluene 
over Na/benzophenone) or purchased as anhydrous and stored over molecular 
sieves (DMF and MeOH). TLC was performed on aluminum sheets precoated 
with Silica gel 60 F254 (Merck) and the spots were visualized by UV and charred 
by using a 1:4 solution of H2SO4 in MeOH, followed by heating. Column 
chromatography was carried out using Silica gel 60 (0.040 – 0.060 mm, Merck). 
Optical rotations were measured with a Perkin-Elmer 241 polarimeter equipped 
with a sodium lamp operating at 589 nm at 24 °C, unless mentioned otherwise. 
HRMS were recorded on a Bruker Micro Q-ToF instrument with electrospray 
ionisation operating in positive or negative mode. 
NMR data was recorded using a Bruker Avance spectrometer operating at 
600.13 MHz for 
1
H, 150.90 MHz for 
13
C and 242.93 MHz for 
31
P. NOESY 
spectra (250 ms mixing time) of tetrasaccharide 18 were recorded using a Bruker 
Avance spectrometer with a proton resonance frequency of 700.17 MHz. The 
complete assignment of proton and carbon spectra was carried out by using a 
standard set of NMR experiments, 
1
H NMR, 
13
C NMR, 
31
P NMR, DQF-COSY, 
Oligosaccharides: The almighty mannose 
56 
 
HSQC (both coupled and decoupled), HMBC. As previously indicated, 1D-
TOCSY was utilized for simplification of the 1H NMR spectra. In addition, 2D 
ROESY (300 ms mixing time, for the trisaccharide) and 2D NOESY (for the 
tetrasaccharide) experiments were performed to assist in the conformational 
analysis. Chemical shifts are expressed on the δ (ppm) scale, referenced to 
signals from TMS (tetramethylsilane, δH = 0.0 ppm, δC = 0.0 ppm), HOD (δH = 
4.79 ppm) or residual solvent signals. 
31
P NMR spectra were referenced to an 
external standard, a 0.0485 M solution of PPh3 in acetone-[d6], (δP = –17.90 
ppm). Coupling constants in the NMR data are reported only the first time they 
are encountered to avoid unnecessary bloating of the NMR data. Accurate 
chemical shifts and coupling constants were obtained with the NMR simulation 
software PERCH.
55
 
Modelling of the molecules was carried out using Maestro,
55
 and the energy 
minimizations and molecular dynamics simulations with Impact.
56
 First, the 
models were drawn, simply in order to create the atoms and bonds, after which 
an iterative energy minimization was performed for obtaining a starting point for 
the dynamics simulation. The acquired models were visually inspected in order 
to verify that they were realistic. The minimizations and molecular dynamics 
simulations were performed using the OPLS_2005 force field, with a constant 
dielectricity 80 (the relative permeability for water). The calculations were 
carried out with continuum solvation with implicit solvent using a surface 
generalized Born model. The algorithm used for the minimization was a 
truncated Newton model. After the minimization, a molecular dynamics 
simulation was performed in 1 000 000 steps, each 2 fs to obtain a total 
simulation time of 2 ns. The force field, electrostatic treatment and solvation 
model were all the similar to those used for the minimization. The equations of 
motion were integrated using the r-RESPA algorithm, and the structure was 
stored every fifth step. From the molecular dynamics simulations, the dihedral 
angles between the mannose units were then recorded and plotted in order to 
provide a model for flexibility of the molecules. The low energy conformations 
obtained by molecular modelling were then compared with the NMR data of 
these compounds in order to verify that the simulations correctly represent the 
molecular structures. 
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2.7.2 Synthetic procedures 
General procedure for β-mannosylation 
To a solution of the donor (1 equiv.) in dry CH2Cl2 (5 mL/0.1 mmol donor) 
under argon at –60 °C (acetone dry ice) was added pre-activated 4 Å molecular 
sieves, BSP (1.20 equiv.), TTBP (1.5 equiv.) and Tf2O (1.3 equiv.). The reaction 
mixture was stirred for 30 minutes until the activation was complete (confirmed 
by TLC), after which 1-octene (1 equiv.) was added and the reaction mixture 
was stirred for another 15 minutes. The reaction mixture was then cooled down 
to –78 °C and a solution of the acceptor (1.15 equiv.) in dry CH2Cl2 (1 mL/0.1 
mmol) was added dropwise. The reaction mixture was stirred for 2 h, at –78 °C 
and, after the reaction was complete, quenched by adding triethylphosphite (3 
equiv.) and stirred for 1 h. The reaction mixture was then warmed to room 
temperature and diluted with CH2Cl2 (30 mL/100 mg) and washed with a 
saturated solution of NaHCO3 in H2O (30 mL/100 mg). The water layer was 
extracted with CH2Cl2 (2 × 30 mL/100 mg) after which the combined organic 
layers were washed with brine (30 mL/100 mg) and dried over Na2SO4. The 
solvent was removed and the crude product was purified by column 
chromatography to yield the β-coupled product. 
General procedure for hydrogenolysis of benzyl and benzylidene protecting 
groups 
To a solution of the protected sugar molecule in dry MeOH (1.5 mL/10 mg 
protected sugar) was added Pd/C 10% w/w (2 equiv. by mass) and the mixture 
was stirred in an autoclave under H2 (2 bar) overnight. The reaction mixture was 
then filtered through celite and evaporated to dryness to yield the corresponding 
unprotected product. 
Phenyl O-(2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-
O-(3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-
4,6-O-benzylidene-1-thio-α-D-mannopyranoside (9): Synthesized from donor 
8 (200 mg, 0.2 mmol, 1 equiv.) and acceptor 5 (107 mg, 0.24 mmol, 1.2 equiv.) 
according to the general procedure for β-mannosylation. The product was 
purified by column chromatography (hexane:EtOAc 2:1, Rf = 0.45) to yield pure 
9 as a white foam. Yield: 166 mg (62%). [α]D
24
 = – 51,5° (c = 1.0, CH2Cl2). 
1
H 
NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.25 – 6.90 (m, 40 H, arom. H), 5.60 (s, 
1 H, 4B,6B-OCHPh), 5.57 (s, 1 H, 4A,6A-OCHPh), 5.51 (d, 1 H, JH1A, H2A = 1.4 
Hz, H1A), 5.37 (s, 1 H, 4C,6C-OCHPh), 5.10 (d, 1 H, JH1C, H2C = 0.5 Hz, H1C), 
4.97 and 5.72 (each d, each 1 H, J = –12.5 Hz, 2A-OCH2Ph), 4.82 and 4.77 
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(each d, each 1 H, J = –12.6 Hz, 3B-OCH2Ph), 4.67 and 4.62 (each d, each 1 H, 
J = –12.2 Hz, 3A-OCH2Ph), 4.65 (s, 1 H, JH1B, H2B = 0.1 Hz, H1B), 4.56 (dd, 1 H, 
JH2A, H3A = 3.0 Hz, H2A), 4.46 and 4.43 (each d, each 1 H, J = –11.6 Hz, 3C-
OCH2Ph), 4.45 (dd, 1 H, JH2C, H3C = 3.2 Hz, H2C), 4.36 (dd, 1 H, JH2B, H3B = 3.1 
Hz, H2B) 4.34 (ddd, 1 H, JH5A, H6Aa = 4.9 Hz, JH5A, H4A = 9.2 Hz, JH5A, H6Ab = 10.2 
Hz, H5A), 4.33 (dd, 1 H, JH6Ca, H5C = 4.9 Hz, JH6Ca, H6Cb = –10.5 Hz, H6Ca), 4.31 
(dd, 1 H, JH6Ba, H5B = 4.8 Hz, JH6Ba, H6Bb = –10.0 Hz, H6Ba), 4.23 (dd, 1 H, JH6Aa, 
H6Ab = –10.3 Hz, H6Aa), 4.22 (dd, 1 H, JH4C, H5C = 9.2 Hz, JH4C, H3C = 9.9 Hz, 
H4C), 4.06 (dd, 1 H, JH4B, H5B = 9.3 Hz, JH4B,H3B = 9.8 Hz, H4B), 3.99 (dd, 1 H, 
JH4A, H3A = 10.1 Hz, H4A), 3.98 (dd, 1 H, H3A), 3.97 (dd, 1 H, JH6Cb, H5C = 10.1 
Hz, H6Cb), 3.77 (dd, 1 H, JH6Ab, H5A = 10.2 Hz, H6Ab), 3.72 (dd, JH6Bb, H5B = 10.1 
Hz, H6Bb), 3.64 (dd, 1 H, H3B), 3.55 (dd, 1 H, H3C), 3.43 (ddd, 1 H, H5C), 
3.33 (ddd, 1 H, H5B) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.0 (arom. C), 103.0 
(C1C), 102.0 (4A,6A-OCHPh), 101.6 (4C,6C-OCHPh), 101.3 (4B,6B-OCHPh), 
98.5 (C1B), 85.6 (C1A), 79.3 (C3C), 79.0 (C4A), 78.2 (C4B), 78.1 (C4C), 76.2 
(C2B and C2C), 75.7 (C3B), 74.9 (2A-OCH2Ph), 74.8 (C2A), 74.6 (C3A), 72.2 
(3C-OCH2Ph), 71.8 (3A-OCH2Ph), 71.0 (3B-OCH2Ph), 68.7 (C6C), 68.6 (C6A 
and C6B), 67.9 (C5C), 67.8 (C5B), 65.2 (C5A) ppm. 
1
JC1A, H1A = 165.3 Hz (α), 
1
JC1B, H1B = 155.1 Hz (β), 
1
JC1C, H1C = 158.5 Hz (β) 
HRMS: m/z calcd. for C73H73O15SNa [M+ Na]
+
: 1243.4490; Found 1243.4502. 
O-(2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-
benzylidene-D-mannopyranose (13): A solution of 9 (255 mg, 1 equiv.) in a 
50:1 mixture of acetone:H2O (5 mL) was cooled on an ice bath and NBS (69 mg, 
2 equiv.) was added and the reaction mixture was stirred ad 0 °C for 30 min after 
which additional NBS (35 mg, 1 equiv.) was added and the reaction mixture was 
again stirred for 30 min. Additional NBS (69 mg, 2 equiv.) was added and the 
reaction mixture was stirred for 30 min after which solid Na2S2O3 was added 
until the yellow color disappeared. The solvent was evaporated and the resulting 
oil was dissolved in CH2Cl2 (50 mL) and washed with H2O (3 × 20 mL) and 
dried over Na2SO4 after which the solvent was removed. The crude product was 
purified by column chromatography (hexane:EtOAc 1:1, Rf = 0.36) to yield 13 
as a white foam. Yield: 61 mg (28%). Due to the complexity of the NMR spectra 
caused by a mixture of anomers, the spectra were not fully assigned. 
HRMS: m/z calcd. for C67H68O16Na [M + Na]
+
: 1151.4405; Found 1151.4401 
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O-(2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-
benzylidene-α-D-mannopyranosyl dibenzylphosphate (15): Method 1: To a 
solution of 13 (40 mg, 1 equiv.) in dry CH2Cl2 under argon was added 1H-
tetrazole (9.3 mg, 3.8 equiv.) after which the reaction mixture was cooled down 
to 0 °C. Dibenzyl(N,N-diisopropyl) phosphoramidite (30 µl, 2.5 equiv.) was 
added after which the reaction mixture was allowed to warm up to room 
temperature and was stirred for 22 h. The reaction mixture was then cooled to –
60 °C and m-CPBA (20 mg, 2.5 equiv.) was added. The reaction mixture was 
stirred at 0 °C for 1.5 h and at room temperature for 2 h after which it was 
diluted with CH2Cl2 (40 mL), washed with a saturated solution of Na2S2O3 (2 × 
15 mL), a saturated solution of NaHCO3 (2 × 15 mL) and H2O (2 × 10 mL). The 
organic layer was purified by column chromatography (hexane:EtOAc 1:1, Rf = 
0.57) to yield 15 as a white foam. Yield of α-product: 20 mg (41%). [α]D
24
 = – 
51.7 ° (c = 1.0 CH2Cl2). 
Method 2: To a solution of 9 (140 mg, 1 equiv.) in dry CH2Cl2 (3 mL) under 
argon was added HOPO(OBn)2 (94.3 mg, 3 equiv.) and 4 Å molecular sieves. 
The reaction mixture was cooled to –20 °C and NIS (30.5 mg, 1.2 equiv.) and 
TfOH, (2.5 µl, 0.12 equiv.) were added. The reaction mixture was stirred at 0 °C 
for 1 h after which the reaction was quenched by adding pyridine (0.5 mL). The 
reaction mixture was diluted with CH2Cl2 (20 mL) and washed with a saturated 
solution of Na2S2O2 (2 × 15 mL), a saturated solution of NaHCO3 (2 × 15 mL) 
and H2O (1 × 15 mL). The organic layer was dried over Na2SO4 and the solvent 
was removed. The crude product was purified by column chromatography 
(hexane:EtOAc 1:1) to yield 15 as a white foam. Yield of α-product: 64.2 mg 
(42 %). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.60 – 7.00 (m, 45 H, arom. 
H), 5.60 (s, 1 H, 4C,6C-OCHPh), 5.58 (dd, 1 H, JH1A, H2A = 1.5 Hz, JH1A, P = 6.2 
Hz, H1A), 5.45 (s, 1 H, 4B,6B-OCHPh), 5.33 (s, 1 H, 4A,6A-OCHPh), 5.08 and 
5.03 [each dd, each, 1 H, J = –11.9 Hz, JCH2a,P = 8.9 Hz, JCH2b,P = 8.2 Hz, 
PO(OCH2Ph)], 5.02 and 4.99 [each dd, each, 1 H, J = –11.8 Hz, JCH2a, P = 13.6 
Hz, JCH2b,P = 9.6 Hz, PO(OCH2Ph)], 5.00 (d, 1 H, JH1A, H2C = 0.1 Hz, H1C), 4.91 
and 4.69 (each d, each 1 H, J = –12.5 Hz, 2C-OCH2Ph), 4.83 and 4.78 (each d, 
each 1 H, J = –12.5 Hz, 3B-OCH2Ph), 4.60 and 4.56 (each d, each 1 H, J = –12.2 
Hz, 3A-OCH2Ph), 4.47 (s, 1 H, H1B), 4.45 and 4.42 (each d, each 1 H, J =  –
11.7 Hz, 3C-OCH2Ph), 4.39 (dd, 1 H, JH2C, H3C = 3.2 Hz, H2C), 4.34 (dd, 1 H, 
JH6Ca, H5C = 4.8 Hz, JH6Ca. H6Cb = –10.4 Hz, H6Ca), 4.29 (d, 1 H, JH2B, H3B = 3.1 Hz, 
H2B), 4.26 (dd, 1 H, JH6Ba, H5B = 4.8 Hz, JH6Ba, H6Bb = –10.2 Hz, H6Ba), 4.22 (dd, 
1 H, JH4C,H5C = 9.2 Hz, JH4C, H3C = 9.8 Hz, H4C), 4.15 (dd, 1 H, JH2A, H3A = 3.3 Hz, 
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H2A), 4.02 (dd, 1 H, JH4B, H5B = 9.4 Hz, JH4B, H3B = 9.7 Hz, H4B), 3.99 (dd, 1 H, 
JH6Aa, H5A = 4.9 Hz, JH6Aa, H6Ab = –10.3 Hz, H6Aa), 3.97 (dd, 1 H, JH6Cb, H5C = 10.2 
Hz, H6Cb), 3.85 (dd, 1 H, JH4A,H5A = 9.0 Hz, JH4A,H3A = 10.2 Hz, H4A), 3.84 
(ddd, 1 H, JH5A, H6Ab = 10.1 Hz, H5A), 3.83 (dd, 1 H, H3A), 3.67 (dd, 1 H, JH6Bb, 
H5B = 10.1 Hz, H6Bb), 3.60 (dd, 1 H, H6Ab), 3.59 (dd, 1 H, H3B), 3.53 (dd, 1 H, 
H3C), 3.41 (ddd, 1 H, H5C), 3.24 (ddd, 1 H, H5B) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.3 – 135.2(arom. C), 103.0 (C1C), 
101.9 (4B,6B-OCHPh), 101.6 (4A,6A-OCHPh), 101.3 (4C,6C-OCHPh), 99.6 
(C1B), 95.7 (
2
JC1A,P = 5.7 Hz, C1A), 79.2 (C3C), 78.1 (C4A, C4B, C4C), 76.2 
(C2B), 76.0 (C2C), 75.5 (C3B), 74.9 (2A-OCH2Ph), 73.7 (
3
JC2A,P = 9.9 Hz, 
C2A), 73.5 (C3A), 72.1 (3C-OCH2Ph), 71.9 (3A-OCH2Ph), 71.1 (3B-OCH2Ph), 
69.9 [
2
JC,P = 6.1 Hz, PO(OCH2Ph)], 69.8 (
2
JC,P = 6.1 Hz, PO(OCH2Ph)], 68.7 
(C6C), 68.5 (C6B), 68.3 (C6A), 67.9 (C5C), 67.6 (C5B), 65.5 (C5A) ppm. 
1
JC1A, H1A = 176.4 Hz (α), 
1
JC1B, H1B = 156.2 Hz (β), 
1
JC1C, H1C = 158.6 Hz (β) 
31
P NMR (242.9 MHz, CDCl3, 25 °C): δ = –2.88 ppm. 
HRMS: m/z calcd. for C81H81O19PNa [M+ Na]
+
: 1411.5007; Found 1411.5025. 
O-(β-D-Mannopyranosyl)-(1→2)-O-(β-D-mannopyranosyl)-(1→2)-α-D-
mannopyranosylphosphate (17): Prepared from 15 (22 mg, 0.016 mmol) 
according to the general procedure for hydrogenolysis of benzyl and benzylidene 
protecting group. Filtration through celite with water yielded the product as a 
colorless oil. Yield: 9 mg (97%). Purity: 95 %, with an impurity possibly 
consisting of a molecule where the phosphate group has been replaced by 
methyl.  [α]D
24
 = – 13 ° (c = 1.0 H2O). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ 
= 5.45 (dd, 1 H, JH1A, H2A = 1.5 Hz, JH1A, P = 7.9 Hz, H1A), 4.96 (d, 1 H, JH1B, H2B 
= 0.2 Hz, H1B), 4.88 (d, 1 H,  JH1C, H2C = 0.5 Hz, H1C), 4.32 (dd, 1 H, JH2B, H3B = 
3.4 Hz, H2B), 4.18 (dd, 1 H, JH2C, H3C = 3.3 Hz, H2C), 4.15 (dd, JH2A, H3A = 3.1 
Hz, H2A), 4.01 (dd, JH3A, H4A = 9.8 Hz, H3A), 3.93 (each dd, each 1 H, JH6Ba, H5B 
= 2.1 Hz, JH6Ba, H6Bb = –11.9 Hz, JH6Ca, H5C = 2.2 Hz, JH6Ca, H6Cb = –12.6 Hz, H6Ba 
and H6Ca), 3.89 (dd, 1 H, JH6Aa, H5A = 2.1 Hz, JH6Aa, H6Ab = –12.4 Hz, H6Aa), 3.86 
(ddd, JH5A, H6Ab = 5.6 Hz, JH5A, H4A = 9.8 Hz, H5A), 3.77 (dd, 1 H, H6Ab), 3.75 
(dd, 1 H, JH6Bb, H5B = 5.9 Hz, H6Bb), 3.73 (dd, 1 H, JH6Cb, H5C = 6.4 Hz, H6Cb), 
3.70 (dd, 1 H, JH3B, H4B = 9.9 Hz, H3B), 3.64 (dd, 1 H, JH3C, H4C = 9.9 Hz, H3C), 
3.61 (each dd, each 1 H, JH4B, H5B = 9.7 Hz, H4A and H4B), 3.57 (dd, 1 H, JH4C, 
H5C = 9.8 Hz, H4C), 3.43 (ddd, 1 H, H5B), 3.37 (ddd, 1 H, H5C) ppm.  
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13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 101.0 (C1C), 98.9 (C1B), 92.9 (
2
JC-1, 
P = 4.0 Hz, C1A), 78.8 (
3
JC2A, P = 6.6 Hz, C2A), 78.7 (C2B), 76.2 (C5C), 76.1 
(C5B), 72.9 (C5A), 72.8 (C3C), 72.1 (C3B), 70.4 (C2C), 69.1 (C3A), 67.3 and 
66.9 (C4A and C4B), 66.7 (C4C), 61.0 (C6C), 60.7 (C6B), 60.5 (C6A) ppm. 
1
JC1A, H1A = 173.4 Hz (α), 
1
JC1B, H1B = 160.5 Hz (β), 
1
JC1C, H1C = 160.3 Hz (β) 
Phenyl O-(2-O-(4-methoxybenzyl)-3-O-benzyl-4,6-O-benzylidene-β-D-
mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-benzylidene-1-thio-α-D-
mannopyranoside (10): Prepared from donor 6 (500 mg 0.876 mmol) and 
acceptor 5 (455 mg 1.01 mmol) according to the general procedure for β-
mannosylation. The crude product was purified by column chromatography 
(hexane:EtOAc 2:1, Rf = 0.45) Yield: 455 mg (57%). [α]D
24
 = – 52,5 ° (c = 1.0 
CH2Cl2). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.75 – 7.20 (m, 29 H, 
arom. H), 5.59 (s, 1 H, 4B,6B-OCHPh), 5.52 (s, 1 H, 4A,6A-OCHPh), 5.50 (d, 1 
H, JH1A, H2A = 1.5 Hz, H1A), 4.97 and 4.89 (each d, each 1 H, J = –11.8, 2B-
OCH2Ph), 4.80 and 4.75 (each d, each 1 H, J = –12.1 Hz, 3A-OCH2Ph), 4.67 and 
4.59 (each d, each 1 H, J = –12.5 Hz, 3B-OCH2Ph), 4.61 (d, 1 H, JH1B, H2B = 0.9 
Hz, H1B), 4.51 (dd, 1 H, JH2A, H3A = 3.2 Hz, H2A), 4.33 (ddd, 1 H, JH5A, H6Aa = 
4.8 Hz, JH5A, H4A = 9.5 Hz, JH5A, HA6b = 10.2 Hz, H5A), 4.24 (each dd, each 1 H, 
JH6Aa, H6Ab = –10.2 Hz, JH6Ba, H5B = 4.9 Hz, JH6Ba, H6Bb = –10.4 Hz, H6Aa and 
H6Ba), 4.23 (dd, 1 H, JH4B, H5B = 9.3 Hz, JH4B, H3B = 9.9 Hz, H4B), 4.17 (dd, 1 H, 
JH4A, H3A = 10.0 Hz, H4A), 3.98 (dd, 1 H, H3A), 3.96 (dd, 1 H, JH2B, H3B = 3.2 Hz, 
H2B), 3.82 (dd, JH6Bb, H5B = 10.1 Hz, H6Bb), 3.79 (dd, 1 H, H6Ab), 3.73 (s, 3 H, 
OCH3), 3.57 (dd, 1 H, H3B), 3.29 (ddd, 1 H, H5A) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.1 – 113.5 (arom. C), 101.7 
(4A,6A-OCHPh), 101.4 (4B,6B-OCHPh), 99.8 (C1B), 86.4 (C1A), 78.7 (C4A), 
78.4 (C4B), 77.5 (C3B), 76.1 (C2A), 75.4 (C2B), 74.3 (C3A), 74.2 (2B-
OCH2Ph), 72.2 (3B-OCH2Ph), 71.4 (3A-OCH2Ph), 68.6 (C6A), 68.5 (C6B), 
67.7 (C5B), 65.4 (C5A), 55.2 (OCH3) ppm. 
1
JC1A, H1A = 166.9 Hz (α), 
1
JC1B, H1B = 154.2 Hz (β). 
HRMS: m/z calcd. for C54H54O11SNa [M + Na]
+
: 933.3285; Found 933.3228; m/z 
calcd. for C54H58O11SN [M + NH4]
+
: 928.3731; Found 928.3634. 
Phenyl O-(3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-
benzyl-4,6-O-benzylidene-1-thio-α-D-mannopyranoside (11): A solution of 
10 (200 mg, 1 equiv.) in CH2Cl2 (3 mL) was cooled down to 0 °C and a 
suspension of DDQ (74 mg, 1.5 equiv.) in H2O (3 mL) was added dropwise. The 
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reaction mixture was stirred for 1 h at 0 °C after which it was diluted with 
CH2Cl2 (25 mL) and washed with of a saturated solution of NaHCO3 (2 × 25 
mL). The water layer was extracted with CH2Cl2 (2 × 25 mL), dried over Na2SO4 
and evaporated to dryness. The crude product was purified by column 
chromatography (hexane:EtOAc 2:1) to yield the 11 as a white foam. Yield: 153 
mg (88%). NMR spectra are in accordance with those published previously.
39
 
Phenyl O-(2,3-di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-
O-(3-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-
benzylidene-1-thio-α-D-mannopyranoside (12): Prepared from donor 8 (290 
mg, 0.33 mmol) and acceptor 11 (300 mg, 0.38 mmol) according to the general 
procedure for β-mannosylation. The crude product was purified by column 
chromatography (hexane:EtOAc 2:1, Rf = 0.50) to afford pure 12. Yield: 182 mg 
(35 %). [α]D
24
 = – 62,0 ° (c = 1.0 CH2Cl2). 
1
H NMR (600.13 MHz, CDCl3, 25 
°C): δ = 7.75 – 7.00 (m, 50 H, arom. H), 5.57 (s, 1 H, 4C,6C-OCHPh), 5.54 (s, 1 
H, 4A,6A-OCHPh), 5.49 (d, 1 H, JH1A, H2A = 1.3 Hz, H1A), 5.44 (s, 1 H, 4B,6B-
OCHPh), 5.40 (s, 1 H, 4D,6D-OCHPh), 5.27 (s, 1 H, H1C), 5.07 (d, 1 H, JH1D, 
H2D = 0.1 Hz, H1D), 5.00 and 4.84 (each d, each 1 H, J = –12.6 Hz, 2D-
OCH2Ph), 4.70 (s, 2 H, 3A-OCH2Ph), 4.68 and 4.61 (each d, each 1 H, J = –12.4 
Hz, 3B-OCH2Ph), 4.68 (s, 1 H, H1B), 4.62 and 4.44 (each d, each 1 H, J = –11.9 
Hz, 3C-OCH2Ph), 4.54 (d, 1 H, JH2C, H3C = 3.0 Hz, H2C), 4.53 (dd, 1 H, JH2A, H3A 
= 3.1 Hz, H2A), 4.50 and 4.40 (each d, each 1 H, J = –11.8 Hz, 3D-OCH2Ph), 
4.48 (d, 1 H, JH2B, H3B = 3.4 Hz, H2B), 4.41 (dd, 1 H, JH2D, H3D = 3.3 Hz, H2D), 
4.33 (dd and ddd, each 1 H, JH6Ca, H5C = 4.8 Hz, JH6Ca, H6Cb = –10.2 Hz, JH5A, H6Aa = 
5.0 Hz, JH5A, H4A = 9.2 Hz, JH5A, H6Ab = 10.2 Hz, H6Ca and H5A), 4.31 (dd, 1 H, 
JH6Ba, H5B = 4.8 Hz, JH6Ba, H6Bb = –10.3 Hz, H6Ba), 4.23 (dd, 1 H, JH6Aa, H6Ab = –
10.3 Hz, H6Aa), 4.19 (each dd, each 1 H, JH4D, H5D  = 9.3 Hz, JH4D, H3D = 9.9 Hz, 
JH6Da, H5D = 4.9 Hz, JH6Da, H6Db = –10.3 Hz, H4D and H6Da), 4.06 (dd, 1 H, JH4C, 
H5C = 9.3 Hz, JH4C, H3C = 9.8 Hz, H4C), 3.99 (dd, 1 H, JH4A, H3A = 9.9 Hz, H4A), 
3.97 (dd, 1 H, H3A), 4.93 (dd, 1 H, JH4B, H5B = 9.3 Hz, JH4B, H3B = 9.8 Hz, H4B), 
3.87 (dd, 1 H, JH6Db, H5D = 10.1 Hz, H6Db), 3.78 (dd, 1 H, JH6Cb, H5C = 10.1 Hz, 
H6Cb), 3.77 (dd, 1 H, JH6Bb, H5B = 10.1 Hz, H6Bb), 3.74 (dd, 1 H, H6Ab), 3.66 
(dd, 1 H, H3B), 3.54 (dd, 1 H, H3D), 3.53 (dd, 1 H, H3C), 3.43 (ddd, 1 H, H5C), 
3.36 (ddd, 1 H, H5B), 3.32 (ddd, 1 H, H5D) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.1 (arom. C), 103.4 
(C1D), 102.1 (4A,6A-OCHPh), 102.0 (4B,6B-OCHPh), 101.8 (C1C), 101.5 
(4D,6D-OCHPh), 101.3 (4C,6C-OCHPh), 99.1 (C1B), 85.7 (C1A), 79.1 (C4A), 
79.0 (C3D), 78.4 (C4B), 78.3 (C4D), 78.2 (C4C), 77.0 (C3C), 76.3 (C3B), 76.1 
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(C2C), 76.0 (C2D), 75.5 (C2A), 74.7 (2D-OCH2Ph), 74.5 (C3A), 74.0 (C2B), 
72.2 (3D-OCH2Ph), 72.1 (3A-OCH2Ph), 71.3 (3B-OCH2Ph), 70.9 (3C-OCH2Ph), 
68.8 (C6D), 68.7 (C6C and C-6B), 68.6 (C6A), 68.0 (C5C), 67.9 (C5B), 67.5 
(C5D), 65.2 (C5A) ppm. 
1
JC1A, H1A = 168.2 Hz (α), 
1
JC1B, H1B = 154.5 Hz (β), 
1
JC1C, H1C = 161.0 Hz (β), 
1
JC1D, H1D = 159.6 Hz (β) 
HRMS: m/z calcd. for C93H92O20SNa [M + Na]
+
: 1583.5800; Found 1583.5812. 
O-(2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-benzyl-4,6-
O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-benzylidene-
D-mannopyranose (14): A solution of 12 (250 mg, 1 equiv.) in a 6:1 mixture of 
acetone:H2O (5 mL) was cooled on an ice bath and NBS (60 mg, 2 equiv.) was 
added and the reaction mixture was stirred for 30 min. Additional NBS (30 mg, 
1 equiv.) was added and the reaction mixture was again stirred for 30 min after 
which additional NBS (30 mg, 1 equiv.) was added and the reaction mixture was 
stirred for 30 min. The reaction was quenched by adding solid Na2S2O3 until the 
yellow color had disappeared. The solvent was evaporated and the residue was 
dissolved in CH2Cl2 (50 mL) and washed with H2O (2 × 20 mL). The organic 
layer was dried over Na2SO4 and evaporated to dryness. The crude product was 
purified by column chromatography (hexane:EtOAc 1:1, Rf = 0.38) to yield 14 
as a white foam. Yield (62 mg (28%). Due to the complexity of the NMR 
spectra, caused by a mixture of anomers, the spectra were not fully assigned. 
HRMS: m/z calcd. for C87H92O21N [M + NH4]
+
: 1486.6162; Found 1486.6174. 
O-(2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-
benzyl-4,6-O-benzylidene-β-D-mannopyranosyl)-(1→2)-O-(3-O-benzyl-4,6-
O-benzylidene-β-D-mannopyranosyl)-(1→2)-3-O-benzyl-4,6-O-benzylidene-
α-D-mannopyranosyl dibenzylphosphate (16): Method 1: To a solution of 14 
(35 mg, 1 equiv.) in dry CH2Cl2 (4 mL) under argon was added 1H-tetrazole (6.3 
mg, 3.8 equiv.) after which the solution was cooled down to 0 °C. 
Dibenzyl(N,N-diisopropyl) phosphoramidite (22 µl, 2.5 equiv.) was added and 
the reaction mixture was allowed to return to room temperature and was stirred 
for 2 h. The reaction mixture was cooled down to –60 °C and m-CPBA (13.5 
mg, 3.8 equiv.) was added and the mixture was stirred at 0 °C for 1 h and then at 
room temperature for 1 h. The reaction mixture was diluted with CH2Cl2 (50 
mL) and washed with a saturated solution of Na2S2O3 (2 × 15 mL), a saturated 
solution of NaHCO3 (2 × 15 mL) and H2O (2 × 10 mL) after which the organic 
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layer was dried over NasSO4 and concentrated to dryness. The crude product was 
purified by column chromatography (hexane:EtOAc 1:1, Rf = 0.57) Yield of α-
product: 25 mg (60 %). [α]D
24
 = – 61,2 ° (c = 1.0 CH2Cl2). 
Method 2: To a solution of 12 (50 mg, 1 equiv.) in dry CH2Cl2 (3 mL) under 
argon was added PO(OBn)2Oh (26.7 mg, 3 equiv.) and 4 Å molecular sieves. 
The reaction mixture was cooled down to –50 °C and NIS (8.6 mg, 1.2 equiv.) 
and TMSOTf (0.7 µl, 0.12 equiv.) were added. The reaction mixture was stirred 
at –50 °C for 1 h and warmed to –20 °C and stirred for 3.5 h after which 
additional TMSOTf (0.7 µl, 0.12 equiv.) was added and the reaction mixture was 
stirred for another 17.5 h at –20 °C. The reaction was quenched by adding 
pyridine (0.5 mL) after which the reaction mixture was diluted with CH2Cl2 (20 
mL) and washed with a saturated solution of Na2S2O3 (2 × 15 mL), a saturated 
solution of NaHCO3 (2 × 15 mL) and H2O (15 mL). The organic layer was dried 
over Na2SO4 and evaporated to dryness. The crude product was purified by 
column chromatography (hexane:EtOAc 1:1). Yield of α-product: 26 mg (47%). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ =7.75 – 6.75 (m, 55 H, arom. H), 5.59 
(dd, 1 H, JH1A, H2A = 1.7 Hz, JH1A, P = 6.3 Hz, H1A), 5.56 (s, 1 H, 4D,6D-
OCHPh), 5.43 (s, 1 H, 4A,6A-OCHPh), 5.41 (each s, each 1 H, 4B,6B-OCHPh 
and 4C,6C-OCHPh), 5.14 (d, 1 H, JH1C, H2C = 0.1 Hz, H1C), 5.08 and 5.02 [each 
dd, each, 1 H, J = –11.9 Hz, JCH2a,P = 9.1 Hz, JCH2b,P = 8.2 Hz, PO(OCH2Ph)], 
5.06 (d, 1 H, JH1C, H2C = 0.1 Hz, H1C), 5.01 and 4.98 [each dd, each, 1 H, J = –
11.6 Hz, JCH2a,P = 8.4 Hz, JCH2b,P = 9.9 Hz, PO(OCH2Ph)], 4.99 and 4.83 (each d, 
each 1 H, J = –12.5 Hz, 2D-OCH2Ph), 4.70 and 4.63 (each d, each 1 H, J = –
12.4 Hz, 3B-OCH2Ph), 4.65 and 4.50 (each d, each 1 H, J = –11.9 Hz, 3C-
OCH2Ph), 4.64 and 4.61 (each d, each 1 H, J = –12.4 Hz, 3A-OCH2Ph), 4.51 
(dd, JH2C, H3C = 3.1 Hz, H2C), 4.50 (d, 1 H, JH1B, H2B = 0.1 Hz, H1B), 4.50 and 
4.38 (each d, each 1 H, J = –11.8 Hz, 3D-OCH2Ph), 4.42 (dd, 1 H, JH2B, H3B = 3.3 
Hz, H2B), 4.39 (dd, 1 H, JH2D, H3D = 3.1 Hz, H2D), 4.36 (dd, 1 H, JH6Ca, H5C = 4.6 
Hz, JH6Ca, H6Cb = –10.2 Hz, H6Ca), 4.26 (dd, 1 H, JH6Ba, H5B = 4.8 Hz, JH6Ba, H6Bb = 
–10.2 Hz, H6Ba), 4.18 (dd, 1 H, JH4D, H5D = 9.2 Hz, JH4D, H3D = 9.9 Hz, H4D), 
4.17 (dd, 1 H, JH6Da, H5D = 4.8 Hz, JH6Da, H6Db = –10.4 Hz, H6Da), 4.10 (dd, 1 H, 
JH2A, H3A = 3.7 Hz, H2A), 4.07 (dd, 1 H, JH4C, H5C = 9.3 Hz, JH4C, H3C = 9.8 Hz, 
H4C), 3.98 (dd, 1 H, JH6Aa, H5A = 4.9 Hz, JH6Aa, H6Ab = –10.3 Hz, H6Aa), 3.88 (dd, 
1 H, JH4B, H5B = 9.4 Hz, JH4B, H3B = 9.9 Hz, H4B), 3.85 (each dd, each 1 H, JH6Db, 
H5D = 10.1 Hz, JH4A, H5A = 9.5 Hz, JH4A, H3A = 10.1 Hz, H6Db and H4A), 3.82 
(ddd, 1 H, JH5A, H6Ab = 10.3 Hz, H5A), 3.80 (dd, 1 H, H3A), 3.78 (dd, 1 H, JH6Cb, 
H5C = 10.0 Hz, H6Cb), 3.73 (dd, 1 H, JH6Bb, H5B = 10.0 Hz, H6Bb), 3.62 (dd, 1 H, 
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H3B), 3.55 (dd, 1 H, H6Ab), 3.53 (dd, 1 H, H3C), 3.52 (dd, 1 H, H3D), 3.40 
(ddd, 1 H, H5C), 3.31 (ddd, 1 H, H5D), 3.27 (ddd, 1 H, H5B) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 139.4 – 126.1 (arom. C), 103.3 
(C1D), 101.9 (C1C, 4A,6A-OCHPh, 4B,6B-OCHPh), 101.5 (4C,6C-OCHPh), 
101.2 (4D,6D-OCHPh), 100.5 (C1B), 95.7 (
2
JC-1, P = 4.9 Hz, C1A), 79.0 (C3D), 
78.4 (C4D), 78.3 (C4B), 71.2 (C4A and C4C), 76.8 (C3C), 76.2 (C2C), 76.1 
(C3B), 75.9 (C2D), 74.9 (
3
JC-2, P = 9.3 Hz, C2A), 74.6 (2D-OCH2Ph), 74.2 
(C2B), 73.4 (C3A), 72.2 (3D-OCH2Ph), 72.1 (3A-OCH2Ph), 71.3 (3B-OCH2Ph), 
70.8 (3C-OCH2Ph), 69.9 [
2
JC,P = 5.4 Hz, 
2
JC,P = 5.8 Hz, PO(OCaH2Ph), 
PO(OCbH2Ph)], 68.8 (C6C), 68.7 (C6D), 68.6 (C6B), 68.3 (C6A), 68.0 (C5C), 
67.7 (C5B), 67.5 (C5D), 65.5 (C5A) ppm. 
1
JC1A, H1A = 175.3 Hz (α), 
1
JC1B, H1B = 155.5 Hz (β), 
1
JC1C, H1C = 161.0 Hz (β), 
1
JC1D, H1D = 158.9 Hz (β). 
31
P NMR (242.9 MHz, CDCl3, 25 °C): δ = –2.92 ppm. 
HRMS: m/z calcd. for C101H101O24PNa [M + Na]
+
: 1751.6318; Found 1751.6341. 
O-(β-d-Mannopyranosyl)-(1→2)-O-(β-D-mannopyranosyl)-(1→2)-O-(β-D-
mannopyranosyl)-(1→2)-α-D-mannopyranosylphosphate (18): Prepared from 
16 (25 mg, 0.014 mmol) according to the general procedure for hydrogenolysis 
of benzyl and benzylidene protecting groups. Filtration through celite with a 4:1 
mixture of MeOH:H2O yielded the product as a colorless oil. Yield: 7 mg (67%). 
Purity: 95 %, with an impurity possibly consisting of a molecule where the 
phosphate group has been replaced by methyl. [α]D
24
 = – 15 ° (c = 1.0 H2O).
 1
H 
NMR (600.13 MHz, CDCl3, 25 °C): δ = 5.47 (dd, 1 H, JH1A, H2A = 1.4 Hz, JH1A, P 
= 7.8 Hz, H1A), 4.96 (s, 1 H, H1C), 4.94 (s, 1 H, H1D), 4.93 (s, 1 H, H1B), 4.43 
(d, 1 H, JH2C, H3C = 3.4 Hz, H2C), 4.29 (d, 1 H, JH2B, H3B = 3.4 Hz, H2B), 4.16 (dd 
and d, each 1 H, JH2A, H3A = 3.2 Hz, JH2D, H3D = 3.4 Hz, H2A and H2D), 4.00 (dd, 
1 H, JH3A, H4A = 9.9 Hz, H3A), 3.94 (dd, 1 H, JH6Ba, H5B = 3.1 Hz, JH6Ba, H6Bb = –
12.3 Hz, H6Ba), 3.93  (dd, 1 H, JH6Da, H5D = 2.5 Hz, JH6Da, H-6Db= –12.3 Hz, 
H6Da), 3.92 (dd, 1 H, JH6Ca, H5C = 2.1 Hz, JH6Ca, H6Cb = –11.9 Hz, H6Ca), 3.87 (dd, 
1 H, JH6Aa, H5A = 2.0 Hz, JH6Aa, H6Ab = –12.3 Hz, H6Aa), 3.84 (ddd, 1 H, JH5A, H6Ab 
= 4.6 Hz, JH5A, H4A = 10.1 Hz, H5A), 3.77 (dd, 1 H, H6Ab), 3.75 (dd, 1 H, JH6Cb, 
H5C = 6.3 Hz, H6Cb), 3.73 (dd and dd, each 1 H, JH6Cb, H5C = 6.5 Hz, JH3B, H4B = 
8.9 Hz, H6Db and H3B), 3.72 (dd, 1 H, JH6Bb, H5B = 5.5 Hz, H6Bb), 3.66 (dd, 1 
H, JH3C, H4C = 10.0 Hz, H3C), 3.62 (dd, 1 H, JH3D, H4D = 9.5 Hz, H3D), 3.60 (dd 1 
H, H4A), 3.58 (dd, 1 H, JH4C, H5C = 9.2 Hz, H4C), 3.56 (dd, 1 H, JH4D, H5D = 9.7 
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Hz, H4D), 3.51 (dd, 1 H, JH4B, H5B = 10.2 Hz, H4B), 3.42 (ddd, 1 H, H5B), 3.39 
(ddd, 1 H, H5D), 3.38 (ddd, 1 H, H5C) ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 101.2 (C1C), 101.0 (C1D), 99.1 
(C1B), 93.2 (
2
JC1A, P = 5.8 Hz, C1A), 79.4 (C2B), 78.9  (
3
JC2A, P = 8.4 Hz, C2A), 
78.4 (C2C), 76.2 (C5C, C5D), 75.9 (C5B), 72.9 (C5A, C3D), 72.1 (C3C), 71.8 
(C3B), 70.4 (C2D), 68.9 (C3A), 67.3 (C4A), 67.1 (C4B), 66.9, 66.7 (C4C, 
C4D), 61.1 (C6B), 60.7 (C6D), 60.5 (C6C), 60.3 (C6A) ppm. 
1
JC1A, H1A = 172.1 Hz (α), 
1
JC1B, H1B = 159.9 Hz (β), 
1
JC1C, H1C = 162.0 Hz (β), 
1
JC1D, H1D = 160.6 Hz (β) 
31
P NMR (242.9 MHz, CDCl3, 25 °C): δ = 1.6 ppm. 
HRMS: m/z calcd. for C24H42O24P [M - H]
-
: 745.1804; Found 745.1835. 
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3 Multivalency: Introducing the second dimension 
Multivalency, as a concept, has received considerable attention ever since its 
discovery in nature in the 1970s. Typically, a multivalent structure bearing 
several binding epitopes will interact more strongly with biological receptors 
than the free binding epitope. Exploiting this property, potentially allows the 
preparation of more efficient compounds for battling infections and other 
diseases. 
Allergies are an increasing problem in the civilized world, with up to 30% of the 
population in some regions suffering from nasal allergies. The options for 
treating the underlying pathological reason for allergies are limited, with specific 
allergen immunotherapy being the only viable alternative. The method does, 
however, suffer from drawbacks such as long treatment times and high 
likelihood of allergic side reactions.  
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In this chapter, the synthesis and thorough characterization of acetylated 
trivalent mannobiose glycoclusters will be discussed, together with the potential 
of using such compounds as adjuvants in specific allergen immunotherapy. 
Optimally, adjuvants could be used to significantly decrease the amount of time 
and allergens required for the treatment. 
The work in this chapter is based on the previously published paper: Acetylated 
Trivalent Mannobioses – Chemical Modification, Structural Elucidation 
and Biological Evaluation, J. Rahkila, R. Panchadhayee, A. Ardá, J. Jiménez-
Barbero, J. Savolainen, R. Leino, ChemMedChem, 2016, 11, 562 – 574. Cover 
picture copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with 
permission. 
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3.1 Introduction 
Multivalency, as a term, is used to describe a molecule where several similar 
structures are attached to a backbone, thus creating a single molecule that can 
interact with several targets at once. The binding affinity of a multivalent 
compound to a receptor, is typically significantly  higher than that of the free 
ligand, with respect to the number of binding epitopes present.
1
 This 
phenomenon has become known as the “cluster effect”.  
Natural glycoproteins, glycolipids, and various polysaccharides make up the 
glycocalyx, a thick layer that covers all cells. This layer expresses multiple 
carbohydrate constituents of the same type, and therefore multivalent 
interactions between carbohydrates and lectins, i.e. carbohydrate-binding 
proteins, are of utmost importance in biological systems. The first steps of the 
infection process for many pathogens, such as bacteria, viruses, fungi etc. are 
typically mediated by protein-carbohydrate interactions.
2–6
 
The multivalent nature of interactions between carbohydrates and proteins has 
been known since the 1970s,
7–9
 and considerable attention has since then been 
focused on imitating nature with, synthetic, multivalent structures.
10,11
 As 
mentioned previously, the interactions between carbohydrates and proteins are 
typically very weak. Since its discovery, multivalency has become a popular 
solution for overcoming this problem, and over the years a large number of 
impressive structures based on protein, polymer, dendrimer, cyclodextrin, 
fullerene, gold nanoparticle, quantum dot and similar scaffolds have been 
prepared and new technologies are constantly emerging.
6,10,12
 
Synthetic, multivalent, carbohydrate structures can be used to prevent pathogens 
from being able to interact with host cells, therefore preventing an infection. 
Combining the concept of multivalency with immunogenic carbohydrate 
structures could, potentially, result in vaccines that imitate the way antigens are 
presented on a cell surface, without having to use dead or attenuated cells.
13
 
The following sections will provide a brief overview of allergic inflammation, 
and the potential use of immunostimulatory mannose-derived glycoclusters as 
adjuvants for specific allergen immunotherapy. 
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3.2 Allergy 
The immune system is highly complex, and immune responses are complicated 
cascades of reactions. Therefore, a detailed description would be beyond the 
scope of this thesis, and only the most relevant aspects will be discussed. 
Immune responses are regulated by a class of cells called helper T cells (TH), 
which are further be divided into TH1, TH2 and regulatory Treg cells based on 
their cytokine secretion profiles. TH1 cells produce interferon-γ (IFN-γ),
14
 which 
activates macrophages, a type of white blood cells that digest foreign particles, 
cells and in general anything that does not display certain proteins which 
identify a particle as part of a healthy body. TH2 cells secrete interleukins (IL) 4, 
5 and 13, which are involved in allergic inflammations via activation of immune 
cells, such as basophils, mast cells and eosinophils.
15–17
 The cytokines secreted 
by TH1 and TH2 cells suppress the effects of the reciprocal phenotype.
18
 Finally, 
Treg cells regulate the responses of both TH1 and TH2 cells by secreting IL-10, 
which suppresses both of these responses.
19,20
 
The secretion of IL-4 by TH2 cells stimulates B cells to differentiate into plasma 
cells, which produce immunoglobulins (Ig), i.e. antibodies. Specifically, the 
antibody IgE stimulates basophils and mast cells to secrete small-molecular local 
mediators, such as histamine and serotonin.
16,21
 These molecules signal the body, 
that it has encountered a potentially harmful substance that it needs to dispose 
of. The response is mucus secretion, coughing, sneezing and diarrhea to expel 
the detected antigens. IL-5, also secreted by TH2 cells, causes local inflammation 
via activation of eosinophils, which release reactive oxygen species, lipid 
mediators such as prostaglandin, and a number of cytokines, including additional 
IL-5 and tumor necrosis factor alpha (TNF-α).21–23 The role of the inflammatory 
response is to kill any harmful pathogens, but unfortunately it can also cause 
damage to native cells. 
When our bodies encounter foreign substances, the immune response can, in a 
very simplified scenario, be dominated by either TH1 or TH2 type responses. If a 
particle of pollen enters our body the typical immune response is via the TH1 
pathway, which causes secretion of IgG4 that targets the antigens on the pollen 
particle and marks it for disposal. This results in the particle being removed from 
the body in a harmless way. If, for some reason, the response is dominated by 
the TH2 pathway, however, the aforementioned inflammatory response takes 
place.
20
 This condition, where the immune system is dominated by TH2 
responses, and reacts excessively towards a normally harmless substance, such 
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as a pollen particle is known as allergy, or more formally as type I 
hypersensitivity disorder. 
There are many ways of treating the symptoms of allergies, such as 
antihistamines which act to negate the effects of histamine, decongestants that 
reduce mucus secretion, steroids that reduce the inflammation and various other 
pharmaceuticals that counteract the chemicals responsible for the allergic 
response. There are, however, limited ways of treating the actual cause of 
allergies. Specific immunotherapy (SIT), also known as hyposensibilization, is a 
treatment form where patients suffering from allergies are treated with repeated 
injections (sublingual and oral treatments are emerging but these are typically 
not as effective)
24
 of increasing amounts of a specific allergen. This treatment 
acts to normalize the response dominated by TH2 cells, towards a protective TH1 
and Treg response. SIT is a potent method for treating allergies, and typically 
offers long-lasting protection. This is currently the only way of treating the 
underlying pathological immune response associated with allergies. The 
traditional method suffers from some drawbacks, though, as the treatment times 
are very long, up to five years, and the required amount of allergen is substantial, 
which can cause severe allergic reactions and in the worst case even 
anaphylaxis. Because of the long time required for the treatment, and large 
number of injections, allergic patients might be forced to wait for more than a 
year to start the treatment. Furthermore, the allergic reactions often cause people 
to abort the treatment.
25
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Figure 3.1. General structure of MPLA used as an adjuvant in allergy treatments. 
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There is, however, great potential in modifying the immune response to optimize 
the SIT procedure. Adjuvants, are compounds that are added to vaccines to 
modify how the immune system interacts with the active ingredient in the 
vaccine. Similar methods can be applied to SIT as well by choosing adjuvants 
that stimulate the immune system to respond in a desired manner.
26
 Because the 
TH1 and TH2 responses suppress the response of the reciprocal phenotype, 
downregulation of TH2 or upregulation of TH1 type responses will yield similar 
effects. 
In human vaccines, the most commonly used adjuvants are based on inorganic 
salts such as aluminum phosphate and aluminum hydroxide, commonly known 
as alum. These adjuvants promote TH2 type responses, causing increased IgE 
production which, while preferable for conventional vaccines, makes them 
unsuitable for adjuvants in allergy treatments. There are, however, promising 
candidates specifically for adjuvants in SIT. Single-strand DNA fragments 
(CpG-ODN), which act as Toll-like receptor (TLR) 9 agonists have shown 
promise in phase I and II clinical studies.
27–31
 Monophosphoryl lipid A (MPLA, 
Figure 3.1), a non-toxic modification of the endotoxin lipid A, is a TLR-4 
agonist, that has been shown to reduce the number of require injections in SIT 
from more than 50 to four. MPLA is marketed under the name Pollinex 
Quattro™ which is a preparation approved for human use.25 
While both CpG-ODN and MPLA are good candidates for adjuvants, they could 
encounter some difficulties due to the nature of the compounds. CPG-ODN is 
essentially a gene, which could result in people regarding it with some 
reluctance. The MPLA used as an adjuvant is derived from a toxic bacterial 
compound, and while it has been found to be safe for human use it might, due to 
its origin, be misinterpreted as harmful. 
The β-(1→2) linked mannosides discussed in the previous chapter are known to 
be immunogenic, and stimulate antibody production. This property could, 
potentially, be exploited for SIT. A very specific class of compounds that 
contain such structures will be discussed in the following section. 
3.3 Trivalent acetylated mannobiose as adjuvants in 
specific allergen immunotherapy 
In previous work, a large number of carbohydrate-based structures have been 
screened for potential adjuvant activity in hyposensibilization treatments. The 
compounds ranged from natural fungal polysaccharides, to synthetic 
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oligosaccharides and oligovalent structures (Figure 3.2).
32–35
 The cytokine 
responses induced by the compounds were investigated in an in vitro model, 
using peripheral blood mononuclear cell (PBMC) samples from atopic subjects. 
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Figure 3.2. Examples of molecules screened in previous studies. 
The broad screening allowed for determination of key structural elements, and 
one particular compound showed great promise as a potential adjuvant in 
allergen immunotherapy due to its unusually strong ability to induce IL-10 and 
IFN-γ production, compared to the other compounds. In this particular 
compound, depicted in Figure 3.3, the key structural elements were identified as 
1) β-(1→2) linked mannobiose, 2) α-linkage to the spacer fragment, 3) 
trivalency and 4) complete acetylation. From here on this compound will be 
referred to as 1.  
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Figure 3.3. Structure of the previously discovered lead compound 1. 
If the distance between the mannobiose units is a critical factor in whether the 
molecule is biologically active or not, it could be reasoned that even a small 
change in the linker length might cause significant changes in the activity. If on 
the other hand the activity is not closely linked to the spatial arrangement of the 
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mannobiose units, a significantly longer linker might be required for achieving a 
difference in activity. Based on these assumptions, and the structure of 1, two 
new molecules, 2 and 3 (Figure 3.4), were designed and prepared. In 2, the 
linker is extended by one CH2 group, and in 3, the linker is replaced by a 
triethylene glycol moiety. 
The biological screening required the compounds to be at least somewhat 
soluble in water, which limited the alternatives for the linker structure. 
Compound 1, with an ethyl linker, had a solubility of approximately 0.4 mg/mL, 
and for compound 2 it was even less, close to the limit of the required solubility 
for the screening. An analogue of 3, with a nonyl chain instead of the triethylene 
glycol, would certainly have been, for all practical purposes, completely 
insoluble in water. Opting to use a triethylene glycol linker instead made the 
compound soluble enough for the screening.  
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Figure 3.4. Structures of compounds 2 and 3. 
In addition to their biological activities, the behavior of the molecules in solution 
was investigated by a combination of NMR spectroscopic techniques and 
molecular dynamics simulations. 
3.4 Synthesis of acetylated trivalent mannobioses 
The synthetic preparation of compounds 2 and 3 is largely based on the previous 
synthesis of multivalent mannobioses.
33
 The synthesis of the monosaccharide 
building blocks 4 and 5 (Figure 3.5), which is practically identical to the 
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synthesis in the previous chapter, has been previously published and will thus 
not be discussed further here. 
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Figure 3.5. Structures of donors 4 and 5. 
The linker moieties were prepared by reacting 3-bromo-1-propanol, and 2-[2-(2-
chloroethoxy)ethoxy]ethanol, respectively, with sodium azide to form the azido-
functionalized linkers 6 and 7, according to previously published methods.
36,37
 
These two compounds were used as acceptors in glycosylation reactions with 4, 
using NIS/TMSOTf as the promotor system. The acetyl group on C-2 directed 
the stereochemical outcome of the reaction via neighboring group participation, 
resulting in excellent stereoselectivity. After the glycosylation reaction, the 
acetyl group was removed under Zemplén conditions to afford acceptors 10 and 
11 (Scheme 3.1). 
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Scheme 3.1. Reagents and conditions: i) NaN3, H2O, 80 °C, 48 h (67%); ii) NaN3, DMF, 
90 °C, 19 h (90%); iii) 6 or 7, NIS/TMSOTf, CH2Cl2, –40 °C, 2 h, 8 (70%), 9 (56%); iv) 
NaOMe/MeOH, r.t., 3 h/30 min (8/9), 10 (96%), 11 (quantitative). 
The β-(1→2) linkage in the disaccharide was constructed in the same way as in 
the previous chapter, using the Crich β-mannosylation protocol. Monosaccharide 
donor 5 was activated with BSP and Tf2O in the presence of TTBP, after which 
acceptors 10 or 11 were added (Scheme 3.2). The yields of the reactions were 
not very impressive, and significant decomposition of the activated donor was 
observed. This could be due to the increased reactivity of the donor caused by 
the electron-donating PMB groups on C-2 and C-3. The yields of disaccharides 
12 and 13 were 57% and 43% respectively. 
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Scheme 3.2. Reagents and conditions: i) 1. BSP, TTBP, Tf2O, CH2Cl2/1-octene 3:1, –60 
°C, 30 min, 2. 10/11, –78 °C, 3h/2h, 12 (57%), 13 (43%). 
The choice of protecting groups allowed, once again, the removal of all 
protecting groups in one step. PMB-ethers can be removed by hydrogenation 
over palladium, but this could have resulted in undesired reduction of the azide 
to amine, which is why another approach was selected. Furthermore, while 
deprotection after forming the trivalent compound would have been possible, 
and this would have circumvented the possibility of reducing the azide, the high 
probability of causing complex mixtures and poor yields, in case of incomplete 
deprotection, prompted to replace the protecting groups with acetyl groups 
before the click reaction. Because hydrogenation to remove the protecting 
groups was to be avoided, PMB ethers were used instead of benzyl ethers, as 
these can be easily removed under acidic conditions (TFA in this case), as can 
the benzylidene acetals. 
Upon hydrolysis, the PMB groups form reactive carbocation intermediates, 
which can, in principle, undergo nucleophilic addition by any free hydroxyl 
group on the target compound. This is an equilibrium reaction and in order to 
drive the reaction to completion, a good nucleophile, 1,3-propanedithiol, was 
used as cation scavenger (Scheme 3.3). 
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Scheme 3.3. Deprotection of PMB ethers in presence of 1,3-propanedithiol. 
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The unprotected intermediates were dissolved in water and washed with 
dichloromethane to remove the byproducts soluble in organic solvents. No 
further purification or isolation of the intermediates was carried out, and they 
were used as such in the subsequent acetylation step. The acetylation was carried 
out by standard protocols using acetic anhydride in pyridine (Scheme 3.4). 
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Scheme 3.4. Reagents and conditions: i) 1,3-propanedithiol, TFA/H2O/CH2Cl2 4:1:10, 
r.t., 3h/2h (12/13); ii) Ac2O, pyridine, r.t., 18 h 14 (61%), 15 (75%). 
The final trivalent compounds were constructed using copper(I)-catalyzed azide-
alkyne cycloaddition (“click” reaction), to attach the finished azido-
functionalized acetylated mannobioses to a central glycerol moiety, bearing 
three propargyl groups. The reaction was carried out under standard conditions, 
and Cu(I) species were generated in situ by reduction of Cu(II) from CuSO4 by 
Na-ascorbate (Scheme 3.5). The glycerol backbone was prepared by treating 
glycerol with sodium hydride in DMF, followed by addition of propargyl 
bromide in toluene according to a previously published method.
38
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Scheme 3.5. Reagents and conditions: i) CuSO4, Na-ascorbate, CH2Cl2/H2O/t-BuOH, 
1:1:1, 55 °C, 18 h, 2 (62%), 3 (89%). 
All isolated products were thoroughly characterized by NMR spectroscopic 
methods to assure that the correct products had formed. The anomeric 
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configurations after the glycosylation reactions were determined by measuring 
the 
1
JC1-H1 coupling constants, which were found to be 170.6 Hz and 170.5 Hz 
for 8 and 9 respectively. For disaccharides 12 and 13, the 
1
JC1A-H1A coupling 
constants were found to be 171.7 Hz and 171.5 Hz respectively, and 
1
JC1A-H1A 
coupling constants were 155.0 Hz and 154.3 Hz respectively. These coupling 
constants confirmed the α-linkage to the linker moiety, and β-linkage between 
mannopyranosyl units. 
After the click reaction, the substituent positions on the triazole rings were 
confirmed, also by NMR methods, using the HMBC experiment which clearly 
showed a correlation between the CH functionality of the triazole and the closest 
CH2 of the linker. This correlation verifies, that the triazoles are 1,4-substituted, 
as is expected based on the mechanism when copper is used as the catalyst 
(Scheme 3.6),
39
 as opposed to 1,5 substituted triazole, which would be the other 
alternative commonly obtained when using ruthenium catalysts.
40
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Scheme 3.6. Mechanism of the copper(I) catalyzed azide-alkyne cycloaddition reaction. 
To clarify the numbering of the atoms in the molecules, which will be important 
for the following section, the two mannose moieties are denoted as A and B 
according to convention. The carbon atoms in the linker are denoted with primed 
numbers starting from the carbon atom closest to the mannobiose and, finally, 
the carbon atoms of the glycerol moiety are denoted only as G1 and G2 (as the 
terminal carbon atoms are not distinguishable by NMR, Figure 3.6) 
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Figure 3.6. Numbering of the atoms in the trivalent compounds. 
3.5 Conformational studies 
As already discussed in the previous chapter, the three-dimensional structure of 
molecules is of importance from a biological perspective and plays an important 
part in how potentially bioactive molecules interact with biological receptors. 
While it is possible to determine the absolute energy minimum of almost any 
molecule, such a single conformation would not be of much relevance in 
molecules like the ones discussed in this chapter. The molecules have a large 
number of degrees of freedom which typically means that the energy minimum 
is not well defined, and the molecules are likely to adopt a number of different 
conformations. 
The three molecules 1, 2 and 3 were investigated by NMR spectroscopic 
techniques, using Diffusion Ordered SpectroscopY (DOSY) and Rotating frame 
Overhauser Effect SpectroscopY (ROESY). It is, perhaps, worth noting that the 
molecular weights of these molecules are significantly larger than those of the tri 
and tetrasaccharide in the previous chapter, but it was still suspected that the 
NOE effect would be too close to the zero-crossing, which is why ROESY was 
used instead of NOESY. 
DOSY, is a technique that is used for measuring diffusion coefficients of 
molecules. The diffusion coefficient gives information about the hydrodynamic 
radius (volume) of the molecules. In this case, only the relative diffusion 
coefficients were of interest and because of that no calibration was necessary. 
The DOSY spectra showed that, even though the length of the linker varies 
significantly between the molecules, the physical size of all molecules was 
practically identical. Ultimately, this is not very surprising as the solvent is very 
polar, and the compounds themselves are rather non-polar. Because of this, the 
molecules are rather interacting with themselves, exposing as little as possible to 
the polar solvent. This indicates that the molecules all adopt similar, folded 
conformations.  
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While all the biological screenings were performed in water, the NMR 
spectroscopic experiments were carried out in methanol (d4) due to the low 
water solubility of the compounds, which would have resulted in long 
experiment times, especially for compound 2. Methanol is quite similar to water 
with respect to polarity and dielectric constant (pH2O = 1.85 D, εH2O = 80.1, pMeOH 
= 1.69 D and εMeOH = 32.7). Because of this the behavior in methanol is expected 
to be very similar to that in water. 
The signals from the three mannobiose units were practically indistinguishable, 
which in itself was not surprising, but it complicated the analysis of the ROESY 
spectra. One advantage of using ROESY (in addition to the obtained correlations 
always being positive), is that the lack of signals can provide as much 
information as the signals themselves, as they are not as sensitive to molecular 
motion as NOESY signals. The severe overlapping in the spectra made it 
impossible to distinguish correlations between mannobiose units, from those 
within the same unit, which also makes the accurate calculation of distances 
practically impossible. It is, however, safe to assume that the distances between 
atoms of the reported correlations are no more than 4 Å apart, as this is the 
approximate limit at which range ROESY correlations can be seen in molecules 
of this size.
41
  
In addition to NMR experiments, the conformational behavior of the molecules 
was also investigated using molecular modelling methods. The exact details are 
described in the experimental section below. Key intramolecular distances were 
extracted from the trajectories obtained from molecular dynamics simulations, 
and these were compared to the correlations seen in the ROESY spectra using 
well-established approaches.
42
 
3.5.1 Conformational behavior of compound 1 
As expected, during the molecular dynamics simulation a large number of 
conformations were observed. During the high-temperature phase of the 
simulated annealing, the dominating conformation had each of the arms pointing 
away from the central core of the molecule. When the temperature was lowered, 
however, the molecule started to fold in on itself. At the final simulation 
temperature, a folded conformation seemed to be preferred over a spread out 
conformation. 
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Figure 3.7. ROESY spectrum of compound 1. 
 
Figure 3.8. Stereoscopic view of 1. Hydrogens are omitted for clarity. 
The most interesting ROESY correlations in this compound were between the 
triazole protons and parts of the carbohydrate region of the spectrum, namely to 
H1A, H2A and H3A (Figure 3.7). The distances between the triazole protons 
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and the carbohydrate protons were, from the molecular dynamics simulations, 
calculated to be 3.3, 3.2 and 4.0 Å respectively. This supports the hypothesis of a 
folded structure, and also shows that the MD simulation seems to correctly 
predict the behavior of the molecule in solution. Furthermore, correlations 
between H1A and H2B are seen, which is characteristic of the αβ configuration 
of the glycosidic linkages present in the molecule. Additionally, correlations 
between protons H3A and H5A, as well as between H1B, H3B and H5B were 
observed confirming that the individual mannopyranosyl units are in 
4
C1 
conformations. While the exact energy minimum of the molecule is not very 
well defined, most of the low-energy conformations after the annealing protocol 
are rather similar. The most populated conformation is depicted in Figure 3.8. 
3.5.2 Conformational behavior of compound 2 
 
Figure 3.9. Stereoscopic view of 2. Hydrogens are omitted for clarity. 
The overall behavior of 2 is very similar to that of 1, which is to be expected, as 
the difference in structure is quite small. The main difference is that the addition 
of one additional CH2 moiety appears to move the triazole far enough, that 
correlations between triazole protons and carbohydrate protons are no longer 
observed. This is a reasonable result, as the distances in 1 are already close to the 
limitations of the experiment itself. Several correlations between the linker 
protons and carbohydrate protons can, however, be seen. The most relevant in 
this case are H1A–H1ʹ (2.4 Å), H1A–H2ʹ (4.0 Å), H5A–H1ʹ (2.6 Å), H5A–H2ʹ 
(3.6 Å) and H5A–H3ʹ (3.6 Å) (Figure 3.10). This indicates that the linker arms 
are located close to the underside of the first mannopyranosyl unit, further 
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supporting a folded conformation. The most populated conformation from the 
MD simulation is depicted in Figure 3.9. 
 
Figure 3.10. ROESY spectrum of compound 2. 
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3.5.3 Conformational behavior of compound 3 
The significantly longer, and slightly more polar, linker of compound 3 changes 
the overall behavior of the molecule compared to the other two. There is, as 
expected, no well-defined energy minimum, and the overlapping of the linker 
protons in the NMR spectra, makes it difficult to analyze the ROESY spectrum 
in detail. It does, however, appear that the preferred conformation of 3 is a 
folded one similar to 1 and 2, and correlations from the linker protons to almost 
all carbohydrate protons except H4A and H4B can be seen (Figure 3.11). As 
discussed in the previous chapter, in the typical conformation of β-(1→2) linked 
mannosides these two protons are hidden inside the helical structure, making it 
difficult for them to move close to the linker. The glycosidic angles ϕ and 
aglyconic angles ψ between the two mannopyranosyl units were found to be 
~60° and ~20–30° respectively, consistent with the typical conformation for this 
class of compounds. One low-energy conformation is depicted in Figure 3.12. 
 
Figure 3.11. ROESY spectrum compound of 3. 
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Figure 3.12. Stereoscopic view of 3. Hydrogens are omitted for clarity. 
It should be noted, that none of the ROESY spectra of molecules 1, 2 and 3, 
show correlations between the glycerol backbone and carbohydrate or linker 
protons. This indicates that the glycerol moiety is on one side of the molecule, 
and the arms with the mannobioses are on the other side. This is consistent with 
the molecular dynamics simulations. All molecules also leave the triazole rings 
on the outside of the structure. This could potentially allow them to interact with 
biological targets, and it is known that triazoles can participate in this type of 
interactions. There are a number of pharmaceuticals where triazole moieties play 
key parts in the biological activity.
43,44
 Although the role of the triazole moiety 
in the biological activity of the trivalent compounds cannot be ruled out 
completely, it must be emphasized, that out of a large number similar structures, 
some with triazole moieties and some without, only compound 1 showed 
significant in vitro activity in previous screenings.
32–35
 This indicates that the 
properties described above, and depicted in Figure 3.3 are in key position for the 
biological activity of this class of compounds. 
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3.6 Biological studies 
3.6.1 PBMC screening. 
The effects of 1, 2, 3, MPLA and CpG-ODN on allergen (Bet v) induced 
cytokine responses in PBMC cultures of 14 birch allergic rhinitis patients were 
screened, and are presented in Figure 3.13. Stimulation with birch induced 
significant response of TH2 cytokine IL-4 (mean 45.3 pg/mL, SEM 11.2 pg mL
-
1
), as compared to non-stimulated culture (mean 0.4 pg mL
-1
, SEM 0.2 pg mL
-1
) 
(p =0.0015). A significant suppression of  birch-induced production of IL-4 was 
seen with 10 (p < 0.001) and 100 µg mL
-1
 (p = 0.036) of compound 2, 10 (p = 
0.016) and 100 µg mL
-1
 (p = 0.021) of compound 3, 10 (p = 0.016) and 100 µg 
mL
-1
 (p = 0.006) of 1, 1 (p = 0.002) and 10 µg/ml (p =0.0.013) of MPLA and 
200 µg mL
-1
  of CpG-ODN (p = 0.002). Dose–response curves of suppression 
were seen only with compounds 1-3, as lower concentrations of CpG-ODN 
increased the IL-4 production, and the highest concentration of MPLA had no 
suppressive effect (Figure 10). Significantly increased production of pro-
inflammatory cytokine TNF was seen with 100 µg mL
-1
 (p=0.021) of compound 
2, 100 µg mL
-1
 (p = 0.0039) of compound 3 and 20 (p = 0.0026) and 200 µg mL
-
1
 (p < 0.001) of CpG-ODN (Figure 3.13). 
Glycoclusters 1, 2 and 3 all had a dose-dependent effect on birch-allergen-
induced IL-4 production by PBMCs from patients suffering from birch allergy. 
MPLA was found to only inhibit IL-4 production at lower concentrations, with 
higher concentrations having no effect. At lower concentrations, CpG-ODN 
seemed to increase the production of IL-4, but at higher concentration the 
production was significantly decreased. With IL-4 being the most important 
cytokine in the development of an allergic inflammation, a clear dose–response 
allows for specific modulation of its production. 
Tumor necrosis factor (TNF) production was not induced by compound 1, and 
for compounds 2 and 3 it was induced only at the highest concentrations. CpG-
ODN, however, was found to be a strong inducer of TNF, whereas the increase 
by MPLA was not statistically significant. TNF is a pro-inflammatory cytokine 
involved in, for example, inflammations in rheumatoid arthritis, cancer, 
Alzheimer’s disease and many others.45,46 An increased TNF production would, 
therefore, be considered unfavorable and even harmful, which needs to be taken 
into account when selecting the adjuvant to use. 
Multivalency: Introducing the second dimension 
92 
 
 
Figure 3.13. IL-4 (left) and TNF (right) responses of PBMCs stimulated with Bet v with 
and without adjuvants. 
3.6.2 TLR ligation screening 
CpG-ODN and MPLA act via activation of TLR receptors (TLR-9 and TLR-4 
respectively), which prompted to screen compounds 1, 2 and 3 for binding to 
human TLRs (TLR 2, 3, 4, 5, 7, 8 and 9) as well. No binding was witnessed 
between the trivalent mannobioses and any of the TLR receptors. The fate of the 
acetyl groups under biological conditions is at present unclear, and it is 
reasonable to assume that they are, at least partially, hydrolyzed. A fully 
deprotected analogue of 1, which was previously shown to have no activity in in 
vitro screening,
33
 also did not bind any of the TLRs screened. 
3.6.3 Possible copper contamination 
Copper is an essential trace element, vital for many biological functions, for 
example metabolism.
47,48
 Copper ions also have the ability to generate reactive 
oxygen species, making them toxic in higher concentrations.
49–51
 Because the 
final synthetic step in preparation of trivalent compounds 1, 2 and 3 is catalyzed 
by copper ions, it is crucial to ensure that the copper content in the final 
compounds is not going to interfere with the biological screening. The copper 
contents of all three glycoclusters were analyzed by ICP-MS, which showed that 
the residual copper content after the purification ranged between 7 – 8 mg kg-1. 
The highest concentrations of the compounds used in the biological screenings 
were 100 µg mL
-1
, giving a final concentration of copper as 0.7 – 0.8 ng kg-1. 
The concentration of copper ions in human blood ranges from ~0.85 µg mL
-1
 to 
2 µg mL
-1
,
52–54
 which is three orders of magnitude higher than the copper 
concentration induced by the glycoclusters. It can therefore safely be assumed 
that the copper content of the investigated molecules is not biologically 
significant. 
Multivalency: Introducing the second dimension 
93 
 
3.7 Conclusions 
A new trivalent acetylated mannobiose glycoclusters, based on the design of a 
previously discovered immunostimulatory lead molecule was prepared. The 
prepared molecules, as well as the previously discovered lead molecule and 
compound 2, were subjected to thorough NMR spectroscopic investigations, 
combined with molecular modelling to elucidate their conformational behavior 
in solution. The modelling results correlate well with the data extracted from 
DOSY and ROESY spectra, verifying that the molecular dynamics simulation 
provides a realistic representation of the molecules. 
It was shown that, while both the length and polarity of the linker was varied 
quite significantly, the conformational behaviors of all three molecules in 
solution were practically identical. The similar behavior of all compounds 
correlated well with their similar biological activities. 
The prepared glycoclusters were found to be able to suppress Bet v induced IL-4 
production by PBMCs from patients with birch allergy, indicating their potential 
as adjuvants in allergen immunotherapy. The low TNF production induced by 
the molecules makes them have potentially fewer harmful side effects than 
currently used adjuvants. Furthermore, the low TNF production induced by the 
glycoclusters indicates that the mechanism behind the immunostimulatory effect 
may be different from the previously disclosed adjuvants CpG-ODN and MPLA, 
which act via TLR activation. This is also consistent with the fact that no 
binding was witnessed in TLR screening. 
3.8 Experimental 
3.8.1 Instrumental and general details 
Preparation and spectral data of compound 2, together with some results from 
the biological screening of compounds 1 and 2 reported here, have also been 
briefly addressed previously in a patent application.
55
 All reagents for synthetic 
work were purchased from Sigma-Aldrich, and used without further purification. 
Dry CH2Cl2 was obtained by distillation over CaH2 and dry DMF was purchased 
as such, and stored over molecular sieves. TLC was performed on aluminum 
sheets precoated with silica gel 60 F254 (Merck) and the spots were visualized by 
UV, and charring by treatment with H2SO4 in MeOH (20 % v/v) followed by 
heating. Column chromatography was performed using Silica gel 60 (0.040–
0.060 mm Merck). 
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Optical rotations were measured with a Perkin-Elmer 241 polarimeter using the 
D-line of sodium at 589 nm at 24 °C, unless mentioned otherwise. HRMS were 
recorded on a Bruker MicroToF-Q with electrospray ionization operating in 
positive mode. 
NMR spectra were recorded on Bruker Avance spectrometers operating at either 
600.13 Hz or 500.13 Hz (
1
H) and 150.90 Hz or 125.77 Hz (
13
C). The complete 
assignment of proton and carbon spectra was carried out by recording a standard 
set of NMR experiments, 
1
H NMR, 
13
C NMR, DQF-COSY, HSQC (both 
coupled and decoupled) and HMBC. The complexities of the spectra were 
reduced to monosaccharide level by using 1D-TOCSY. ROESY and DOSY 
methods were used to help with the conformational studies. The chemical shifts 
are referenced to an internal standard (tetramethylsilane, δ = 0.0 ppm in both 1H 
and 
13
C) or residual solvent signals (CDCl3, δ = 7.26 ppm in 
1
H and 77.16 ppm 
in 
13
C) and reported with two decimals for 1H NMR and one decimal for 
13
C 
NMR. Where this was not enough to separate the signals, an additional decimal 
was reported. Accurate coupling constants were, where possible, determined 
with the NMR simulation software PERCH
56
 and reported with one decimal. To 
avoid unnecessary bloating of the NMR data, each coupling constant was 
reported only the first time it is encountered. 
The molecular modeling and visualization was done in Maestro, and the 
calculations were performed by Desmond using the built-in interface in Maestro. 
Initially, the molecules were constructed in Maestro
57
 after which the 
calculations were carried out using Desmond,
58
 controlled via the built-in 
interface in Maestro. For a good starting point for the molecular dynamics 
simulations, a quick minimization sequence over 1000 steps was performed after 
constructing the molecules, and the results visually inspected in order to see if 
they were reasonable. The molecular dynamics simulations started with a 
simulated annealing sequence, where the temperature was first raised to 600 K 
and then slowly lowered from to the final simulation temperature, which in our 
case was lower than ambient temperature in order to shift the solvent signals, so 
they do not overlap with important signals in the NMR spectra. Furthermore, the 
lower temperature caused some of the overlapping proton signals to shift apart, 
making it easier to extract information from the ROESY spectra. The annealing 
was repeated to make sure that the molecules were not stuck in a high energy 
local minimum. After the annealing, the molecular dynamics simulation was run 
for 2 ns, during which the structures were stored every 1 ps. From these 
structures, the average distances between protons were measured, and since the 
NOE effect is proportional to r
-6
,
41
 this factor was used as weight when 
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calculating the average distances. Out of the generated structures, the most 
populated conformation families were analyzed, and verified using the 
correlations seen in the recorded ROESY spectra. 
3.8.2 Synthetic procedures 
3-Azido-1-propyl 2-O-acetyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-
mannopyranoside (8):  A solution of Phenyl 2-O-acetyl-4,6-O-benzylidene-3-
O-(4-methoxybenzyl)-1-thio-α-D-mannopyranoside (2 g, 3.82 mmol, 1 
equivalent) and 3-azido-1-propanol (464 mg, 4.59 mmol, 1.2 equivalents) in dry 
CH2Cl2 (15 mL) under argon was cooled down to –40 °C. NIS (1.03 g, 4.59 
mmol, 1.2 equivalents) and TMSOTf, (36 µl, 0.20 mmol, 0.05 equivalents) were 
added and the reaction mixture was stirred at –40 °C for 2 h. The reaction was 
quenched by adding 100 µl Et3N. The reaction mixture was filtered and diluted 
with CH2Cl2 (40 mL) and then washed with water (30 mL), satd. NaHCO3 (2 
×30 mL) and brine (2 × 30 mL). The organic layer was dried over Na2SO4 and 
concentrated. The crude mixture was purified by column chromatography 
(hexane : EtOAc 2 : 1) to afford pure product 8 as a colorless foam. Rf = 0.31. 
Yield: 1.09 g (56 %). [α]D
25
 = –3.1° (c 1.0, CHCl3). 
1
H NMR (600.13 MHz, 
CDCl3, 25 °C): δ = 7.50 (m, 2 H, arom. H), 7.40–7.35 (m, 3 H, arom. H), 7.27 
(m, 2 H, arom. H), 6.84 (m, 2 H, arom. H), 5.62 (s, 1 H, 4,6-OCHPh), 5.36 (dd, 
1 H, JH2, H1 = 1.6 Hz, JH2, H3 = 3.5 Hz, H2), 4.77 (d, 1 H, H1), 4.63 and 4.58 (each 
d, each 1 H, J = –11.6 Hz, 3-OCH2Ph), 4.26 (dd, 1 H, JH6a, H5 = 4.8 Hz, JH6a, H6b = 
–10.3 Hz, H6a), 4.04 (dd, 1 H, JH4, H3 = 10.0 Hz, JH4, H5 = 9.3 Hz, H4), 3.97 (dd, 1 
H, H3), 3.83 (dd, 1 H, JH6b, H5 = 10.4 Hz, H6b), 3.81 (ddd, 1 H, H5), 3.79 (s, 3 H, 
OCH3), 3.78 (ddd, 1 H, JH1ʹa, H1ʹb = –9.8 Hz, JH1ʹa, H2ʹa = 6.2 Hz, JH1ʹ, H2ʹb = 6.1 Hz, 
H1ʹa), 3.49 (ddd, 1 H, JH1ʹb, H2ʹa = 6.8 Hz, JH1ʹb, H2ʹb = 5.5 Hz, H1ʹb), 3.78 (ddd, 1 
H, JH3ʹa, H2ʹa = 8.1 Hz, JH3ʹa, H2ʹb = 8.5 Hz, JH3ʹa, H3ʹb = –13.0 Hz, H3ʹa), 3.37 (ddd, 1 
H, JH3ʹb, H2ʹa = 4.1 Hz, JH3ʹb, H2ʹb = 5.6 Hz, H3ʹb), 2.16 (s, 3 H, 2-OCOCH3), 1.87 
(ddddd, 1 H, JH2ʹa, H2ʹb = –7.8 Hz, H2ʹa), 1.86 (ddddd, 1 H, H2ʹb). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 170.4 (2-OCOCH3), 159.4, 137.5, 
130.1, 129.5, 129.0, 128.3, 126.2, 113.9 (arom. C), 101.7 (4,6-OCHPh), 99.0 
(C1), 78.3 (C4), 73.6 (C3), 72.0 (3-OCH2Ph), 69.8 (C2), 68.8 (C6), 64.8 (C1ʹ), 
64.2 (C5), 55.4 (OCH3), 48.4 (C3ʹ), 28.9 (C2ʹ), 21.2 (2-OCOCH3). 
HRSM: m/z calcd. for C26H32N3O8 [M+H]
+
: 514.2184, found 514.2149; m/z 
calcd. for C26H31N3NaO8 [M+Na]
+
: 536.2003, found 536.1952; m/z calcd. for 
C26H31N3KO8 [M+K]
+
: 552.1743, found 552.1712. 
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3-Azido-1-propyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-
mannopyranoside (10): The pH of a solution of 8 (920 mg, 1.79 mmol) in 
MeOH (20 mL) was adjusted to ~10 – 12 with 0.1 M NaOMe and the reaction 
mixture was stirred at room temperature for 4 h. The reaction mixture was 
neutralized with DOWEX-50WX8 H
+
 form, filtered and concentrated to afford 
pure product 10 as a colorless oil. Rf = 0.26 (hexane : EtOAc 2 : 1). Yield: 827 
mg (96 %). [α]D
25
 = +31.3° (c 1.0, CHCl3). 
1
H NMR (600.13 MHz, CDCl3, 25 
°C): δ = 7.42 (m, 2 H, arom. H), 7.32–7.25 (m, 3 H, arom. H), 7.20 (m, 2 H, 
arom. H), 6.78 (m, 2 H, arom. H), 5.62 (s, 1 H, 4,6-OCHPh), 4.83 (d, 1 H, JH1, H2 
= 1.5 Hz, H1), 4.80 and 4.66 (each d, each 1 H, J = –11.3 Hz, 3-OCH2Ph), 4.28 
(dd, 1 H, JH6a, H5 = 5.0 Hz, JH6a, H6b = –10.4 Hz, H6a), 4.10 Hz (dd, 1 H, JH4, H3 = 
9.63 Hz, JH4, H5 = 9.5 Hz, H4), 5.42 (ddd, 1 H, JH2, H1 = 1.5 Hz, JH2, 2-OH = 1.7 Hz, 
JH2, H3 = 3.5 Hz, H2), 3.90 (dd, 1 H, H3), 3.86 (dd, 1 H, JH6b, H5 = 10.4 Hz, H6b), 
3.81, (ddd, 1 H, H5), 3.80 (s, 3 H, OCH3), 3.79 (ddd, 1 H, JH1ʹa, H1ʹb = –10.0 Hz, 
JH1ʹa, H2ʹa = 6.1 Hz, JH1ʹa, H2ʹb = 6.0 Hz, H1ʹa), 3.49 (ddd, JH1ʹb, H2ʹa = 5.8 Hz, JH1ʹb, 
H2ʹb = 6.5 Hz, H1ʹb) 3.39 (ddd, 1 H, JH3ʹa, H2ʹa = 7.5, JH3ʹa, H2ʹb = 6.2 Hz, JH3ʹa, H3ʹb = –
12.3 Hz, H3ʹa), 3.37 (ddd, 1 H, JH3ʹb, H2ʹa = 6.2, JH3ʹb, H2ʹb = 7.0 Hz, H3ʹb), 1.87 
(each dddd, each 1 H, H2ʹa and H2ʹb). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.5, 137.6, 130.1, 129.6, 129.0, 
128.3, 126.1, 113.9 (arom. C), 101.6 (4,6-OCHPh), 100.2 (C1), 78.8 (C4), 75.4 
(C3), 72.9 (3-OCH2Ph), 70.0 (C2), 68.9 (C6), 64.5 (C1ʹ), 63.6 (C5), 55.3 (3 × 
OCH3), 48.4 (C3ʹ), 28.8 (C2ʹ). 
HRSM: m/z calcd. for C24H30N3O7 [M+H]
+
: 472.2078, found 472.2053; m/z 
calcd. for C24H29N3NaO7 [M+Na]
+
: 494.1900, found 494.1849; m/z calcd. for 
C24H29N3KO7 [M+K]
+
: 510.1637, found 510.1583. 
3-Azido-1-propyl O-[4,6-O-benzylidene-2,3-di-O-(4-methoxybenzyl)-β-D-
mannopyranosyl]-(1→2)-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-
mannopyranoside (12): To a solution of phenyl 4,6-O-benzylidene-2,3-di-O-(4-
methoxybenzyl)-1-thio-α-D-mannopyranoside (1.24 g, 2.03 mmol, 1.2 
equivalents) in CH2Cl2 (20 mL) was added 4 Å molecular sieves and the solution 
was stirred at room temperature for 30 min. The solution was then cooled down 
to –60 °C after which BSP (511 mg, 2.44 mmol 1.4 equivalents), TTBP (727 
mg, 2.92 mmol, 1.7 equivalents) and Tf2O (412 µl, 2.44 mmol, 1.4 equivalents) 
were added. The reaction mixture was stirred at –60 °C for 30 min (complete 
activation confirmed by TLC) and then cooled down to –78 °C. Compound 10 
(800 mg, 1.69 mmol, 1 equivalent) in CH2Cl2 (10 mL) was added slowly. The 
reaction mixture was then stirred at –78 °C for 2 h and then quenched by adding 
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Et3N (1 mL) and stirring for 1 h during which the temperature was allowed to 
rise to room temperature. The reaction mixture was diluted with CH2Cl2 (60 mL) 
and washed with water (2 × 30 mL) and brine (20 mL). The organic layer was 
dried over Na2SO4 and concentrated. The crude product was purified by column 
chromatography (hexane : EtOAc 2 : 1) to afford pure 12 as a colorless foam. Rf 
= 0.3. Yield: 930 mg (57 %). [α]D
25
 = –61.1° (c 1.0, CHCl3).
 1
H NMR (600.13 
MHz, CDCl3, 25 °C): δ = 7.49 (m, 4 H, arom. H), 7.42 (m, 2 H, arom. H), 7.40–
7.32 (m, 8 H, arom. H), 7.19 (m, 2 H, arom. H), 6.85–6.80 (m, 6 H, arom. H), 
5.59 (s, 1 H, 4A,6A-OCHPh), 5.51 (s, 1 H, 4B,6B-OCHPh), 4.95 and 4.89 (each 
d, each 1 H, J = –11.9 Hz, 2B-OCH2Ph), 4.79 (d, 1 H, JH1A, H2A = 1.7 Hz, H1A), 
4.70 and 4.65 (each d, each 1 H, J = –11.6 Hz, 3A-OCH2Ph), 4.61 and 4.54 
(each d, each 1 H, J = –12.1 Hz, 3B-OCH2Ph), 4.59 (s, 1 H, H1B), 4.27 (dd, 1 H, 
JH6Ba, H5B = 4.7 Hz, JH6Ba, H6Bb = –10.5 Hz, H6Ba), 4.25 (dd, 1 H, JH6Aa, H5A = 4.1 
Hz, JH6Aa, H6Ab = –9.6 Hz, H6Aa),  4.22 (dd, 1 H, JH4B, H3B = 9.8 Hz, JH4B, H5B = 9.1 
Hz, H4B), 4.18 (dd, 1 H, JH2A, H3A = 3.4 Hz, H3A), 4.09 (dd, 1 H, JH4A. H3A = 10.0 
Hz, JH4A, H5A = 8.8 Hz, H4A), 3.93 (d, 1 H, JH2B, H3B = 3.3 Hz, H2B), 3.92 (dd, 1 
H, H3A), 3.88 (dd, 1 H, JH6Bb, H5B = 10.0 Hz, H6Bb), 3.802 (ddd, 1 H, JH1ʹa, H1ʹb = 
–9.9 Hz, JH1ʹa, H2ʹa = 2.3 Hz, JH1ʹa, H2ʹb = 11.6 Hz, H1ʹa), 3.801 (s, 3 H, OCH3), 
3.783 (dd, 1 H, JH6Ab, H5A = 10.0 Hz, H6Ab), 3.776 (s, 3 H, OCH3), 3.765 (ddd, 1 
H, H5A), 3.763 (s, 3 H, OCH3), 3.55 (dd, 1 H, H3B), 3.47 (ddd, 1 H, JH1ʹb, H2ʹa = 
7.7 Hz, JH1ʹb, H2ʹb = 4.5 Hz, H1ʹb), 3.38 (ddd, 1 H,JH3ʹa, H2ʹa = 5.1 Hz, JH3ʹa, H2ʹb = 8.2 
Hz, JH3ʹa, H3ʹb = –12.4 Hz, H3ʹa), 3.34 (ddd, 1 H, JH3ʹb, H2ʹa = 5.0 Hz, JH3ʹb, H2ʹb = 7.5 
Hz, H3ʹb), 3.31 (ddd, 1 H, H5B), 1.86 (each dddd, each 1 H, H2ʹa and H2ʹb). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.12, 159.11, 159.0, 137.6, 137.5, 
130.8, 130.6, 130.4, 130.3, 129.3, 129.1, 128.9, 128.8, 128.18, 128.17, 126.1, 
126.0, 113.7, 113.54, 113.50 (arom. C), 101.6 (4B,6B-OCHPh), 101.3 (4A,6A-
OCHPh), 100.8 (C1B), 98.5 (C1A), 78.5 (C4A), 78.4 (C4B), 77.2 (C3B), 75.3 
(C2B), 75.0 (C2A), 74.0 (2B-OCH2Ph), 73.7 (C3A), 71.9 (3B-OCH2Ph), 71.0 
(3A-OCH2Ph), 68.9  (C6A), 68.6 (C6B), 67.8 (C5B), 64.5 (C1ʹ), 64.4 (C5A), 
55.26, 55.25, 55.2 (3 × OCH3), 48.2 (C3ʹ), 28.8 (C2ʹ). 
HRSM: m/z calcd. for C53H59N3NaO14 [M+Na]
+
: 984.3890, found: 984.3821; m/z 
calcd. for C53H59N3KO14 [M+K]
+
: 1000.3629, found: 1000.3596. 
3-Azido-1-propyl O-(2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl)-(1→2)-
3,4,6-tri-O-acetyl-α-D-mannopyranoside (14):  To a solution of 12 (800 mg, 
0.832 mmol, 1 equivalent) in CH2Cl2 (10 mL) was added 1,3-propanedithiol 
(835 µl, 8.32 mmol, 10 equivalents) and the solution was cooled down to –10 
°C. TFA (4 mL) and water (1 mL) were added and the reaction mixture was 
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stirred at room temperature for 2 h. The reaction mixture was then diluted with 
water (15 mL) and washed with CH2Cl2 (4 × 15 mL) to remove all non-polar 
organic material. The aqueous layer was evaporated and co-evaporated with 
toluene. The crude product was dissolved in pyridine (15 mL) and cooled down 
to 0 °C. Ac2O (10 mL) was added and the reaction mixture was stirred at room 
temperature for 18 h. The reaction was quenched by adding methanol (10 mL) 
and then evaporated and co-evaporated with toluene. The crude product was 
purified by column chromatography (hexane : EtOAc 1 : 1) to afford pure 
product 14 as a white powder. Rf = 0.3. Yield: 365 mg (61 %). [α]D
25
 = –46.1° (c 
1.0, CHCl3).
 1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 5.51 (dd, 1 H, JH2B, H1B 
= 1.0 Hz, JH2B, H3B = 3.4 Hz, H2B), 5.26 (t, 1 H, JH4A, H3A = JH4A, H5A = 10.1, 
H4A), 5.23 (dd, 1 H, JH4B, H3B = 10.0 Hz, JH4B, H5B = 9.8 Hz, H4B), 4.81 (d, 1 H, 
JH1A, H2A = 1.9 Hz, H1A), 4.67 (d, 1 H, H1B), 4.32 (dd, 1 H, JH6Bb, H5B = 6.0 Hz, 
JH6Bb, H6Ba = –12.2 Hz, H6Bb), 4.31 (dd, 1 H, H2A), 4.24, (dd, 1 H, JH6Ab, H5A = 
4.2 Hz, JH6Ab, H6Aa = –12.3 Hz, H6Ab), 4.08 (dd, 1 H, JH6Aa, H5A = 2.3 Hz, H6Aa) 
4.03 (dd, 1 H, JH6Ba, H5B = 2.5 Hz, H6Ba), 3.85 (ddd, 1 H, H5A), 3.83 (ddd, 1 H, 
JH1ʹa, H1ʹb = –9.9 Hz, JH1ʹa, H2ʹa = 6.2 Hz, JH1ʹa, H2ʹb = 5.7 Hz, H1ʹa), 3.63 (ddd, 1 H, 
H5B), 3.52 (ddd, 1 H, JH1ʹb, H2ʹa = 5.5 Hz, JH1ʹb, H2ʹb = 6.6 Hz, H1ʹb), 3.45 (ddd, 1 
H, JH3ʹa, H2ʹa = 5.8 Hz, JH3ʹa, H2ʹb = 6.9 Hz, JH3ʹa, H3ʹb = –12.4 Hz, H3ʹa), 3.41 (ddd, 1 
H, JH3ʹb, H2ʹa = 7.2 Hz, JH3ʹb, H2ʹb = 5.8 Hz, H3ʹb), 2.24, 2.13, 2.10, 2.042, 2.037, 
2.03, 2.01 (each s, each 3 H, COCH3), 1.91 (ddddd, 1 H, JH2ʹb, H2ʹa = –11.1 Hz, 
H2ʹb), 1.90 (ddddd, 1 H, H2ʹa). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ =171.0, 170.7, 170.30, 170.28, 169.7, 
169.3 (OCOCH3), 97.6 (C1A), 96.4 (C1B), 72.3 (C5B), 72.2 (C2A), 70.6 (C3B), 
70.3 (C3A), 68.7 (C5A), 68.5 (C2B), 66.1 (C4B), 65.1 (C4A), 64.7 (C1ʹ), 62.4 
(C6B), 61.9 (C6A), 48.2 (C3ʹ), 28.7 (C2ʹ). 
HRSM: m/z calcd. for C29H41N3NaO18 [M+Na]
+
: 742.2277, found: 724.2282; m/z 
calcd. for C29H41N3KO18 [M+K]
+
: 758.2017, found: 758.1995. 
1,2,3-tris [1-(3-{O-(2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl)-(1→2)-3,4,6-
tri-O-acetyl-α-D-mannopyranosyloxy}propyl)-4-methyloxy-1,2,3-
triazolyl]propane (2): To a solution of 14 (300 mg, 0.41 mmol, 3.2 equivalents) 
and 1,2,3-tris (prop-2-yn-1-yloxy)propane in 
t
BuOH:H2O:CH2Cl2 (6 mL 1:1:1) 
were added CuSO4 (6.3 mg, 0.042 mmol, 0.3 equivalents) and sodium ascorbate 
(15.4 mg 0.08 mmol, 0.6 equivalents). The reaction mixture was stirred at 55 °C 
for 12 h after which it was quenched by adding satd. NH4Cl solution and H2O 
(20 mL 1:1).  The mixture was extracted with CH2Cl2 (3 × 20 mL) and the 
organic layer was dried over Na2SO4 and concentrated. The crude mixture was 
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purified by column chromatography (4 % MeOH in CH2Cl2) to afford pure 
product 10 as a white solid. Rf = 0.20. Yield: 160 mg (62 %). [α]D
25
 = –53.7° (c 
1.0, CHCl3). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.72 (s, 1 H, triaz. H), 
7.65 (s, 2 H, 2 × triaz. H), 5.52–5.49 (m, 3 H, 3 × H2B), 5.26 (m, 3 H, 3 × H4A), 
5.25 (m, 3 H, 3 × H4B), 5.08–5.04 (m, 3 H, 3 × H3B), 4.96, (m, 3 H, 3 × H3A), 
4.79 (s, 2 H, G2-OCH2), 4.79–4.76 (m, 3 H, 3 × H1A), 4.76–4.73 (m, 3 H, 3 × 
H1B), 4.65 (s, 4 H, G1-OCH2), 4.55–4.43 (m, 6 H, 6 × H3ʹ), 4.34 (m, 3 H, 3 × 
H6Bb), 4.32–4.29 (m, 3 H, 3 × H2A), 4.25 (m, 3 H, 3 × H6Ab), 4.08–4.01 (m, 6 
H, 3 × H6Aa, 3 × H6Ba), 3.90–3.85 (m, 3 H, 3 × H5A), 3.83 (m, 1 H, HG2), 
3.80–3.73 (m, 3 H, 3 × H1ʹa), 3.72–3.60 (m, 7 H, 3 × H5B, 4 × HG1), 3.46–3.39 
(m, 3 H, 3 × H1ʹb), 2.28–2.17 (m, 15 H, 6 × H2ʹ, 3 × COCH3), 2.11, 2.09, 2.042, 
2.038, 2.03, 2.01 (each s, each 9 H, 18 × COCH3). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ =171.0, 170.6, 170.34, 170.32, 169.9, 
169.7, 169.3 (COCH3), 145.6, 145.2 (C4, triaz.), 122.9, 122.8 (C5, triaz.), 97.8 
(C1A), 96.3 (C1B), 77.3 (CG2), 72.14, 72.13 (C5B), 72.1 (C2A), 70.7 (C3B), 
70.3 (C3A), 70.3, 70.2 (CG1), 68.8, 68.7 (C5A), 68.5 (C2B), 66.1 (C4B), 65.0 
(C4A), 64.8 (G1-OCH2), 64.61, 61.58 (C1ʹ), 63.8 (G2-OCH2), 62.4 (C6B), 61.8 
(C6A), 47.19, 47.16, (C3ʹ), 29.98, 29.95 (C2ʹ), 20.81, 20.76, 20.7, 20.62, 20.58 
(COCH3). 
HRSM: m/z calcd. for C99H138N9O57 [M+H]
+
: 2364.8171, found: 2364.8168. 
2-[2-(2-azidoethoxy)ethoxy]ethyl 2-O-acetyl-4,6-O-benzylidene-3-O-(4-
methoxybenzyl)-α-D-mannopyranoside (9): To a solution of  Phenyl 2-acetyl-
4,6-O-benzylidene-3-O-(4-methoxybenzyl)-thio-α-D-mannopyranoside (1000 
mg, 1.92 mmol, 1 equivalent) and 2-[2-(2-azidoethoxy)ethoxy]ethanol (403 mg, 
2.30 mmol, 1.2 equivalents) in dry CH2Cl2 (40 mL) at –40 °C were added 4 Å 
molecular sieves NIS (517 mg, 2.30 mmol, 1.2 equivalents) and TMSOTf (83 
µl, 0.23 mmol, 0.24 equivalents). The reaction mixture was stirred at –40 °C for 
2 h and then quenched by adding a satd. solution of NaHCO3 (20 mL). The 
reaction mixture was brought to room temperature and diluted with CH2Cl2 (50 
mL) and washed with satd. NaHCO3 solution (50 mL)  after which the aqueous 
layer was extracted with CH2Cl2 (2 × 50 mL). The combined organic layers were 
washed with of brine (100 mL), dried over Na2SO4 and concentrated. The crude 
mixture was purified by column chromatography (hexane : EtOAc 2 : 1 → 1 : 1) 
to afford the pure product 9 as a slightly yellow oil. Rf: 0.33 (hexane: EtOAc 1 : 
1). Yield 790 mg (70 %). [α]D
24
 = +20.0° (c 2.30, CHCl3). 
1
H NMR (600.13 
MHz, CDCl3, 25 °C): δ = 7.50 (m, 2 H, arom. H), 7.40–7.34 (m, 3 H, arom. H), 
7.27 (m, 2 H, arom. H), 6.83 (m, 2 H, arom. H), 5.62 (s, 1 H, 4,6-OCHPh), 5.42, 
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(dd, 1 H, JH2, H1 = 1.6 Hz, JH2, H3 = 3.5 Hz, H2), 4.83, (d, 1 H, H1), 4.64 and 4.58 
(each d, each 1 H, J = –11.56 Hz, 3-OCH2Ph), 4.25 (dd, 1 H, JH6a, H5 = 4.8 Hz, 
JH6a, H6b = –10.24 Hz, H6a), 4.03 (dd, 1 H, JH4, H3 = 10.0 Hz, JH4, H5 = 9.5 Hz, H4), 
4.01 (dd, 1 H, H3), 3.91 (ddd, 1 H, JH5, H6b = 10.4 Hz, H5), 3.83 (dd, 1 H, H6b), 
3.80 (m, 1 H, H1ʹa), 3.79 (s, 3 H, 3-OCH3), 3.68–3.61 (m, 9 H, H1ʹb, H2ʹ, H3ʹ, 
H4ʹ, H5ʹ), 3.34 (m, 2 H, H6ʹ), 2.15 (s, 3 H, COCH3). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ =170.2 (2-OCOCH3), 159.2, 137.5, 
130.1, 129.3, 128.9, 128.1, 126.1, 113.7 (arom. C), 101.5 (4,6-OCHPh), 98-8 
(C1), 78.3 (C4) 73.6 (C3), 71.8 (3-OCH2Ph), 70.8, 70.7, 70.1 (C2ʹ, C3ʹ, C4ʹ, 
C5ʹ), 69.7 (C2), 68.7 (C6), 67.0 (C1ʹ), 63.8 (C5), 55.2 (3-OCH3), 50.6 (C6ʹ), 
21.0 (2-OCOCH3). 
HRSM: m/z calcd. for C29H41N4O10 [M+NH4]
+
: 605.2817, found: 605.2829, m/z 
calcd. for C29H37N3NaO10 [M+Na]
+
: 610.2371, found: 610.2361. 
2-[2-(2-azidoethoxy)ethoxy]ethyl 4,6-O-benzylidene-3-O-(4-methoxybenzyl)-
α-D-mannopyranoside (11):  The pH of a solution of 9 (490 mg, 0.83 mmol) in 
dry methanol (4 mL) under argon atmosphere was adjusted to ~10 – 12 by 
adding a few drops of a 5.4 M solution of NaOMe in MeOH. The reaction 
mixture was stirred at room temperature for 30 min and then neutralized with 
DOWEX-50WX8 H
+
 form. The reaction mixture was filtered and concentrated 
to afford the pure product 11 as a yellow/orange oil. Yield: 441 mg (97 %). 
[α]D
24
 = +21.0° (c 1.10, CHCl3). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.51 
(m, 2 H, arom. H), 7.42–7.35 (m, 3 H, arom. H), 7.30 (m, 2 H, Arom. H), 6.88 
(m, 2 H, arom. H), 5.61 (s, 1 H, 4,6-OCHPh), 4.91 (d, 1 H, JH1, H2 = 1.5 Hz, H1), 
4.78 and 4.65 (each d, each 1 H, J = –11.4 Hz, 3-OCH2Ph), 4.26 (dd, 1 H, JH6a, H5 
= 4.5 Hz, JH6a, H6b = –9.3 Hz, H6a), 4.081 (dd, 1 H, JH2, H3 = 3.5 Hz, H2), 4.076 
(dd, 1 H, JH4, H3 = 9.6 Hz, JH4, H5 = 9.5 Hz, H4), 3.93 (dd, 1 H, H3), 3.88 (ddd, 1 
H, JH5, H6b = 9.6 Hz, H5), 3.84 (dd, 1 H, H6b), 3.85–3.82 (m, 1 H, H1ʹa), 3.81 (s, 
3 H, 3-OCH3), 3.71–3.65 (m, 9 H, H1ʹb, H2ʹ, H3ʹ, H4ʹ, H5ʹ), 3.37 (m, 2 H, H6ʹ) 
 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.5, 137.7, 130.3, 129.6, 129.0, 
128.3, 126.2, 114.0 (arom. C), 101.6 (4,6-OCHPh), 101.1 (C1), 79.0 (C4), 75.4 
(C3), 72.8 (3-OCH2Ph), 70.91, 70.87, 70.4, 70.3 (C2ʹ, C3ʹ, C4ʹ, C5ʹ), 70.0 (C2), 
69.0 (C6), 66.9 (C1ʹ), 63.4 (C5), 55.4 (3-OCH3), 50.8 (C6ʹ). 
HRSM: m/z calcd. for C27H39N4O9 [M+NH4]
+
: 563.2712, found: 563.2691, m/z 
calcd. for C27H35N3NaO9 [M+Na]
+
: 568.2266, found: 568.2267. 
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2-[2-(2-azidoethoxy)ethoxy]ethyl O-[4,6-O-benzylidene-2,3-di-O-(4-
methoxybenzyl)-β-D-mannopyranosyl]-(1→2)-4,6-O-benzylidene-3-O-(4-
methoxybenzyl)-α-D-mannopyranoside (13): To a solution of Phenyl 4,6-O-
benzylidene-2,3-di-O-(4-methoxybenzyl)-thio-α-D-mannopyranoside (1059 mg, 
1.76 mmol, 1.3 equivalents) in dry CH2Cl2 (15 mL) and 1-octene (5 mL) was 
added 4 Å molecular sieves after which the solution was cooled down to –60 °C.  
BSP (526 mg, 2.12 mmol, 1.56 equivalents), TTBP (568 mg, 2.71 mmol, 2 
equivalents) and Tf2O (386 µl, 2.29 mmol, 1.69 equivalents) were added and the 
reaction mixture was stirred at –60 °C for 30 min. The reaction mixture was then 
cooled down to –78 °C and 11 (740 mg, 1.36 mmol, 1 equivalent) in dry CH2Cl2 
(5 mL) was added. The reaction mixture was stirred at –78 °C for 3 h and then 
quenched by adding Et3N (1 mL) and allowing the reaction mixture return to 
room temperature over 30 min. The reaction mixture was diluted with CH2Cl2 
(50 mL) and then washed with satd. NaHCO3 solution (50 mL). The water layer 
was extracted with CH2Cl2 (2 × 50 mL) and the combined organic layers were 
washed with brine (100 mL), dried over Na2SO4 and concentrated. Column 
chromatography (Hexane : EtOAc 2 : 1 → 1 : 1) afforded pure 13 as a clear oil. 
Rf = 0.35 (Hexane : EtOAc 1 : 1). Yield: 613 mg (43 %). [α]D
24
 = –36.0° (c 1.36, 
CHCl3). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 7.51–7.47 (m, 4 H, arom. 
H), 7.43 (m, 2 H, arom. H), 7.40–7.32 (m, 8 H, arom. H), 7.19 (m, 2 H, arom. 
H), 6.86–6.79 (m, 6 H, arom. H), 5.59 (s, 1 H, 4B,6B-OCHPh), 5.51 (s, 1 H, 
4A,6A-OCHPh), 4.96 and 4.89 (each d, each 1 H, J = –11.9 Hz, 2B-OCH2Ph), 
4.84 (d, 1 H, JH1A, H2A = 0.7 Hz, H1A), 4.71 and 4.62 (each d, each 1 H, J = –11.5 
Hz, 3A-OCH2Ph), 4.60 and 4.53 (each d, each 1 H, J = –12.0 Hz, 3B-OCH2Ph), 
4.60 (s, 1 H, H1B), 4.27 (dd, 1 H, JH2A, H3A = 3.0 Hz, H2A), 4.26 (dd, 1 H, JH6Ba, 
H5B = 5.9 Hz, JH6Ba, H6Bb = –10.6 Hz, H6Ba), 4.25 (dd, 1 H, JH6Aa, H5 = 4.9 Hz, 
JH6Aa, H6Ab = –11.2 Hz, H6Aa), 4.22 (dd, 1 H, JH4B, H3B = 9.8 Hz, JH4B, H5B = 9.5 
Hz, H4b), 4.08 (dd, 1 H, JH4A, H3A = 9.9 Hz, JH4A, H5A = 9.7 Hz, H4A), 3.96 (dd, 1 
H, H3A), 3.93 (d, 1 H, JH2B, H3B = 3.1 Hz, H2B) 3.87 (dd, 1 H, JH6Bb, H5B = 9,9 Hz, 
H6Bb), 3.85 (ddd, 1 H, JH5A, H6Ab = 9.9 Hz, H5A), 3.82 (m, 1 H, H1ʹ), 3.80 (s, 3 
H, OCH3), 3.774 (s, 3 H, OCH3), 3.766 (dd, 1 H, H6Ab), 3.76 (s, 3 H, OCH3), 
3.69–3.59  (m, 9 H, H1ʹb, H2ʹ, H3ʹ, H4ʹ, H5ʹ), 3.55 (dd, 1 H, H3B), 3.32 (m, 2 
H, H6ʹ), 3.30 (ddd, 1 H, H5B). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 159.23, 159.22, 159.1, 137.71, 
137.70, 131.1, 130.7, 130.52, 130.45, 129.3, 129.2, 128.9, 128.30, 128.26, 
126.22, 126.15, 113.79, 113.65, 113.6 (arom. C), 101.7 (4A,6A-OCHPh), 101.5 
(4B,6B-OCHPh), 101.0 (C1B), 98.5 (C1A), 78.7 (C4A), 78.6 (C4B), 77.3 
(C3B), 75.3 (C2B), 74.9 (C2A), 74.2 (2B-OCH2Ph), 72.0 (3B-OCH2Ph), 70.94 
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(3A-OCH2Ph), 70.91, 70.8, 70.3, 70.2 (C2ʹ, C3ʹ, C4ʹ, C5ʹ), 69.0 (C6A), 68.7 
(C6B), 67.9 (C5B), 67.0 (C1ʹ), 64.3 (C5A), 55.38, 55.36, 55,3 (3 × OCH3), 50.7 
(C6ʹ). 
HRSM: m/z calcd. for C56H69N4O16 [M+NH4]
+
: 1053.4703, found: 1053.4669, 
m/z calcd. for C56H65N3NaO16 [M+Na]
+
: 1058.4257, found: 1058.4208. 
2-[2-(2-azidoethoxy)ethoxy]ethyl O-(2,3,4,6-tetra-O-acetyl-β-D-
mannopyranosyl)-(1→2)-3,4,6-tri-O-acetyl-α-D-mannopyranoside (15): To a 
solution of 13 (200 mg, 0.19 mmol, 1 equivalent) in 10 mL of CH2Cl2 was added 
1,3-propanedithiol (155 µl, 1,54 mmol, 8 equivalents) and the mixture was 
cooled down on an ice bath. TFA (4 mL) and H2O (1 mL) were added and the 
reaction mixture was stirred at room temperature for 3 h. The reaction mixture 
was then diluted with H2O (100 mL) and washed with CH2Cl2  (4 × 50 mL) after 
which the aqueous layer was evaporated and coevaporated with toluene. The 
residue was dissolved in pyridine (20 mL) and cooled on an ice bath while Ac2O 
(10 mL) was added. The reaction mixture was then stirred at room temperature 
for 18 h after which the reaction was cooled on an ice bath and quenched by 
adding methanol (10 mL). The reaction mixture was diluted with CH2Cl2 (50 
mL), washed with H2O (4 × 50 mL) and brine (50 mL). The organic layer was 
dried over Na2SO4 and concentrated. The crude mixture was purified by column 
chromatography (hexane : EtOAc 1 : 1 → CH2Cl2 : methanol 20 : 1) to afford 
pure 15 as a clear oil. Rf = 0.34 (CH2Cl2 : methanol 20 : 1). Yield: 113 mg (75 
%). [α]D
24
 = –51.5° (c 1.62, CHCl3). 
1
H NMR (600.13 MHz, CDCl3, 25 °C): δ = 
5.51 (dd, 1 H, JH2B, H1B = 0.7 Hz, JH2B, H3B = 3.4 Hz, H2B), 5.27 (t, 1 H, JH4A, H3A = 
JH4A, H5A = 10.1 Hz, H4A), 5.22 (dd, 1 H, JH4B, H3B = 10.0 Hz, JH4B, H5B = 9.9 Hz, 
H4B), 5.05 (dd, 1 H, H3B), 5.02 (dd, 1 H, JH3A, H2A = 3.4 Hz, H3A), 4.88 (d, 1 H, 
JH1A, H2A = 1.8 Hz, H1A), 4.69 (d, 1 H, H1B), 4.36 (dd, 1 H, H2A), 4.32 (dd, 1 H, 
JH6Bb, H5B = 6.0 Hz, JH6Bb, H6Ba = –12.2 Hz, H6Bb), 4.26 (dd, 1 H, JH6Ab, H5A = 3.8 
Hz, JH6Ab, H6Aa = –12.3 Hz, H6Ab) 4.06 (dd, 1 H, JH6Aa, H5A = 2.3 Hz, H6Aa), 4.02 
(dd, 1 H, JH6Ba, H5B = 2.4 Hz, H6Ba), 3.94 (ddd, 1 H, H5A), 3.81 (m, 1 H, H1ʹa), 
3.72–3.64 (m, 9 H, H1ʹb, H2ʹ, H3ʹ, H4ʹ, H5ʹ), 3.64 (ddd, 1 H, H5B), 3.40 (m, 2 
H, H6ʹ), 2.25 (s, 3 H, 2B-COCH3), 2.13 (s, 3 H, 6A-COCH3), 2.10 (s, 3 H, 6B-
COCH3), 2.05 (s, 3 H, 4A-COCH3), 2.03 (s, 3 H, 4B-COCH3), 2.02 (s, 3 H, 3A-
COCH3), 2.01 (s, 3 H, 3B-COCH3). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 171.0 (6A-COCH3), 170.7 (6B-
COCH3), 170.3 (2B-COCH3), 170.2 (3A-COCH3), 170.0 (3B-COCH3), 169.7 
(4B-COCH3), 169.3 (4A-COCH3), 97.5 (C1A), 96.3 (C1B), 72.22 (C5B), 72.17 
(C2A), 70.73, 70.72 (C3ʹ, C4ʹ), 70.6 (C3B), 70.3 (C3A), 70.2 (C2ʹ), 70.1 (C5ʹ), 
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68.52 (C2B), 68.50 (C5A), 67.1 (C1ʹ), 66.1 (C4B), 65.1 (C4A), 62.5 (C6B), 61.8 
(C6A), 50.7 (C6ʹ), 20.8, 20.74, 20.70, 20.62, 20.57 (COCH3). 
HRSM: m/z calcd. for C32H51N4O20 [M+NH4]
+
: 811.3091, found: 811.3083, m/z 
calcd. for C32H47N3NaO20 [M+Na]
+
: 816.2645, found: 816.2621. 
1,2,3-tris (1-{2-[2-(2-[O-(2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl)-(1→2)-
3,4,6-tri-O-acetyl-α-D-mannopyranosyloxy]ethoxy)ethoxy]ethyl}-4-
methyloxy-1,2,3-triazolyl)propane (3): To a solution of 15 (70 mg, 0.088 
mmol, 3.3 equivalents)  and 1,2,3-tris (prop-2-yn-1-yloxy)propane (5.5 mg,  
0.027 mmol, e equivalent)  in of CH2Cl2 (2 mL) were added t-BuOH (2 mL) and 
H2O (2 mL). CuSO4 (2.8 mg, 0.017 mmol, 0.66 equivalents) and Na-ascorbate 
(7.0 mg, 0.035 mmol, 1.32 equivalents) were added and the reaction mixture was 
stirred at 55 °C for 18 h. A saturated solution of NH4Cl (10 mL) and H2O (10 
mL) were added and the reaction mixture was extracted with CH2Cl2 (4 × 20 
mL). The combined organic layers were dried over Na2SO4 and concentrated. 
The crude mixture was purified by column chromatography (CH2Cl2 : methanol 
20 : 1 → 5 : 1) to afford the pure product 15 as a white solid. Rf =0.16 (CH2Cl2 : 
methanol 20 : 1). Yield: 62 mg (89 %). [α]D
24
 = –37.0° (c 1.05, CHCl3). 
1
H NMR 
(600.13 MHz, CDCl3, 25 °C): δ = 7.81, 7.772, 7.769 (each s, each 1 H, 3 × triaz. 
H), 5.52–5.49 (m, 3 H, 3 × H2B), 5.27 (m, 3 H, 3 × H4A), 5.23 (m, 3 H, 3 × 
H4B), 5.06 (m, 3 H, 3 × H3B), 5.01–4.97 (m, 3 H, 3 × H3A), 4.85 (m, 3 H, 3 × 
H1A), 4.78 (s, 2 H, G2-OCH2), 4.72 (m, 3 H, 3 × H1B), 4.64 (s, 4 H, G1-OCH2), 
4.60–4.51 (m, 6 H, 6 × H6ʹ), 4.36–4.30 (m, 6 H, 3 × H6Bb, H2A), 4.24 (m, 3 H, 
3 × H6Ab), 4.06 (m, 3 H, 3× H6Aa), 4.03–3.98 (m, 3 H, 3 × H6Ba), 3.95–3.86 
(m, 9 H, 3 × H5A, 6 × H5ʹ), 3.85–3.75 (m, 4 H, HG2, 3 × H1ʹa), 3.68–3.58 (m, 
28 H, 3 × H5B, 4 × HG1, 3 × H1ʹb, 6 × H2ʹ, 6 × H3ʹ, 6 × H4ʹ), 2.24, 2.12, 2.09, 
2.04, 2.03, 2.02, 2.01 (each s, each 9 H, 21 × COCH3). 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 171.0, 170.6, 170.33, 170.29, 170.0, 
169.7, 169.3 (COCH3), 145.1, 144.7 (C4, triaz.), 124.0, 123.9 (C5, triaz.), 97.6 
(C1A), 96.29, 96.27 (C1B), 77.2 (CG2), 72.11, 72.08 (C5B, C2A), 70.67, 70.65 
(C3B), 70.51, 70.49 (C3ʹ, C4ʹ), 70.29, 70.26 (C3A), 70.2 (CG1), 70.1 (C2ʹ), 69.5 
(C5ʹ), 68.53 (C2B), 68.49 (C5A), 67.0 (C1ʹ), 66.1 (C4B), 65.1 (C4A), 64.8 (G1-
OCH2), 63.8 (G2-OCH2), 62.4 (C6B), 61.8 (C6A), 50.2, 50.16 (C6ʹ), 20.79, 
20.75, 20.7, 20.62, 20.57 (COCH3). 
HRSM: m/z calcd. for C108H155N9NaO63 [M+Na]
+
: 2608.9094, found: 2608.8944. 
Biological study subjects: During pollen season, 14 adult birch allergic subjects 
with allergic rhinoconjunctivitis (12 females and two males) were enrolled in the 
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study (mean age 42.5 years, SD 12.4 years; mean birch-specific IgE 
(Immunocap, Thermo Fisher Scientific Phadia, Uppsala, Sweden) 36.1 kU L
-1
, 
SD 31.5 kU L
-1
). They were selected for the study from an earlier cohort based 
on good birch induced IL-4 responses during pollen season. All samples were 
taken after informed consent. The study was approved by the local ethics 
committee. 
Adjuvants in the biological studies: Compound 1 was synthesized as 
previously described.
33
 Compounds 2 and 3 were prepared according to the 
methods described herein. Synthetic MPLA and CpG-ODN (tlrl-2006) were 
purchased from Invivogen (San Diego, CA, USA). The CpG-ODN had a 
sequence of 5´-TCG TCG TTT TGT CGT TTT GTC GTT-3´, identical to one 
used in a previous study.
59
 
PBMC cultures: The PBMC were isolated by Ficoll-Paque density gradient 
centrifugation (Ficoll-Paque PLUS, GE Healthcare Bio-Sciences AB, Uppsala, 
Sweden) from heparinized blood samples from study subjects during pollen 
season. The PBMC were washed twice with Hanks’ balanced salt solution 
(HBSS) buffered with NaHCO3 (pH 7.4) and resuspended in RPMI-1640 culture 
medium (Invitrogen Co., Carlsbad, CA, USA) supplemented with 5% 
autologous serum, 2.5 mM L-glutamine (Sigma-Aldrich Co., St. Louis, MO) and 
100 µg mL
-1
 gentamycin sulfate (Biological Industries Ltd., Kibbutz Beit 
Haemek, Israel) and applied on 48-well flat-bottomed cell culture plates (Costar, 
Corning Inc., New York, United States) at a density of 106/ml. Cells were co-
cultured in the presence of birch allergen (50 μg mL-1, Betula verrucosa, Bet v, 
Aquagen, ALK-Abelló A/S, Hørsholm, Denmark) and adjuvants 1, 2, 3 and 
MPLA with concentrations 1, 10 and 100 µg mL
1
 and adjuvant CpG-ODN with 
concentrations 2, 20 and 200 µg mL
-1
 (marked as 1, 10 and 100 µg mL
-1
 in 
figures 10 and 11 for the sake of simplicity) to achieve equal molarities. Medium 
alone served as an unstimulated control. All incubations were performed at 
+37ºC in humidified atmosphere with 5% CO2. Supernatants from cultures 
performed in duplicate were collected 72 h after beginning of the stimulation 
and stored at -70ºC. 
IL-4 and TNF production: The cytokines IL-4 and TNF in supernatants were 
measured with high-sensitivity human cytokine Lincoplex kits (LINCO 
Research, St. Charles, MO, USA). The assays were performed in accordance 
with the manufacturer’s protocol by employing Luminex technology. 
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Statistics: Wilcoxon´s Signed Rank test was used to test statistical significance 
in PBMC experiments. Data are expressed as mean ± SEM and P-values of < 
0.05 are considered statistically significant. 
TLR ligation screening: Ligation screening was performed with molecules 1
33
 
and 3 as well as with the fully deacetylated analogue of 1
 by InvivoGen™,60 
using HEK-293 cell lines functionally overexpressing human TLR:s 2,3,4,5,7,8 
and 9. Two different concentrations, 4 µM and 40 µM were used which 
approximately correspond to the concentrations employed in the PBMC 
screening. 
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Polysaccharides are one of the most important renewable resources, and new 
applications are sought constantly. Their important roles in biological systems 
make them attractive targets for investigating biological events and developing 
treatments for various conditions. Natural polysaccharides are, however, 
inherently heterogeneous, which often complicates the use of them as such. In 
this chapter, preparation of well-defined natural polysaccharide mimics is 
explored and their interactions with biological targets are investigated. 
Furthermore, a new method for fragmenting polysaccharides into regularly sized 
fragments using readily available reagents is presented.  
This chapter is based on unpublished results: Mimicking Saccharide 
Interactions in Nature: NMR Studies of Dextran-Supported Multivalent 
Molecular Probes Show Distinct Glycan-Lectin Recognition Features, J. 
Rahkila, F. S. Ekholm, J. Savolainen, A. Ardá, S. Delgado, J. Jiménez-Barbero, 
R. Leino, manuscript submitted; Cu(I) Mediated Degradation of 
Polysaccharides Leads to Fragments With Narrow Polydispersities, J. 
Rahkila, F. S. Ekholm, R. Leino, Eur. J. Org. Chem. 2018, Accepted manuscript 
online: 17 Jan 2018, DOI: 10.1002/ejoc.201800033.  
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4.1 Introduction 
Polysaccharides play many important roles in nature, for example as structural 
components, such as cellulose in plants and chitin in the exoskeletons of 
arthropods, as well as energy storage molecules in the form of starch and 
glycogen. Additionally, polysaccharides are involved in a number of cell-
recognition and cell-signaling events. The surface of cells is covered with a thick 
layer of complex polysaccharides, the glycocalyx, that can reach out up to 3 µm 
from the cell surface.
1,2
  
Bacterial capsular polysaccharides cover the cells of several types of bacteria, 
e.g.  Escherichia coli, Neisseria meningitidis, Haemophilus influenzae, and 
many others.
3,4
 These polysaccharides allow the bacteria to very efficiently 
avoid the immune system, by hiding antigenic proteins and other molecules on 
the cell surface. This prevents the cells from being internalized, and 
subsequently destroyed by immune cells.
3,5,6
 
The biological roles of polysaccharides are an attractive area of research that can 
provide in-depth understanding of biological systems. The study of natural 
polysaccharides is, however, often complicated by the inherent difficulties of 
working with them. Polysaccharides from natural sources are typically 
heterogeneous, which complicates the purification procedures and analytical 
work. Isolating sufficient quantities, pure enough for biological investigations is 
difficult. Furthermore, the intrinsic heterogeneity of this class of compounds 
makes it difficult to interpret the analytical data, and it is often difficult to 
determine which part of the polysaccharides interact with for example proteins 
in biological systems. 
Synthetic approaches can provide solutions to problems associated with 
heterogeneity and availability of compounds. As discussed in the first chapter of 
this thesis, however, the chemical synthesis of even smaller oligosaccharides can 
be highly time consuming and expensive. Furthermore, small oligosaccharides 
do not necessarily act in the same way in a biological environment as large 
polysaccharides. Because of this, a hybrid method might provide insight in 
biological mechanisms while avoiding the high cost and time requirements for 
synthetic compounds, as well as the problems with acquiring natural 
polysaccharides. 
There exists a number of linear, or almost linear, polysaccharides consisting of a 
single type of monosaccharide moiety. Two examples of such homogeneous 
polysaccharides are the previously mentioned cellulose and chitin. These two 
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polysaccharides have rather low water solubility, which could potentially 
complicate the use of them as biological probes. Dextran, however, is a highly 
homogeneous water-soluble polysaccharide, produced by Leuconostoc species. 
Structurally, it is an α-(1→6) linked glucopolysaccharide with occasional α-
(1→3) branches. Its commercially availability makes it an attractive starting 
material for further modifications. 
As discussed previously, the interactions between ligands and receptors in nature 
typically occur in a multivalent manner. This concept has been widely utilized 
by attaching a vast array of carbohydrates to various scaffolds and backbones, 
ranging from small-molecular compounds to large macromolecules such as 
peptides, nanoparticles etc.
7–9
 
Modification of natural polysaccharides has found, in addition to applications 
based purely on material properties, numerous biological applications both as 
such,
10
 and as scaffolds for drugs or other biologically relevant compounds. 
Polysaccharides typically have high biocompatibility, biodegradability, meaning 
that they are not immunogenic, and are ultimately metabolized in the body. 
Furthermore, Polysaccharides are often water-soluble, making them excellent 
carriers for ligands in a biological environment.
11
 
In addition to purely biological applications, polysaccharides are, due to their 
renewable nature and material properties, attractive targets for various research 
fields.
12–14
 These applications suffer from the same problems associated with 
natural polysaccharides as described above. High heterogeneity and 
polydispersity makes behavior of the bulk material unpredictable, and while 
there are methods for fractionation and fragmentation of polysaccharides to 
obtain more evenly sized polysaccharide fragments, these are typically 
expensive and often difficult to control. New and more efficient methods are 
thus needed. 
In the following sections, a novel approach combining the use of biologically 
active carbohydrate-based ligands and polysaccharide-based scaffolds will be 
discussed. The preparation of polysaccharide mimics based on a dextran 
backbone, functionalized with three biologically important disaccharides is 
presented. All prepared compounds are thoroughly characterized by NMR 
spectroscopic and chromatographic methods. Furthermore, the ability of the 
modified dextran to interact with human Galectin-3 (Gal-3) will be discussed. 
Finally, the degradation of polysaccharides under conventional “click” chemistry 
conditions will be explored. 
Size matters (or does it?) 
114 
 
4.2 Functionalization of dextran 
As mentioned above, the high heterogeneity of natural polysaccharides is a 
common problem for biological investigations. A homogeneous polysaccharide 
with well-defined binding epitopes would thus be preferable as it would simplify 
the analysis of results. To this end, compounds that mimic natural 
polysaccharides were designed, based on smaller, well-defined, oligosaccharide 
fragments attached to a homogeneous polysaccharide backbone. For reliability 
of the obtained data, it is important to ensure that the interactions between the 
biological target molecule and the polysaccharide-based backbone are kept to a 
minimum. In this work, Galectin-3, a lectin that binds β-D-galactopyranosyl 
units, was selected as the biological target. Accordingly, dextran consisting of α-
D-glucopyranosyl units was deemed a suitable scaffold. The dextran selected for 
this work had an average molecular weight of 70 kDa, which corresponds to 
approximately 430 glucose units. Dextran typically has occasional α-(1→3) 
branches, and in this particular case they were found on approximately every 25 
glucose units. 
The method for functionalizing dextran with disaccharides consisting of lactose, 
maltose and a β-(1→2) linked mannobiose, was based on a copper(I) catalyzed 
azide-alkyne cycloaddition (CuAAC) approach similar to that presented in the 
previous chapter. Dextran was selected to carry the alkyne functionalities 
required for the reaction, and the disaccharides were functionalized with azide 
groups. 
4.2.1 Propargylation of dextran 
The initial modification of dextran was carried out by introducing alkyne 
functionalities to the dextran with propargyl bromide under alkaline conditions 
in water, according to a modification of a previously published method.
15
 
Dextran was dissolved in water and cooled on an ice bath, after which solid 
potassium hydroxide was added. When everything had dissolved propargyl 
bromide was added, and the reaction mixture was allowed to return to room 
temperature and stirred overnight. The reaction was quenched by neutralization 
using acetic acid, which formed potassium acetate as a byproduct. The reaction 
mixture was purified by precipitation into ethanol to remove any unreacted 
propargyl bromide, as well as the potassium bromide produced during the 
neutralization. A small amount of potassium acetate remained in the 
propargylated dextrans, but this constituted a few mass-percent at most and 
further purification was deemed unnecessary (Scheme 4.1). 
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Modification of polysaccharides is in many ways similar to modification of 
smaller molecules. There are, however, some factors that need to be considered. 
With large molecules, it is often difficult to drive a reaction to completion and 
because of this it is of utmost importance to determine the degree of substitution 
(DS) after a reaction. The DS indicates how complete the reaction has been, and 
determines the reaction parameters (such as equivalents of reagent) for 
subsequent modifications. Herein DS will refer to the number of substitutions 
per monosaccharide unit, i.e. 0 – 3. 
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Scheme 4.1. Reagents and conditions: i) PgBr, KOH, H2O, 0 °C → r.t., 19 h.  
The DS of the propargylation reaction was easily varied by using different 
amounts of propargyl bromide in the reaction. Six different degrees of 
substitution were prepared, ranging from 0.17 to 0.8 (P1: DS = 0.17; P2: DS = 
0.25; P3: DS = 0.41; P4: DS = 0.51; P5: DS = 0.60; P6: DS = 0.80) which 
seemed to be the practical upper limit. Above DS = 0.8 the solubility of the 
polysaccharide decreased to a level where analysis and subsequent modification 
became difficult, and because of this a higher DS was not pursued. 
4.2.2 Preparation of azido-functionalized disaccharides 
Three azido-functionalized disaccharides: lactose, maltose and β-(1→2) linked 
mannobiose were selected for this work (Figure 4.1). The preparation of all of 
these is slightly different, and the selected approaches will be discussed next. 
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Figure 4.1. Azido-functionalized disaccharides. 
Lactose was first benzoylated using benzoyl chloride in pyridine. The anomeric 
position on the glucopyranosyl unit was selectively deprotected using (N,N-
dimethylamino)-1-propylamine (DMAPA), a cheap alternative to the commonly 
used methylamine, which in some regions is a regulated compound due to its use 
in the production of methamphetamine. The hemiacetal was then reacted with 
trichloroacetonitrile in presence of a strong base DBU, which promotes the 
formation of the α-product. The finished glycosyl donor was glycosylated using 
4 as the acceptor (preparation of which is escribed in the previous chapter), and 
TMSOTf as promotor after which the product was deprotected under Zemplén 
conditions, affording the final azido-functionalized lactose 1 (Scheme 4.2). 
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Scheme 4.2. Reagents and conditions: i) BzCl, Pyridine, r.t., 1.5 h (96%); ii), DMAPA, 
THF, r.t., 24 h (54%); iii) Trichloroacetonitrile, DBU, CH2Cl2, 0 °C, 1.5 h (77%), iv) 4, 
TMSOTf, CH2Cl2, 4 Å MS, –30 °C, 2 h (81%); v) NaOMe, MeOH/THF, r.t., 2.5 h 
(94%). 
Azido-functionalized β-(1→2) linked mannobiose 2 was prepared by 
deprotection of the benzyl protected analogue discussed in the previous chapter 
(compound 13 in the previous chapter, Scheme 4.3). 
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Scheme 4.3. Reactions and conditions: i) 1,3-propanedithiol, TFA/H2O/CH2Cl2, 4:1:10, 
0 °C → r.t., 24 h (74%). 
The maltose derivative was prepared by reacting peracetylated maltose with 2[-
2-(chloroethoxy)ethoxy]ethanol, promoted by BF3∙OEt2, after which the chloride 
was replaced by azide, by reacting it with NaN3 in DMF in the presence of 
Bu4NI. The acetyl groups were removed under Zemplén conditions to afford the 
final azido-functionalized maltose 3 (Scheme 4.4). 
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Scheme 4.4. Reagents and conditions: i) 1) 2[-2-(chloroethoxy)ethoxy]ethanol, 
BF3∙OEt2, CH2Cl2, 0 °C → r.t., 5 h; 2) NaN3, TBAI, DMF, 87 °C, o/n; 3) NaOMe, 
MeOH, r.t., 1.5 h (27% over three steps). 
4.2.3 Click reactions 
Azides 1 – 4 were attached to the dextran backbone by conventional CuAAC 
reactions, using copper sulfate and sodium ascorbate. The reactions were carried 
out in water using two equivalents of azide for each propargyl group. Cu(I) 
required for the reaction was produced in situ via reduction of Cu(II) from 
CuSO4 by Na-ascorbate (Scheme 4.5).  
The compounds were purified by precipitating into, and washing with, methanol 
to remove unreacted azide after which they were passed through Sephadex PD-
15 G-25 columns to remove other small-molecular compounds. Finally, the 
compounds were treated with a generous amount of Quadrapure™ TU thiourea-
based metal ion chelator to remove any copper residues. The prepared 
compounds are presented in Table 4.1 below.  
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Scheme 4.5. Reagents and conditions: i) 1, 2, 3 or 4, CuSO4, Na-ascorbate, H2O, 55 °C, 
20 h. 
Table 4.1. List of final compounds prepared in this work. 
Compound Dextran Ligand DS Yield 
Lac1 P1 A 0.17 64% 
Lac2 P2 A 0.25 66% 
Lac3 P3 A 0.41 57% 
Lac4 P4 A 0.51 59% 
Lac5 P5 A 0.60 57% 
Lac6 P6 A 0.80 62% 
Man P6 B 0.80 87% 
LM1 P6 A:C; 1:3 0.80 58% 
LM2 P6 A:C, 3:1 0.80 62% 
T P6 D 0.80 60% 
4.3 Characterization 
All isolated new compounds were thoroughly characterized by NMR 
spectroscopic methods, using a set of standard experiments: 1H, 13C, DQF-
COSY, HSQC and HMBC. The complexities of the spectra were reduced to 
monosaccharide level by using 1D-TOCSY. Accurate coupling constants and 
Size matters (or does it?) 
119 
 
shifts for the small-molecular compounds were extracted by using the NMR 
simulation software PERCH.
16
 
While the spectra of the small-molecular compounds 1, 2, and 3 are not 
particularly difficult to assign, extracting coupling constants and even accurate 
chemical shifts, is virtually impossible without quantum-mechanical simulation. 
Compound 1 in particular, shows very significant second order effects caused by 
the close proximity of coupled signals. Even simulation does not provide a 
perfect fit for the triethylene glycol moiety, due to overlapping in the spectrum 
which results in information being lost due to insufficient resolution. 
 
Figure 4.2. Experimental 
1
H NMR spectrum of 1 (bottom) and simulated spectrum 
(top). 
Typically, the signals H2A, H3A, H4A and H5A in compound 1 would be 
expected to appear as dd (except for H5A which would be expected to appear as 
ddd).  As can be seen in the 
1
H spectrum (Figure 4.2 and Figure 4.3), however, 
this is not the case and the signals are far more complex than expected. This is 
due to signals H3A (at 3.701 ppm) and H4A (3.697 ppm) being very close to one 
another, and sharing a strong scalar coupling constant. The signals are separated 
by only 2.5 Hz (on a 600 MHz instrument) and have a coupling constant of 8.8 
Hz. Since the difference in chemical shift is of the same order as the coupling 
constant (and in this case even smaller), the nuclei are said to be strongly 
coupled and strong second order effects will be seen in the form of so-called 
“virtual coupling”.17 This effect significantly complicates the appearance of the 
affected signals, and makes extraction of coupling constants challenging as they 
can no longer be reliably measured manually. This effect has previously been 
reported for carbohydrates, for example in N,N’-diacetyl chitobiose, where the 
anomeric signal at the reducing end of the β-anomer is not a simple doublet as 
expected.
18,19
 Virtual coupling can cause unexpected peaks in the spectra, and 
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such peaks could incorrectly be assigned as impurities, unless proper multiplet 
analysis is done. 
 
Figure 4.3. Selected region of the 
1
H NMR spectrum of 1 showing the unexpected shape 
of signals H2A, H3A, H4A and H5A due to virtual coupling (overlapping signals have 
been removed in the top two spectra to show the true shape of H3A and H4B). 
The DS of the propargylated dextrans could not accurately be determined by 
1
H 
NMR due to overlapping of the HDO signal with both the anomeric region, and 
the CH2 group of the propargyl side chains. Because of this, quantitative 
13
C 
NMR was utilized instead. In the carbon spectrum the anomeric signals are well 
separated at around 93 – 102 ppm, as are the CH2 signals from the propargyl 
side chains at 57 – 62 ppm. This made the integration of these regions easy and 
reliable (Figure 4.4). 
The substitution pattern was determined by using a combination of DQF-COSY, 
HSQC, HSQC-TOCSY and HMBC. To increase the resolution of the HMBC 
spectra without suffering from folding effects, a band selective modification was 
used and spectra were recorded of regions 54 – 64 ppm and 75 – 85 ppm on the 
F1 axis. The HSQC spectra showed that some signals shifted approximately 7 – 
8 ppm downfield in the carbon spectrum during the propargylation reaction, and 
HMBC was used to verify that this shift was due to a propargyl group being 
added. The position on the glucose unit was determined by a combination of 
DQF-COSY, HSQC, and HSQC-TOCSY (Figure 4.5). The dextran that was 
used in this work had an α-(1→3) branch approximately every 25 glucose units. 
The cross-peaks from the branching overlap with the cross-peaks from 
propargylated C3-H3 correlations in the HSQC spectra. The high homogeneity 
of the starting material allowed for fairly simple characterization of the 
propargylated products. 
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Figure 4.4. Quantitative 
13
C spectra of the propargylated dextrans. 
 
Figure 4.5. HSCQ-TOCSY (black) and HSQC (red) spectra of P6. 
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The majority of the propargyl groups were located on C-2 (~59%), which is also 
seen in the quite significant change in the shift of the anomeric signal (~0.25 
ppm in proton and ~2 ppm in carbon spectra). The remaining substituents are on 
C-3 and C-4 but due to overlapping, the ratio of these could not be determined. 
The final products were, like the intermediates, characterized by NMR 
spectroscopic methods. In this case the combination of 
1
H, 
13
C and HSQC 
proved to be the most useful. The 
1
H and 
13
C spectra are strongly dominated by 
the attached disaccharides, as is to be expected as these fragments are more 
homogeneous than the dextran backbone, and will thus give sharper peaks. The 
rather long linkers ensure that all attached disaccharide moieties behave in 
identical fashion. It can clearly be seen in the proton spectra, that the CH2 of the 
propargyl groups at approximately 4.5 ppm, shifts downfield (and ends up 
beneath the water signal), and that the CH2N3 of 1 shifts from 3.55 ppm to 4.7 
ppm, in the final products (Figure 4.6). These shifts are to be expected, as the 
triazole ring is aromatic, and therefore more electron-withdrawing than the 
alkyne and azide present in the starting materials. Similar changes can be seen in 
the carbon spectra. The two alkyne signals at 79 ppm and 77 ppm in the 
spectrum of P6 disappear, and are replaced by two triazole signals at 125 ppm 
and 144 ppm. The proton spectrum also shows a new peak at 8.17 ppm which is 
the signal from the triazole proton (the terminal alkyne proton in the starting 
material is typically not present due to its acidic nature and slow relaxation). The 
same changes can also be seen when comparing the HSQC spectra of the azido-
sugars, propargylated dextrans, and final compounds (Figure 4.7). 
The carbohydrate region in the HSQC spectra is quite visually complex, due to 
the presence of several types of carbohydrate moieties. The disappearance of 
signals from starting materials, mainly the disappearance of the CH2 of the 
propargyl moieties, indicates full conversion and no free propargyl groups left 
on the polysaccharide. This is further confirmed by quantitative 
13
C NMR, 
which shows that the ratio between attached disaccharide and glucose signals 
from dextran is the same as the ratio of propargyl groups to glucose in the 
starting materials. 
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Figure 4.6. 
1
H (bottom) and 
13
C (top) spectra of Lac6 (black), P6 (red) and 1 (green). 
 
Figure 4.7. HSQC spectra of Lac6 (Black), P6 (red) and 1 (green). 
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Finally, the final compounds were characterized by high-pressure size-exclusion 
chromatography (HPSEC) and multiangle laser light scattering (MALLS), to 
determine the size of the polymers. The expected size of the polymers, based on 
the DS lies approximately between 110 – 250 kDa. The observed size for the 
polymers was, however, found to be 40 – 50 kDa. 
It is known that that carbohydrates can degrade in strongly alkaline conditions, 
such as those used in the propargylation reaction, via a so called peeling reaction 
by β-elimination.20,21 This is, however, only possible if the anomeric position of 
the reducing end is a free hydroxyl. In the case of these polysaccharides, the 
anomeric position at the reducing end is expected to be the first one to react, and 
therefore the peeling reaction should have minimal effect on the final polymer 
size. HPSEC/MALLS analysis showed that no significant degrading took place 
during this step. 
It has also been reported that Cu(I) species can produce reactive oxygen species 
that can be detrimental to biomolecules,
22,23
 and the depolymerization of 
polysaccharides by such species can be traced back to the 1960’s.24,25 It does, 
indeed, seem that the conditions used for the click reaction can degrade the 
polysaccharide backbone. The degradation of biomolecules under such 
conditions has, however, previously been prevented by using copper chelators 
that trap the Cu(I) species and keep them in this oxidation state.
26,27
 In this work, 
similar methods for preventing the degradation was explored using a TGTA
26
 
chelator which did prevent the degradation to some degree. Even a five-fold 
excess of the chelator in relation to the copper was, however, not enough to 
completely prevent the degradation. Since, rather serendipitously, the final 
compounds were all of very similar size, making them optimal for biological 
studies, no further effort was put towards trying to completely prevent the 
degradation. The fact that the molecules all degraded to very similar sizes, 
prompted further investigations into this phenomenon, the results of which will 
discussed in more detail in section 4.5. 
4.4 Interactions of modified dextrans with galectin-3 
Interactions between the modified dextrans and human galectin-3 (Gal-3) were 
investigated using NMR spectroscopic techniques. To simplify the analysis of 
data, only the carbohydrate-recognition domain (CRD) of the protein was used. 
Samples of the protein were titrated with the polysaccharides and 
15
N – 1H 
HSQC spectra were recorded after each addition. The cross peaks in the spectra 
were monitored, and any changes during the titration were recorded.  
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If a ligand is in close proximity to the protein, the change in chemical 
environment of the NH cross-peaks close to the site of interaction will cause the 
NH correlations to shift. The chemical shift perturbation can be used to 
determine the binding site of the protein and, provided that the binding process 
is in the fast regime, the binding affinity can be estimated by fitting the data to 
the function Δδ/Δδmax = [L]/(Kd + [L]) where [L] is the free ligand concentration 
([L] = [Ltot] – [Lbound]) and Kd is the dissociation constant.
28,29
 
4.4.1 Galectin-3 
Gal-3, is a lectin that recognizes β-D-galactopyranosides. Out of the 14 
mammalian galectins it is probably the most studied one, known to play 
important parts in biological systems such as cell differentiation, growth, and 
apoptosis, as well as in inflammatory responses. Structurally it is a chimera type 
lectin with a single carbohydrate recognition domain, consisting of 
approximately 150 amino acids and an N-terminal tail consisting of collagen-
like repeats, the length of which depends on the species (nine in human Gal-
3).
30,31
 
An increase in the expression of Gal-3 is commonly associated with cancer,
32
 
and it is known to inhibit antitumor immunity and promote tumor growth via T-
cell activation and apoptosis.
33,34
 Competitive inhibition of Gal-3 in mice has 
been shown to slow down the growth of cancer cells in vivo.
33,35
 Furthermore, in 
vitro studies using human breast carcinoma cells have shown, that inhibition of 
Gal-3 also prevents the adhesion of the cells to endothelial cells.
35
 The 
increasing number of cancer patients demands new treatments for this group of 
diseases. The properties of Gal-3 make it an attractive target for developing such 
treatments. 
In addition to β-D-galactopyranosyl units, Gal-3 has, on multiple occasions, been 
suggested to also recognize the cell wall of C. albicans
36–40
 which is quite 
unexpected as lectins are typically highly specific for their substrates. The cell-
wall of Saccharomyces cerevisiae, however, is not recognized by the lectin.
41
 
One of the major differences between the cell walls of these two yeasts, is the 
presence of β-(1→2) linked mannose units on the cell wall polysaccharide of C. 
albicans.
41–43
 Since, as discussed previously, β-(1→2) linked mannosides are 
known to be immunogenic
44,45
 and Gal-3 is involved in modulating the immune 
system
46,47
 investigation of this rather unusual binding phenomenon could lead 
to better understanding of the interactions between proteins and carbohydrates. 
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4.4.2 Lactose-containing dextrans 
One of the great benefits of using synthetically modified polysaccharides is that 
the ligand content can easily be calculated. The DS of the modified dextrans 
were, for convenience, converted to µmol ligand/mg polysaccharide. This made 
it possible to compare results between different polysaccharides, considering 
only the actual ligand concentration. 
Samples of the
 15
N labeled Gal-3 was titrated with lactose-containing dextrans 
up to a lactose:protein ratio of 50:1, which caused the chemical shift 
perturbations to flatten out to a horizontal line indicating saturation of the 
protein (Figure 4.8). 
As mentioned above, multivalency typically results in stronger binding, 
compared to increasing the concentration of a monovalent ligand. In this case, 
however, the determined KD values were in the range of 0.25 – 0.45 mM for all 
lactose samples. This is approximately the same as the binding affinity of Gal-3 
to pure lactose,
48,49
 i.e. no cluster effect was observed for the lactose-
functionalized dextran. The dextrans with lower degree of substitution showed 
somewhat higher binding affinity than the dextrans with higher DS, but the 
overall small differences correspond only to a small difference in binding 
energy. Due to the similarity in KD values observed for the lactose-
functionalized compounds, not all of them were analyzed as no large deviations 
are to be expected. The results are summarized in Table 4.2.  
 
Figure 4.8. Chemical shift perturbations of a selected region in the HSQC spectrum of 
Gal-3CRD (left), and binding curves (right), upon titration with lactose-functionalized 
dextran. 
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Table 4.2. Binding affinities of the lactose-functionalized dextrans. 
Compound KD (mM) CGal-3 (µM) 
Lac1 0.44 169 
Lac3 0.25 105 
Lac5 0.32 169 
Lac6 0.45 246 
LM1 0.38 169 
LM2 0.37 97 
Only the most affected cross-peaks were monitored during the titration. The 
most perturbed signals were found to be from the amino acids associated with 
the canonical galactose binding site of the protein (Figure 4.9). This is, naturally, 
the expected result as the ligands contain a β-D-galactopyranosyl moiety. 
As a negative control, dextran modified by only the triethylene glycol linker was 
used. This compound caused no changes in the shifts of the protein signals, 
which verified that any interactions between Gal-3 and the modified dextrans 
does, indeed, stem from the carbohydrate moieties attached, and not the linker or 
the dextran backbone. 
4.4.3 β-(1→2) linked mannoses 
No significant chemical shift perturbations were observed upon titration of Gal-3 
with the dextran functionalized with β-(1→2) linked mannobiose. 
Approximately 15 signals (Figure 4.10) did, however, decrease in intensity 
compared to the other signals. Typically, a decrease in signal intensity of a 
binding site is witnessed if the exchange rate is slow, i.e. if koff is slow. In such 
cases new signals from the bound protein should appear, however, and the total 
intensity associated with a signal should remain constant, and the ratio 
represents the fraction of bound protein.
28,29
 Furthermore, decrease in all the 
protein signals could be indicative of non-specific binding, and generally all 
protein signals will decrease somewhat over the course of a titration. 
The observations during the titration suggests, that the protein does indeed 
interact with the β-(1→2) linked mannobiose units on the dextran, but the type 
of binding is different than for the galactose-functionalized dextrans. The 
decrease in signal intensity is likely due to broadening, caused by an 
interconversion of an ensemble of different complexes between the protein and 
ligand. The ligand is interacting with a specific region of the protein, defined by 
the affected residues, but in multiple orientations. This could be seen  as 
nonspecific binding from the ligand perspective.
50
 
Size matters (or does it?) 
128 
 
All the affected signals corresponded to amino acids located in the same region 
of the protein (Figure 4.9). The affected region was, however, not the canonical 
binding site responsible for binding β-D-galactopyranosyl units, but located on 
the opposite side of the CRD. Visual inspection of the site does not indicate the 
presence of a clear binding pocket, as is the case for the canonical binding site. 
This could explain why the ligands can interact with the site in multiple 
orientations. Gal-3 has previously been reported to also bind mannose-
containing polysaccharides.
49
 
 
Figure 4.9. Gal-3 CRD displaying the canonical binding site (left) and non-canonical 
binding site (right). 
The galectin was titrated to a ligand/protein ratio of 100:1 and the intensities of 
the signals were monitored. As mentioned previously, the overall intensity of the 
protein signals typically decreases over the course of the titration and because of 
this, the intensities of the signals of interest were normalized against signals 
unaffected by the binding. This indicated that the binding clearly depends on the 
concentration of the ligand. Reliable quantification of such binding is, however, 
difficult, and no KD values are reported here. 
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Figure 4.10. 
15
N–1H HSQC spectra of Gal-3 (blue) and the endpoint of the titration with 
mannose-functionalized dextran (red). 
In addition to the mannose-functionalized dextran, the binding of Gal-3 to 
mannans extracted from the C. albicans cell wall was investigated. These 
polysaccharides did, however, not appear to interact with the galectin to any 
noticeable degree. In previous studies, the interactions of Gal-3 with mannose-
containing polysaccharides has only been investigated using full-length Gal-
3
37,38,49
 whereas in this study only the CRD of Gal-3 was used. It is possible that 
the collagen-like tail of Gal-3 facilitates the binding of larger mannans. In this 
work, the disaccharide units are located quite far from the dextran backbone, and 
are thus allowed to behave more freely than they would if they were 
incorporated into the backbone itself. This might also explain the difference 
between these results and those published before. 
Rather surprisingly, the dextrans functionalized with both maltose and lactose 
seemed, in addition to the galactose binding site, also to interact with the same 
region of the protein as the mannose-functionalized dextran.  
The unexpected binding of Gal-3 to various carbohydrates suggests that the 
understanding of interactions between carbohydrates and proteins is far from 
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being complete, and further investigations into the binding phenomenon are 
required. 
4.5 Depolymerization of polysaccharides 
As mentioned in the introduction to this chapter, polysaccharides are valuable 
targets for development of renewable materials. Obtaining oligosaccharide 
fragments with desired size and properties is not always straightforward, 
however. Synthetic procedures for combining monosaccharides or small 
oligosaccharides into larger structures exist, but these are typically laborious and 
expensive if larger quantities are required. Even with the emergence of 
automated systems as discussed in the first chapter of this thesis, preparation of 
large structures in desired amounts for material purposes is often not feasible. 
Fragmentation of natural polysaccharides into smaller structures can be achieved 
in multiple ways, but the generally applied methods typically suffer from some 
drawbacks. Enzymatic methods are highly selective which, while often desired, 
can cause problems as natural polysaccharides typically contain many different 
types of linkages, and glycosylases (enzymes that hydrolyze glycosidic linkages) 
are typically specific for a certain type of linkage. Because of this, a mixture of 
enzymes is often required.
51
 Furthermore, non-selective methods such as 
hydrolysis by strong mineral acids, or under oxidative conditions are often 
difficult to control, and produce fragments with large polydispersities.
20,52
 Due to 
the problems associated with the existing methods, new approaches are needed 
for processing polysaccharides from natural sources. 
During the final step in the functionalization of dextran, i.e. the CuAAC 
reaction, significant degradation of the dextran backbone was observed. This 
prompted a more thorough investigation into the reaction and its effect on other 
polysaccharides. The phenomenon itself, can be traced back to the 1960s when it 
was discovered that polysaccharides can be depolymerized by a combination of 
ascorbic acid and copper ions.
24,25
 Even though the degradation of 
polysaccharides under these conditions has been known for over 50 years, it is 
still regularly neglected today.
53–58
 Furthermore, the potential applications of this 
reaction for intentional degradation of polysaccharides have not been addressed 
previously. 
4.5.1 Dextran as a model compound 
The high homogeneity of dextran makes it an excellent model compound for this 
study. The fragments created by the degradation are very similar in structure, 
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which makes the analysis of results straightforward, and the commercial 
availability of analytical standards of various sizes of dextran allows for 
obtaining of reliable calibration curves. 
To investigate the roles of the different reagents and reaction times, different 
conditions were screened while keeping the solvent (water), temperature (55 
°C), and starting material (70 kDa dextran) fixed (the general scheme for the 
reaction is shown in Scheme 4.6). Neither CuSO4 nor Na-ascorbate caused any 
significant depolymerization on their own (entry 6 and 7 in Table 4.3). CuCl, 
however, caused significant fragmentation resulting in smaller polymers with 
molecular weights of approximately 17 – 18 kDa (entry 8 in Table 4.3). This 
suggests that Cu(I) ions are the active species in the reactions. This is in 
accordance with previous results where Cu(I) ions have been suggested to 
generate reactive oxygen species, that are the driving force of the 
degradation.
22,23
 In the reagent system consisting of CuSO4 and Na-ascorbate, 
Cu(II) gets reduced to Cu(I). The degradation was studied by varying the 
amounts of these reagents. All experiments resulted in fragments of 
approximately 7 – 10 kDa, i.e. the exact amount of reagents did not seem to be 
very significant (entries 2 – 4 in Table 4.3). 
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Scheme 4.6. Degradation of dextran. Reagents and conditions: i) 70 kDa dextran, 55 °C, 
H2O, reagents (Table 4.3). 
From these results it is quite clear that Cu(I) ions are the active species in the 
reaction. The reason why the reagent system consisting of CuSO4 and Na-
ascorbate is more effective than using CuCl, could be explained by the fact that 
Cu(I) species are readily oxidized to Cu(II) species in the presence of water and 
oxygen. The combined effect of Cu(I) species and Na-ascorbate cannot, 
however, be ruled out completely. 
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Table 4.3. Degradation of dextran under different reaction conditions. 
Entry CuSO4 
(equiv) 
Na-asc 
(equiv) 
t (h) MHPSEC 
(kDa) 
MMALLS 
(kDa) 
Mw/Mn ~DP 
1 0 0 0 70 72 1.20 430 
2 0.1 0.2 20 12.8 15.9 1.43 100 
3 0.3 0.6 20 10.3 11.1 1.34 70 
4 0.5 1.0 20 9.1 10.2 1.22 65 
5 0.5 1.0 48 7.1 10.9 1.55 65 
6 0.5 0 20 67 71 1.21 430 
7 0 1.0 20 68 71 1.21 430 
8 0.5 (CuCl) 0 20 18 17 1.67 105 
All equivalents are given as equivalents per monosaccharide unit. The data is 
visualized in Figure 4.11. 
 
Figure 4.11. Visualization of the data in Table 4.3. 
Based on the results from the initial screening, the reagent system consisting of 
CuSO4 and Na-ascorbate was selected for all the remaining experiments. The 
degradation of dextran was repeated on 200 mg scale using 0.05 equivalents of 
CuSO4 and 0.1 equivalents of Na-ascorbate, and the reaction progress was 
monitored for five days to investigate the degradation over time. The results 
from this experiment are shown in Figure 4.12. It was found that at a certain 
point, interpreted herein as terminal oligomer size, the degradation rate 
decreased significantly. Neither using large excess of reagents or long reactions 
times were found to have a large impact on this size (entries 2 – 5 in Table 4.3). 
For dextran, this limit was found to be approximately 7 – 10 kDa, corresponding 
to a degree of polymerization (DP) of approximately 40 – 60 (The starting 
material with a molecular weight of 70 kDa has a DP of ~400). To verify the 
existence of a terminal oligomer size, the reaction was repeated using a 
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commercial maltoheptaose. In this case no degradation was detected which 
confirmed the hypothesis. 
Figure 4.12 shows that the degradation has a rather strict logarithmic 
dependency on the reaction time. This could, in principle, allow the calculation 
of the time required to produce polysaccharides of desired length, by applying a 
simple mathematical function. The predictability combined with the low 
polydispersity of the produced fragments, makes this a promising method for 
fragmenting polysaccharides into smaller structures with desired properties. The 
predictable behavior may, however, be limited to linear polysaccharides. 
Nonetheless, intrigued by these findings, the behaviors of three other 
polysaccharides under the same reaction conditions were investigated, the results 
of which will be discussed next. 
 
Figure 4.12. Degradation of dextran over five days. 
4.5.2 Polysaccharides from biomass feedstock 
To investigate the applicability of the method for processing polysaccharides 
from biomass feedstock, three naturally occurring polysaccharides: xylan, starch, 
and galactoglucomannan (GGM), were subjected to the degradation conditions. 
The chemical structures of the polysaccharides are displayed in Figure 4.13. 
Xylans, are a group of hemicelluloces found in plant cell walls, where they can 
constitute up to 10 – 35% of the total hemicellulose content.59 Due to their 
abundance, they are a relevant renewable source of polysaccharides. 
Structurally, this class of compounds consists of a β-(1→4) linked xylose 
backbone, with various branches depending on the species of origin.
60
 In this 
particular study, 36 kDa birchwood xylan with α-(1→2) linked branches of 4-O-
methyl-D-glucuronic acid units approximately 10 xylan residues was used.
61,62
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Figure 4.13. Chemical structures of xylan, starch and GGM. 
Starch is the energy storage molecule in most green plants, and is thus one of the 
most abundant naturally occurring polysaccharides, and an important raw 
material in food and paper industries.
63
 Starch consists of two types of 
molecules, linear α-(1→4)-D-glucopyranan (amylose) that is insoluble due to the 
ordered helical conformation it forms, and amylopectin that in addition to the α-
(1→4)-linked backbone, also contains branches connected via α-(1→6)- 
linkages. The branching breaks the regular structure of starch, and makes 
amylopectin water soluble. The wide industrial applicability of starch makes it 
an excellent substrate for this investigation, and a 70 kDa starch polysaccharide 
was thus used here for degradation studies. 
Finally, GGM is a hemicellulose commonly found in softwoods, where it can 
constitute up to 10-20% of the dry weight.
62,64
 Structurally it is a polysaccharide, 
with a backbone consisting of β-(1→4) linked glucopyranosyl and 
mannopyranosyl units, with occasional galactopyranosyl units attached to the 
mannoses via α-(1→6) linkages. The Man/Glc/Gal ratio of the GGM can vary 
slightly depending on the isolation procedure and source.
65,66
 The ratio in the 
GGM used in this study was 4:1:0.1. Similar to xylan, GGM is also an important 
starting material for future biorefineries. The industrial applications, as well as 
the potential biological applications make it an attractive target for future 
research.
67
 Previously a 22 step synthetic protocol was devised for preparation of 
a tetrasaccharide fragment present in GGM.
68
 Understandably, more feasible 
ways of preparing such fragments would be preferred for large-scale production. 
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Table 4.4. Results from degradation of xylan, starch and GGM. 
Entry Polysaccharide CuSO4 
(equiv.) 
Na-asc 
(equiv.) 
t (h) MHPSEC 
MMALLS 
MDOSY 
Mw/Mn DP 
 
1a 
 
 
Xylan 
 
0 
 
0 
 
0 
- 
- 
36 
 - 
- 
200 
 
1b 
 
 
Xylan 
 
0.1 
 
0.2 
 
18 
5.5 
12
[a]
 
6.4 
 
1.29 
35 
75 
40 
 
1c 
 
 
Xylan 
 
0.5 
 
1.0 
 
18 
5.0 
11
[a]
 
6.3 
 
1.32 
30 
70 
40 
 
2a 
 
 
Starch 
 
0 
 
0 
 
0 
- 
- 
70 
 - 
- 
430 
 
2b 
 
 
Starch 
 
0.1 
 
0.2 
 
19 
- 
- 
5.5 
 - 
- 
35 
 
2c 
 
 
Starch 
 
0.5 
 
1.0 
 
19 
- 
- 
5.5 
 - 
- 
35 
 
3a 
 
 
GGM 
 
0 
 
0 
 
0 
12 
11 
- 
 
1.38 
75 
70 
- 
 
3b 
 
 
GGM 
 
0.1 
 
0.2 
 
18 
4.2 
3.9 
- 
 
2.01 
25 
24 
- 
 
3c 
 
 
GGM 
 
0.5 
 
1.0 
 
18 
2.0 
2.3 
- 
 
1.38 
12 
14 
- 
[a]
The large deviation is probably caused by an incorrect dn/dc value. Reaction 
conditions: starting material, H2O, 55 °C, reagents. The data are visualized in 
Figure 4.14. 
The three polysaccharides; xylan, starch and GGM, were subjected to the 
degradation conditions using two different concentrations of CuSO4 and Na-
ascorbate. The results of these reactions are summarized in Table 4.4 and Figure 
4.14. The xylan and starch were degraded into approximately 5 – 6 kDa 
polysaccharide fragments, corresponding to DPs of 30 – 40 (Figure 4.15). These 
fragments are similar to those obtained from dextran. The GGM, however, was 
degraded into even smaller fragments of approximately 2 – 2.5 kDa, 
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corresponding to a DP of 10 – 15 (Figure 4.15). The difference could stem from 
the fact that GGM is significantly more heterogeneous than xylan or starch, and 
thus has a less ordered structure in solution, which might allow the reaction to 
proceed further than for the more homogeneous polysaccharides. It has been 
reported previously, that the ability of the polysaccharides to form complexes 
with copper is a crucial part of the degradation reaction.
69
 Complexation would 
allow the generation of oxidative species in close proximity of the glycosidic 
linkages, where they can hydrolyze the bonds. The requirement for 
complexation would, at least in part, explain the existence of a terminal oligomer 
size. In addition to what has been mentioned previously, it also appears that the 
stereochemistry of the monosaccharide units can have a significant impact on the 
final oligomer size. The polysaccharides consisting of monosaccharides with 
“gluco”-stereochemistry, i.e. dextran, starch and xylan, had a final DP of 
approximately 30 – 60 whereas GGM, which is dominated by mannose units, 
had a final DP of only 10 – 15. More detailed studies about the reaction, its 
mechanism, and the correlation to the final oligomer size are, however, required. 
 
 
Figure 4.14. Visualization of the data in Table 4.4. 
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Figure 4.15. Normalized SEC chromatograms for degraded xylan (top) and GGM 
(bottom). 
4.5.3 Analysis of degradation products. 
The degradation products were mainly analyzed with high pressure size 
exclusion chromatography (HPSEC) and multiangle laser light scattering 
(MALLS). HPSEC is a method that separates molecules based on their size, and 
MALLS is a method that measures how molecules in solution scatter light. The 
light scattering can be related to molecular weight, if the so-called Rayleigh ratio 
Rθ (also known as dn/dc), which relates the molecular weight to the scattering 
angle and intensity, is known. By this method, molecular weights and 
polydispersities can be calculated. There are tables of dn/dc values available, but 
these are dependent on several other factors such as solvent, buffer, temperature, 
and exact polysaccharide type as well. Because of this, there might be slight 
errors in the calculated molecular weights, but by analyzing also the starting 
materials, and combining the MALLS data with HPSEC and NMR data, the 
degradation is quite evident. All methods used in the analysis are in good 
agreement, indicating that the methods are reliable at least in a qualitative 
manner. The HPSEC and DOSY data was calibrated using dextran standards 
ranging from 50 – 270 kDa (Figure 4.16). 
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Figure 4.16. DOSY spectra (top) and normalized SEC chromatograms (bottom) of 
dextran standards. 
The most useful NMR techniques for this type of analysis are DOSY and HSQC. 
DOSY, is a technique that separates compounds in the sample based on their 
diffusion coefficients, and thus it gives data similar to that from HPSEC. Over 
the years DOSY has become a frequently used method for polymer analysis in 
solution.
70,71
 Conventional 
1
H and 
13
C spectra are not of much use in this type of 
analysis due to severe overlapping in the spectra, which complicates the 
comparison of spectra. HSQC, however, can be used to detect an increasing 
number of end-groups, which indicates depolymerization. 
The poor solubility of starch and xylan, resulted in some analytical problems, 
especially in the case of starch which did not become appreciably soluble at 
room temperature even after the reaction. Both of these could be dissolved by 
briefly heating the samples to 80 °C, but upon cooling some precipitate appeared 
in the samples. To avoid the risk of precipitating the compounds on the SEC 
column, the unreacted xylan and all starch samples were analyzed by NMR 
techniques alone. HSQC and DOSY spectra of starch, xylan and degradation 
products 2c and 1c can be seen in Figure 4.17 and Figure 4.18. 
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Figure 4.17. HSQC (top) and DOSY (bottom) spectra of starch (blue) and degradation 
product 2c (red). 
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Figure 4.18. HSQC (top) and DOSY (bottom) spectra of xylan (blue) and degradation 
product 1b (red). 
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4.6 Conclusions 
By combining the concepts of using carbohydrate-based ligands for protein 
receptors and carbohydrates as carriers for biomolecules a method for preparing 
natural polysaccharide mimics has been developed. The potential applicability of 
the method has been evaluated, by investigating the binding between Gal-3 and 
dextran functionalized with various disaccharide fragments. All compounds have 
been meticulously characterized by NMR, HPSEC and MALLS to assure that 
they correctly represent the assumed structures. 
In the binding studies, unexpected interactions between Gal-3 and dextrans 
functionalized with other than galactose-containing disaccharides was witnessed, 
suggesting that the interactions between carbohydrate ligands and protein 
receptors might be a more complex phenomenon, than what is typically 
assumed. These findings might also, due to the nature of the studied protein, in 
the future provide insights into the complicated mechanisms of cancerous 
diseases. 
During the modification of dextran, one of the most well-known and widely 
applied “click” reactions, the copper(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC), was found to be detrimental to the polysaccharide backbone. These 
findings prompted a more in-depth investigation into the applicability of the 
same conditions, for obtaining well-defined polysaccharide fragments from 
natural polysaccharides. The reaction was found to generate fragments of well-
defined size, and thus these findings could provide access to molecules that are 
extremely laborious to prepare by conventional methods. 
4.7 Experimental 
4.7.1 Instrumental and general information 
All reagents for synthetic work were purchased from Sigma-Aldrich, unless 
mentioned otherwise, and used without further purification. GGM was obtained 
from the Laboratory of Wood and Paper chemistry at Åbo Akademi University. 
Dry solvents were either distilled (CH2Cl2 Over CaH2). TLC was performed on 
aluminum sheets precoated with Silica gel 60 F254 (Merck) and the spots were 
visualized by UV and charred by using a 1:4 solution of H2SO4 in MeOH, 
followed by heating. Column chromatography was carried out using Silica gel 
60 (0.040 – 0.060 mm, Merck) for normal phase and silica gel 100 C18 (0.015 – 
0.035 mm, Fluka) for reverse phase. 
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NMR spectra were recorded on a Bruker AVANCE III spectrometer operating at 
500.20 MHz (
1
H) and 125.78 MHz (
13
C) equipped with a Prodigy BBO 
CryoProbe or a Bruker AVANCE III spectrometer operating at 600.16 MHz 
(
1
H) and 150.9 MHz (
13
C) equipped with a Prodigy TCI inverted CryoProbe 
optimized for proton detection. 
15
N-
1
H HSQC experiments were performed on a 
Bruker Avance II instrument with a standard triple-channel probe operating at 
600.13 MHz (
1
H) and 60.8 MHz (
15
N). Coupling constants in the NMR data are 
reported only the first time they are encountered to avoid unnecessary bloating 
of the NMR data. Accurate chemical shifts and coupling constants were obtained 
with the NMR simulation software PERCH.
16
 
Kd values of the interactions between Gal-3 and the ligands were estimated by 
plotting Δδ/Δδmax vs [L] and fitting a function Δδ/Δδmax = [L]/(Kd+[L]) to the 
plot. The Δδ values were measured as weighted average values for 1H and 15N 
shifts using α = 0.2 as weighting factor for the 15N shifts.29,72 
DOSY spectra were recorded at a concentration of approximately 2 mg/mL and 
HSQC at a concentration of 10 mg/mL. The starch samples and the unreacted 
xylan sample had to be heated to approximately 80 °C to make everything 
dissolve. Upon cooling some precipitate was observed, which could mean that 
the lower molecular-weights might be slightly overrepresented in these samples. 
HPSEC/MALLS analysis was performed on an Agilent 1260 series (G1311B) 
instrument equipped with a refractive index detector (Shimadzu RID-10A) and 
MALLS detector (Wyatt Technology miniDAWN Tristar). The setup consisted 
of a guard column (Waters, Ultrahydrogel 6 mm × 40 mm) and two columns (2 
× Ultrahydrogel linear 7.8 mm × 300 mm) connected in series. Eluent: 100 mM 
NaNO3; flow rate: 0.5 mL/min; injection volume: 200 µL. 
HRMS were recorded on a Bruker MicroToF-Q with electrospray ionization 
operating in positive mode. 
4.7.2 Synthetic procedures 
2-[2-(2-Azidoethoxy)ethoxy)ethyl O-(2,3,4,6-tetra-O-benzoyl-β-D-
galactopyranosyl)-(1→4)-2,3,6-tri-O-benzoyl-β-D-glucopyranoside (5): To a 
solution of 1-O-(2,3,4,6-Tetra-O-benzoyl-β-D-galactopyranosyl)-(1→4)-2,3,6-
tri-O-benzoyl-α-d-glucopyranosyl Trichloroacetimidate  (4.00 g, 3.29 mmol, 1 
equiv.) and 2-[2-(2-azidoethoxy)ethoxy)ethanol (864 mg, 4.94 mmol, 1.5 equiv.) 
in freshly distilled CH2Cl2 (40 mL) was added 4 Å molecular sieves after which 
the solution was cooled down to –30 °C and TMSOTf (60 µL, 0.33 mmol, 0.1 
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equiv.) was added. The reaction mixture was stirred at –30 °C for 2 h and then 
quenched with Et3N and evaporated. The crude product was purified by column 
chromatography (hexane : EtOAc, 1 : 1) which yielded pure 1 as a white foam. 
Yield 3.18 g (81%), Rf = 0.39. 
1
H NMR (600.16 MHz, CDCl3, 25 °C): δ = 8.05 – 7.10 (m, 35 H, arom. H), 5.80 
(1 H, dd, JH3A, H2A = 9.9 Hz, JH3A, H4A = 9.1 Hz, H3A), 5.73 (dd, 1 H, JH4B, H3B = 
3.4 Hz, JH4B,  H5B = 1.1 Hz, H4A), 5.72 (dd, 1 H, JH2B, H1B = 7.9 Hz, JH2B, H3B = 
10.3 Hz, H2B), 5.46 (dd, 1 H, JH2A, H1A = 7.9 Jz, H2A), 5.37 (dd, 1 H, H2B), 4.88 
(d, 1 H, H1B), 4.82 (d, 1 H, H1A), 4.60 (dd, 1 H, JH6Aa, H5A = 1.9 Hz, JH6Aa, H6Ab = 
–12.1 Hz, H6Aa), 4.49 (dd, 1 H, JH6Ab, H5A = 4.3 Hz, H6Ab), 4.25 (dd, 1 H, JH4A, 
H5A = 9.9 Hz, H4A), 3.90 (ddd, 1 H, JH1ʹa, H1ʹb = –11.5 Hz, JH1ʹa, H2ʹa = 4.83 Hz, 
JH1ʹa, H2ʹb = 3.4 Hz, H1ʹa), 3.88 (ddd, 1 H, JH5B, H6Ba = 6.7 Hz, JH5B, H6Bb = 6.6 Hz, 
H5B), 3.83 (ddd, 1 H, H5A), 3.73 (dd, 1 H, JH6Ba, H6Bb = –11.4 Hz, H6Ba), 3.71 
(ddd, 1 H, JH1ʹb, H2ʹa = 3.3 Hz, JH1ʹa, H2ʹb = 7.4 Hz, H1ʹb), 3.69 (dd, 1 H, H6Bb), 
3.57 (ddd, 1 H, JH2ʹa, H2ʹb = –11.4 Hz, H2ʹa), 3.53 (ddd, 1 H, H2ʹb), 3.499 (ddd, 1 
H, JH5ʹa, H5ʹb = –13.2 Hz, JH5ʹa, H6ʹa = 6.5 Hz, JH5ʹa, H6ʹb = 7.0 Hz, H5ʹa), 3.497 (ddd, 
1 H, JH5ʹb, H6ʹa = 4.2 Hz, JH5ʹb, H6ʹb = 7.0 Hz, H5ʹb), 3.44 (ddd, 1 H, JH3ʹa, H3ʹb = –10.9 
Hz, JH3ʹa, 4ʹa = 6.4 Hz, JH3ʹa, H4ʹb = 3.2 Hz, H3ʹa), 3.43 (ddd, 1 H, JH3ʹb, H4ʹa = 3.1 Hz, 
JH3ʹb, H4ʹb = 6.0 Hz, H3ʹb), 3.36 (ddd, 1 H, JH4ʹa, H4ʹb = –10.9 Hz, H4ʹa), 3.35 (ddd, 
1 H, H4ʹb), 3.284 (ddd, 1 H, JH6ʹa, H6ʹb = –8.5 Hz, H6ʹa), 3.282 (ddd, 1 H, H6ʹb) 
ppm. 
13
C NMR (150.9 MHz, CDCl3, 25 °C): δ = 165.8, 165.6, 165.40, 165.39, 165.22, 
165.16, 164.8 (OCOPh), 133.5, 133.40, 133.38, 133.37, 133.3, 133.17. 133.15 
(arom. C), 130.0 – 128.8 (35 C, arom. C), 101.2 (C1A), 101.0 (C1B), 76.1 
(C4A), 73.0 (C5A), 72.9 (C3A), 72.0 (C2A, C2B), 71.4 (C5B), 70.6 (C3ʹ), 70.5 
(C4ʹ), 70.4 (C2ʹ), 69.90 (C3B), 69.88 (C5ʹ), 69.4 (C1ʹ), 67.5 (C4B), 62.4 (C6A), 
61.1 (C6B), 50.6 (C6ʹ) ppm. 
HRMS: m/z calcd. for C67H61N3NaO20 [M + Na]
+
 = 1250.3741, found 
1350.3742. 
2-[2-(2-Azidoethoxy)ethoxy)ethyl O-(β-D-galactopyranosyl)-(1→4)-β-D-
glucopyranoside (1): To a solution of 5  (3.10 g, 1.59 mmol) in THF (5 mL) 
and MeOH (10 mL) was added 5.4 M NaOMe/MeOH solution (0.5 mL) and the 
reaction mixture was stirred at ambient temperature for 2.5 h. The mixture was 
then neutralized with DOWEX 50WX8 H
+
 form and evaporated to dryness to 
obtain pure 1 as a white powder. Yield 1.22 g (94%). 
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1
H NMR (600.16 MHz, D2O, 25 °C): δ = 4.56 (d, 1 H, JH1A, H2A = 8.0 Hz, H1A), 
4.49 (d, 1 H, JH1B, H2B = 7.9 Hz, H1B), 4.11 (ddd, 1 H, JH1ʹa, H1ʹb = –11.6 Hz, JH1ʹa, 
H2ʹa = 4.0 Hz, JH1ʹa, H2ʹb = 4.4 Hz, H1ʹa), 4.02 (dd, 1 H, JH6Aa. H5A = 2.3 Hz, JH6Aa, 
H6Ab = –12.3 Hz, H6Aa), 3.97 (dd, 1 H, JH4B, H3B = 3.4 Hz, JH4B, H5B = 0.2 Hz, 
H4B), 3.89 (ddd, 1 H, JH1ʹb, H2ʹa = 4.9 Hz, JH1ʹb, H2ʹb = 4.7 Hz, H1ʹb), 3.85 (dd, 1 H, 
JH6Ab, H5A = 5.4 Hz, H6Ab), 3.83 (dd, 1 H, JH6Ba, H5B = 8.8 Hz, JH6Ba, H6Bb = –12.2 
Hz, H6Ba), 3.804 (each dd, each 1 H, H2ʹa, H2ʹb), 3.796 (dd, 1 H, JH6Bb, H5B = 
3.9 Hz, H6Bb), 3.79 – 3.75 (m, 6 H, H3ʹa, H3ʹb, H4ʹa, H4ʹb, H5ʹa, H5ʹb), 3.77 
(ddd, 1 H, H5B), 3.71 (dd, 1 H, JH3B, H2B = 9.9 Hz, H3B), 3.701 (dd, 1 H, JH3A, 
H2A = 9.6 Hz, JH3A, H4A = 8.8 Hz, H3A), 3.967 (dd, 1 H, JH4A, H5A = 9.4 Hz, H4A), 
3.64 (ddd, 1 H, H5A), 3.59 (dd, 1 H, H2B), 3.55 (m, 2 H, H6ʹa, H6ʹb), 3.39 (dd, 
1 H, H2A) ppm. 
13
C NMR (150.9 MHz, D2O, 25 °C): δ =103.0 (C1B), 102.1 (C1A), 78.4 (C4A), 
75.4 (C5B), 74.8 (C5A), 74.3 (C3A), 72.8 (C2A), 72.6 (C3B), 71.0 (C2B), 69.7 
(C2ʹ), 69.6, 69.5 (C3ʹ, C4ʹ), 69.2 (C5ʹ), 68.8 (C1ʹ), 68.6 (C4B), 61.0 (C6B), 60.1 
(C6A), 50.2 (C6ʹ) ppm. 
HRMS: m/z calcd. for C18H33N3NaO13 [M + Na]
+
 = 522.1906, found 522.1934. 
2-[2-(2-Azidoethoxy)ethoxy)ethyl O-(β-D-mannopyranosyl)-(1→2)-α-D-
mannopyranoside (2): To a solution of 2-[2-(2-azidoethoxy)ethoxy]ethyl O-
[4,6-O-benzylidene-2,3-di-O-(4-methoxybenzyl)-β-D-mannopyranosyl]-(1→2)-
4,6-O-benzylidene-3-O-(4-methoxybenzyl)-α-D-mannopyranoside (1.00 g, 0.97 
mmol, 1 equiv.) in CH2Cl2 (10 mL) was added 1,3-propanedithiol (775 µL, 7.7 
mmol, 8 equiv.) and then the mixture was cooled on an ice bath. H2O (1 mL) and 
TFA (4 mL) were added and the reaction was stirred at ambient temperature for 
24 h. The reaction mixture was then diluted with H2O (50 mL) and washed with 
CH2Cl2 (4 × 50 mL) after which the water layer was evaporated. The crude 
product was purified by reverse phase column chromatography (H2O : MeOH, 3 
: 1) which yielded pure 2 as a white powder. Yield: 360 mg (74%), Rf = 0.56. 
1
H NMR (600.16 MHz, D2O, 25 °C): δ = 5.03 (d, 1 H, JH1A, H2A = 1.7 Hz, H1A), 
4.80 (s, 1 H, H1B), 4.21 (dd, 1 H, JH2A, H3A = 3.4 Hz, H2A), 4.08 (d, 1 H, JH2B, H3B 
= 3.3 Hz, H2B), 3.96 (dd, 1 H, JH6Ba, H5B = 2.3 Hz, JH6Ba, H6Bb = –12.0 Hz, H6Ba), 
3.93 (ddd, 1 H, JH1ʹa, H1ʹb = –11.7 Hz, JH1ʹa, H2ʹa = 4.5 Hz, JH1ʹa, H2ʹb = 4.0 Hz, H1ʹa), 
3.91 (dd, 1 H, JH6Aa, H5A = 2.1 Hz, JH6Aa, H6Ab = –12.3 Hz, H6Aa), 3.88 (dd, 1 H, 
JH3A, H4A = 9.4 Hz, H3A), 3.82 (dd, 1 H, JH6Ab, H5A = 5.7 Hz, H6Ab), 3.78 (each 
dd, each 1 H, JH2ʹa, H1ʹb = 7.2 Hz, JH2ʹb, H1ʹb = 2.8 Hz, H2ʹa, H2ʹb), 3.78 – 3.75 (m, 6 
H, H3ʹa, H3ʹb, H4ʹa, H4ʹb, H5ʹa, H5ʹb), 3.77 (dd, 1 H, JH6Bb, H5B = 7.0 Hz, 
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H6Bb), 3.74 (dd, 1 H, JH4A, H5A = 10.6 Hz, H4A), 3.72 (ddd, 1 H, H1ʹb), 3.70 
(ddd, 1 H, H5A), 3.68 (dd, 1 H, JH3B, H4B = 9.7 Hz, H3B), 3.61 (dd, 1 H, JH4B, H5B 
= 9.8 Hz, H4B), 3.53 (m, 2 H, H6ʹa, H6ʹb), 3.41 (ddd, 1 H, H5B) ppm. 
13
C NMR (150.9 MHz, D2O, 25 °C): δ = 98.6 (C1B), 97.8 (C1A), 77.1 (C2A), 
76.4 (C5B), 72.80 (C5A), 72.76 (C3B), 70.8 (C2B), 69.9 (C3A), 69.6 (C2ʹ), 
69.53, 69.47 (C3ʹ, C4ʹ), 69.3 (C5ʹ), 67.0 (C4A), 66.7 (C4B), 66.6 (C1ʹ), 61.0 
(C6B), 60.6 (C6A), 50.1 (C6ʹ) ppm. 
1
JC1A, H1A = 171.1 Hz, 
1
JC1B, H1B = 160.9 Hz. 
HRMS: m/z calcd. for C18H33N3NaO13 [M + Na]
+
 = 522.1906, found 522.1905. 
2[2-(2-azidoethoxy)ethoxy]ethyl O-(-D-glucopyranosyl)-(14)--D-
glucopyranoside (3). Peracetylated maltose (4.4 g, 6.4 mmol) was dissolved in 
dry CH2Cl2 (20 mL, under an argon atmosphere). 2-[2-(2-
chloroethoxy)ethoxy]ethanol (5 ml, 35 mmol, 5.5 equiv.) was added to the 
solution and the reaction mixture was cooled on an ice bath. BF3OEt2 (6.5 ml, 
53 mmol, 8.3 equiv.) was added dropwise and the reaction mixture was slowly 
warmed to r.t. and left to stir for 5 hours (MALDI-TOF analysis was utilized to 
monitor the reaction progress: [M+Na]
+
 calculated for C32H47ClO20Na: 809.22; 
observed: 809.65). The reaction mixture was cooled on an ice bath and 
neutralized with Et3N. The mixture was brought to rt, diluted with CH2Cl2 (30 
mL) and washed with satd. NaHCO3-solution (30 mL) and brine (30 mL). The 
organic phase was separated dried over Na2SO4, filtered and concentrated. The 
crude product was partially purified by column chromatography (EtOAc:hexane 
2:1; Rf = 0.35 in EtOAc:hexane 1:1) to give an oil (4.6 g). The partially purified 
product was utilized as such in the following step.   
The oil (4.6. g) was dissolved in dry DMF (30 mL) and Bu4NI (2 g, 5.85 mmol, 
~ 1 equiv.) and NaN3 (2.3 g, 35 mmol, ~ 6 equiv.) was added. The resulting 
mixture was refluxed at 87 C overnight (MALDI-TOF analysis was utilized to 
monitor the reaction progress; [M+Na]
+ 
calculated for C32H47N3O20Na: 816.26; 
observed: 816.47) and concentrated. The crude product was filtered through a 
pad of silica (EtOAc:hexane 3:1; Rf = 0.39 in EtOAc:hexane 3:1) (impurities still 
present). The partially purified product was utilized as such in the following 
step. 
The crude product was dissolved in dry MeOH (10 mL) and the pH was adjusted 
to 10-11 with a 5 M solution of NaOMe. TLC-monitoring (MeOH:CH2Cl2 1:3) 
of the reaction progress indicated that the reaction was complete after 1.5 hours. 
Size matters (or does it?) 
146 
 
The reaction mixture was neutralized with AG 50-X8 (H
+
-form), diluted with 
MeOH (20 mL), filtered and concentrated to give the crude product. The crude 
product was purified by column chromatography (MeOH:CH2Cl2 1:3; Rf = 0.42 
in MeOH:CH2Cl2 1:3) to give the title compound as a white foam (870 mg, 1.7 
mmol, yield over three steps: 27 %). 
1
H NMR (500.10 MHz, D2O, 25 °C): δ = 5.41 (d, 1 H, JH1B, H2B = 4.0 Hz, H1B), 
4.52 (d, 1 H, JH1A, H2A = 8.0 Hz, H1A), 4.08 (ddd, 1 H, JH1ʹa, H1ʹb = –11.7 Hz, JH1ʹa, 
H2ʹa = 4.0 Hz, JH1ʹa, H2ʹb = 4.6 Hz, H1ʹa), 3.94 (dd, 1 H, JH6Aa, H5A = 2.1 Hz, JH6Aa, 
H6Ab = –12.2 Hz, H6Aa), 3.863 (dd, 1 H, JH6Ba, H5B = 2.2 Hz, JH6Ba, H6Bb = –12.4 
Hz), 3.860 (ddd, 1 H, JH1ʹb, H2ʹa = 7.9 Hz, JH1ʹb, H2ʹb = 1.4 Hz, H1ʹb), 3.79 (dd, 1 H, 
JH3A, H2A = 8.8 Hz, JH3A, H4A = 9.8 Hz, H3A), 3.78 (dd, 1 H, JH6Ab, H5A = 5.5 Hz, 
H6Ab), 3.773 (each dd, each 1 H, H2ʹa, H2ʹb), 3.772 (dd, 1 H, JH6Bb, H5B = 5.4 
Hz, H6Bb), 4.744 (s, 4 H, H3ʹa, H3ʹb, H4ʹa, H4ʹb), 4.738 (each 1 H, each dd, 
JH5ʹa, H6ʹa = 7.5 Hz, JH5ʹa, H6ʹb = 2.3 Hz, JH5ʹb, H6ʹa = 2.6 Hz, JH5ʹb, H6ʹb = 7.3 Hz, H5ʹa, 
H5ʹb), 3.72 (ddd, 1 H, JH5B, H4B = 10.1 Hz, H5B), 3.69 (dd, 1 H, JH3B, H2B = 9.9 
Hz, JH3B, H4B = 9.2 Hz, H3B), 3.64 (dd, 1 H, JH4A, H5A = 9.8 Hz, H4A), 3.60 (ddd, 
1 H, H5A), 3.59 (dd, 1 H, H2B), 3.524 (ddd, 1 H, JH6ʹa, H6ʹb = –11.6 Hz, H6ʹa), 
3.519 (ddd, 1 H, H6ʹb), 3.43 (dd, 1 H, H4B), 3.34 (dd, 1 H, H2A) ppm. 
13
C NMR (125.8 MHz, D2O, 25 °C): δ = 102.1 (C1A), 99.6 (C1B), 76.8 (C4A), 
76.1 (C3A), 74.5 (C5A), 73.0 (C2A), 72.8 (C3B), 72.7 (C5B), 71.6 (C2B), 69.7 
(C2ʹ), 69.6, 69.5 (C3ʹ, C4ʹ), 69.3 (C4B), 69.2 (C5ʹ), 68.7 (C1ʹ), 60.7 (C6A), 60.5 
(C6B), 50.1 (C6ʹ) ppm. 
HRMS: m/z calcd. for C18H33N3NaO13 [M + Na]
+
 = 522.1906, found 522.1906. 
Propargylated dextran: KOH (4.85 g, 86 mmol, 14 equiv.) was dissolved in 8 
ml H2O and cooled on an ice bath, after which 70 kDa dextran (1 g, 6 mmol 
glucose units, 1 quivalent) was added and the mixture was stirred until 
everything dissolved. Propargyl bromide (80% in toluene, 0.33 – 2.67 mL, 3 – 
24 mmol, 0.5 – 4 equivalents) and the mixture was stirred on an ice bath for 1 h 
and at room temperature for 19 h. The reaction mixture was then neutralized by 
adding acetic acid followed by precipitation int 100 mL EtOH. The residue was 
dissolved in 10 mL H2O and precipitated into 100 mL EtOH two more times. 
Click reactions: Propargylated dextran (1 equiv. propargyl groups) was 
dissolved in 3 ml H2O after which one of the azidofunctionalized disaccharides 
(2 equiv./propargyl group), CuSO4 (0.3 equiv.) and Na-ascorbate (0.6 equiv.) 
were added. The reaction mixture was stirred at 55 °C for 19 h after which the 
mixture was evaporated down to a few drops. MeOH (5 mL) was added, and the 
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precipitate was collected and washed with additional MeOH (5 mL). The residue 
was then passed through a PD-10 G-25 desalting column according to 
manufacturer instructions. Any remaining copper residues were removed by 
QuadraPure® TU thiourea-based metal ion chelator. 
  
Size matters (or does it?) 
148 
 
4.8 References 
1. Nieuwdorp, M. et al. The endothelial glycocalyx: a potential barrier 
between health and vascular disease. Curr. Opin. Lipidol. 16, 507–511 
(2005). 
2. Reitsma, S., Slaaf, D. W., Vink, H., Van Zandvoort, M. A. M. J. & Oude 
Egbrink, M. G. A. The endothelial glycocalyx: Composition, functions, 
and visualization. Pflugers Arch. Eur. J. Physiol. 454, 345–359 (2007). 
3. Willis, L. M. & Whitfield, C. Structure, biosynthesis, and function of 
bacterial capsular polysaccharides synthesized by ABC transporter-
dependent pathways. Carbohydr. Res. 378, 35–44 (2013). 
4. Kröncke, K. D., Golecki, J. R. & Jann, K. Further electron microscopic 
studies on the expression of Escherichia coli group II capsules. J. 
Bacteriol. 172, 3469–72 (1990). 
5. Spinosa, M. R. et al. The Neisseria meningitidis capsule is important for 
intracellular survival in human cells. Infect. Immun. 75, 3594–3603 
(2007). 
6. Noel, G. J., Hoiseth, S. K. & Edelson, P. J. Type b capsule inhibits 
ingestion of haemophilus influenzae by murine macrophages: Studies 
with isogenic encapsulated and unencapsulated strains. J. Infect. Dis. 
166, 178–182 (1992). 
7. Bernardi, A. et al. Multivalent glycoconjugates as anti-pathogenic agents. 
Chem. Soc. Rev. 42, 4709–4727 (2013). 
8. Cecioni, S., Imberty, A. & Vidal, S. Glycomimetics versus multivalent 
glycoconjugates for the design of high affinity lectin ligands. Chemical 
Reviews 115, 525–561 (2015). 
9. Renaudet, O. & Roy, R. Multivalent scaffolds in glycoscience: an 
overview. Chem. Soc. Rev. 42, 4515 (2013). 
10. Li, S. et al. Molecular Modification of Polysaccharides and Resulting 
Bioactivities. Compr. Rev. Food Sci. Food Saf. 15, 237–250 (2016). 
11. Wen, Y. & Oh, J. K. Recent Strategies to Develop Polysaccharide-Based 
Nanomaterials for Biomedical Applications. Macromol. Rapid Commun. 
35, 1819–1832 (2014). 
12. Lapasin, R. & Pricl, S. in Rheology of Industrial Polysaccharides: 
Theory and Applications 134–161 (Springer US, 1995). 
Size matters (or does it?) 
149 
 
13. Lapasin, R. & Pricl, S. in Rheology of Industrial Polysaccharides: 
Theory and Applications 1–133 (Springer US, 1995). 
14. Stephen, A. M. & Churms, S. C. in Food Polysaccharides and Their 
Applications (eds. Stephen, A. M., Phillips, G. O. & Williams, P. A.) 1–
24 (Taylor & Francis Group, 2006). 
15. Grischenko, L. A. et al. Propargylation of arabinogalactan with propargyl 
halides-a facile route to new functionalized biopolymers. Carbohydr. 
Res. 376, 7–14 (2013). 
16. PERCH. (PERCH Solutions Ltd., 2014). 
17. Musher, J. I. & Corey, E. J. Virtual long-range spin-spin couplings in 
NMR. Tetrahedron 18, 791–809 (1962). 
18. Bruch, R. C., Burch, M. D., Noggle, J. H. & White, H. B. 
Characterization of virtual coupling in the proton nuclear magnetic 
resonance spectrum of N,N’-diacetylchitobiose by two-dimensional J-
resolved spectroscopy. Biochem. Biophys. Res. Commun. 123, 555–561 
(1984). 
19. Brisson, J.-R. & Carver, J. P. Virtual coupling in the 1H NMR spectrum 
of N,N’-diacetyl chitobioside. J. Biol. chemsitry 257, 11207–11209 
(1982). 
20. Whistler, R. L. & BeMiller, J. N. Alkaline Degradation of 
Polysaccharides. Adv. Carbohydr. Chem. 13, 289–329 (1958). 
21. Mozdyniewicz, D. J. & Sixta, H. Carbohydrate degradation reactions 
during alkaline steeping of dissolving pulp- Influence of air exclusion. 
Lenzinger Berichte 90, 103–107 (2012). 
22. Lallana, E., Riguera, R. & Fernandez-Megia, E. Reliable and efficient 
procedures for the conjugation of biomolecules through huisgen azide-
alkyne cycloadditions. Angew. Chem., Int. Ed. 50, 8794–8804 (2011). 
23. McKay, C. S. & Finn, M. G. Click chemistry in complex mixtures: 
Bioorthogonal bioconjugation. Chem. Biol. 21, 1075–1101 (2014). 
24. Matsumura, G. & Pigman, W. Catalytic role of copper and iron ions in 
the depolymerization of hyaluronic acid by ascorbic acid. Arch. Biochem. 
Biophys. 110, 526–533 (1965). 
25. Herp, A., Rickards, T., Matsumura, G., Jakosalem, L. B. & Pigman, W. 
Depolymerization of some polysaccharides and synthetic polymers by L-
ascorbic acid. Carbohydr. Res. 4, 63–71 (1967). 
Size matters (or does it?) 
150 
 
26. Ekholm, F. S. et al. Synthesis of the copper chelator TGTA and 
evaluation of its ability to protect biomolecules from copper induced 
degradation during copper catalyzed azide-alkyne bioconjugation 
reactions. Org. Biomol. Chem. 14, 849–852 (2015). 
27. Hong, V., Udit, A. K., Evans, R. A. & Finn, M. G. Electrochemically 
protected copper(I)-catalyzed azide-alkyne cycloaddition. ChemBioChem 
9, 1481–1486 (2008). 
28. Fielding, L. NMR methods for the determination of protein-ligand 
dissociation constants. Prog. Nucl. Magn. Reson. Spectrosc. 51, 219–242 
(2007). 
29. Williamson, M. P. Using chemical shift perturbation to characterise 
ligand binding. Prog. Nucl. Magn. Reson. Spectrosc. 73, 1–16 (2013). 
30. Henderson, N. C. & Sethi, T. The regulation of inflammation by galectin-
3. Immunol. Rev. 230, 160–171 (2009). 
31. Kopitz, J. et al. Human chimera-type galectin-3: Defining the critical tail 
length for high-affinity glycoprotein/cell surface binding and functional 
competition with galectin-1 in neuroblastoma cell growth regulation. 
Biochimie 104, 90–99 (2014). 
32. Zeinali, M., Adelinik, A., Papian, S., Khorramdelazad, H. & 
Abedinzadeh, M. Role of galectin-3 in the pathogenesis of bladder 
transitional cell carcinoma. Hum. Immunol. 76, 770–774 (2015). 
33. Peng, W., Wang, H. Y., Miyahara, Y., Peng, G. & Wang, R. F. Tumor-
associated galectin-3 modulates the function of tumor-reactive T cells. 
Cancer Res. 68, 7228–7236 (2008). 
34. Cardoso, A. C. F., Andrade, L. N. de S., Bustos, S. O. & Chammas, R. 
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed 
Tumor Microenvironments. Front. Oncol. 6, 127 (2016). 
35. Nangia-Makker, P., Nakahara, S., Hogan, V. & Raz, A. Galectin-3 in 
apoptosis, a novel therapeutic target. J. Bioenerg. Biomembr. 39, 79–84 
(2007). 
36. Jouault, T. et al. β-1,2-linked oligomannosides from Candida albicans act 
as signals for tumor necrosis factor alpha production. Infect. Immun. 63, 
2378–2381 (1995). 
37. Jouault, T. et al. Specific Recognition of Candida albicans by 
Macrophages Requires Galectin-3 to Discriminate Saccharomyces 
cerevisiae and Needs Association with TLR2 for Signaling. J. Immunol. 
Size matters (or does it?) 
151 
 
177, 4679–4687 (2006). 
38. Fradin, C., Poulain, D. & Jouault, T. beta -1,2-Linked Oligomannosides 
from Candida albicans Bind to a 32-Kilodalton Macrophage Membrane 
Protein Homologous to the Mammalian Lectin Galectin-3. Infect. Immun. 
68, 4391–4398 (2000). 
39. Netea, M. G., Brown, G. D., Kullberg, B. J. & Gow, N. A. R. An 
integrated model of the recognition of Candida albicans by the innate 
immune system. Nat. Rev. Microbiol. 6, 67–78 (2008). 
40. Gow, N. A. & Hube, B. Importance of the Candida albicans cell wall 
during commensalism and infection. Curr. Opin. Microbiol. 15, 406–412 
(2012). 
41. Jawhara, S. et al. Murine model of dextran sulfate sodium-induced colitis 
reveals Candida glabrata virulence and contribution of β-
mannosyltransferases. J. Biol. Chem. 287, 11313–11324 (2012). 
42. Klis, F. M., de Koster, C. G. & Brul, S. Cell wall-related bionumbers and 
bioestimates of Saccharomyces cerevisiae and Candida albicans. 
Eukaryotic Cell 13, 2–9 (2014). 
43. Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D. & 
Martínez, J. P. Cell wall and secreted proteins of Candida albicans: 
identification, function, and expression. Microbiol. Mol. Biol. Rev. 62, 
130–180 (1998). 
44. Nelson, R. D., Shibata, N., Podzorski, R. P. & Herron, M. J. Candida 
mannan: Chemistry, suppression of cell-mediated immunity, and possible 
mechanisms of action. Clin. Microbiol. Rev. 4, 1–19 (1991). 
45. Shibata, N., Kobayashi, H. & Suzuki, S. Immunochemistry of pathogenic 
yeast, Candida species, focusing on mannan. Proc. Japan Acad. Ser. B 
88, 250–265 (2012). 
46. Rabinovich, G. A. & Toscano, M. A. Turning ‘sweet’ on immunity: 
galectin-glycan interactions in immune tolerance and inflammation. Nat. 
Rev. Immunol. 9, 338–352 (2009). 
47. Chung, A. W. et al. Galectin-3 Regulates the Innate Immune Response of 
Human Monocytes. J. Infect. Dis. 207, 947–956 (2013). 
48. Diehl, C. et al. Protein flexibility and conformational entropy in ligand 
design targeting the carbohydrate recognition domain of galectin-3. J. 
Am. Chem. Soc. 132, 14577–14589 (2010). 
Size matters (or does it?) 
152 
 
49. Miller, M. C. et al. Binding of polysaccharides to human galectin-3 at a 
noncanonical site in its carbohydrate recognition domain. Glycobiology 
26, 88–99 (2015). 
50. Park, S. J., Borin, B. N., Martinez-Yamout, M. A. & Dyson, H. J. The 
client protein p53 adopts a molten globule–like state in the presence of 
Hsp90. Nat. Struct. Mol. Biol. 18, 537–541 (2011). 
51. Stone, B. A., Svensson, B., Collins, M. E. & Rastall, R. A. in 
Glycoscience: Chemistry and Chemical Biology (eds. Fraser-Reid, B. O., 
Tatsuta, K. & Thiem, J.) 2325–2375 (Springer-Verlag Berlin Heidelberg, 
2008). 
52. Duan, J. & Kasper, D. L. Oxidative depolymerization of polysaccharides 
by reactive oxygen/nitrogen species. Glycobiology 21, 401–409 (2011). 
53. Hein, C. D., Liu, X.-M. & Wang, D. Click chemistry, a powerful tool for 
pharmaceutical sciences. Pharm. Res. 25, 2216–30 (2008). 
54. Liebert, T., Hänsch, C. & Heinze, T. Click chemistry with 
polysaccharides. Macromol. Rapid Commun. 27, 208–213 (2006). 
55. Hafrén, J., Zou, W. & Córdova, A. Heterogeneous ‘organoclick’ 
derivatization of polysaccharides. Macromol. Rapid Commun. 27, 1362–
1366 (2006). 
56. Hasegawa, T. et al. ‘Click chemistry’ on polysaccharides: A convenient, 
general, and monitorable approach to develop (1→3)-β-d-glucans with 
various functional appendages. Carbohydr. Res. 341, 35–40 (2006). 
57. Sawa, M. et al. Glycoproteomic probes for fluorescent imaging of 
fucosylated glycans in vivo. Proc. Natl. Acad. Sci. U. S. A. 103, 12371–6 
(2006). 
58. Tanaka, H., Tago, H., Adachi, Y., Ohno, N. & Takahashi, T. Synthesis of 
a β-glucan polysaccharide analogue by an iterative copper-catalyzed 
azide-acetylene coupling reaction. Tetrahedron Lett. 53, 4104–4107 
(2012). 
59. Ebringerová, A. & Heinze, T. Xylan and xylan derivatives – biopolymers 
with valuable properties, 1. Naturally occurring xylans structures, 
isolation procedures and properties. Macromol. Rapid Commun. 21, 542–
556 (2000). 
60. Koch, G. in Handbook of Pulp (ed. Sixta, H.) 21–68 (WILEY-VCH 
Verlag, GmbH & Co. KGaA, 2006). 
Size matters (or does it?) 
153 
 
61. Lebel, R. G., Goring, D. A. I. & Timell, T. E. Solution properties of birch 
xylan . I. measurement of molecular weight. J. Polym. Sci. 28, 9–28 
(1963). 
62. Timell, T. E. Recent progress in the chemistry of wood hemicelluloses. 
Wood Sci. Technol. 1, 45–70 (1967). 
63. Koch, H. & Röper, H. New Industrial Products from Starch. Starch 40, 
121–131 (1988). 
64. Willför, S., Sundberg, K., Tenkanen, M. & Holmbom, B. Spruce-derived 
mannans - A potential raw material for hydrocolloids and novel advanced 
natural materials. Carbohydr. Polym. 72, 197–210 (2008). 
65. Lundqvist, J. et al. Isolation and characterization of galactoglucomannan 
from spruce (Picea abies). Carbohydr. Polym. 48, 29–39 (2002). 
66. Lundqvist, J. et al. Characterization of galactoglucomannan extracted 
from spruce (Picea abies) by heat-fractionation at different conditions. 
Carbohydr. Polym. 51, 203–211 (2003). 
67. Ebringerová, A. et al. Norway spruce galactoglucomannans exhibiting 
immunomodulating and radical-scavenging activities. Int. J. Biol. 
Macromol. 42, 1–5 (2008). 
68. Ekholm, F. S. et al. Studies related to Norway spruce 
galactoglucomannans: Chemical synthesis, conformation analysis, NMR 
spectroscopic characterization, and molecular recognition of model 
compounds. Chem. - A Eur. J. 18, 14392–14405 (2012). 
69. Uchida, K. & Kawakishi, S. Oxidative depolymerization of 
polysaccharides induced by the ascorbic acid-copper ion systems. Agric. 
Biol. Chem. 50, 2579–2583 (1986). 
70. Morris, K. F. & Johnson, C. S. J. Resolution of Discrete and Continuous 
Molecular Size Distributions by Means of Diffusion-Ordered 2D NMR 
Spectroscopy. J. Am. Chem. Soc. 115, 4291–4299 (1993). 
71. Jerschow, A. & Müller, N. Diffusion-separated nuclear magnetic 
resonance spectroscopy of polymer mixtures. Macromolecules 6573–
6578 (1998). 
72. Wang, W. et al. Fast conformational exchange between the sulfur-free 
and persulfide-bound rhodanese domain of E. coli YgaP. Biochem. 
Biophys. Res. Commun. 452, 817–821 (2014). 
 
Summary, conclusions and future prospects 
154 
 
5 Summary, conclusions and future prospects 
The aim of this thesis was to gain a fundamental understanding of carbohydrate 
chemistry: protecting group strategies, stereoselective glycosylations and 
analysis of products. These concepts were then expanded into developing 
carbohydrate-based structures for potential biological applications and exploring 
the interactions between carbohydrates and other macromolecules.  
The first chapter of this thesis provided an overview of carbohydrate chemistry 
starting from the pioneering work of Emil Fischer towards the end of the 19
th
 
century and into the 20
th
 century. Fundamental concepts about the structure, 
nomenclature and methods for modification were introduced. Furthermore, the 
biological importance and existing, as well as emerging, carbohydrate-based 
therapeutics were discussed. Finally, new emerging technologies, such as 
automated synthesis, were discussed. 
The second chapter introduced a cornerstone of this thesis: β-(1→2) linked 
mannosides derived from the cell wall of Candida albicans together with their 
structure and biological properties. The synthetic challenges associated with 
creating cis-glycosides were assessed and the effect of a charged phosphate 
group on the unique structure of this class of compounds was investigated by 
NMR and molecular modelling methods. All prepared compounds were 
thoroughly characterized by NMR spectroscopic techniques and complete 
assignment of shifts and coupling constants was done by quantum-mechanical 
simulation of the spectra by the NMR simulation software PERCH. 
 
Figure 5.1. NMR spectrum from 5.7 ppm to 3.1 ppm of compound 16 in chapter 2 
(bottom) and simulated spectrum (top). 
It was discovered that the previously used methods for introducing an anomeric 
phosphate group to β-(1→2) linked mannosides were not applicable to 
trisaccharides and tetrasaccharides due to unwanted side reactions during the 
hydrolysis of the thiophenol group resulting in low yields in this step. A new 
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method based on direct activation of the thioglycosides towards glycosylation 
was devised and the target compounds were obtained in satisfactory yields. 
Conformational studies showed that the anomeric phosphate group has no 
significant impact on the overall conformation of β-(1→2) linked mannosides.  
The third chapter introduced the concept of multivalency. This can be seen as 
the second dimension of carbohydrate chemistry, with the first dimension being 
oligosaccharides. Multivalency is a prevalent phenomenon in nature where it 
increases the affinity of ligands towards their target receptors. The potential 
applications of multivalent β-(1→2) linked mannosides as adjuvants for specific 
allergen immunotherapy were explored and first steps towards elucidating their 
mechanism of action were taken. Conformational behavior of the compounds 
was investigated by a combination of NMR spectroscopy and molecular 
dynamics simulations. 
 
Figure 5.2. Stereoscopic view of compound 3 in chapter 3. 
The new compounds 2 and 3 were shown to have similar biological activity as 
the previously prepared lead compound 1. The similar activity is explained by all 
three compounds adopting similar conformations in solution. Preliminary steps 
towards elucidating the mechanisms behind the biological activity of the 
compounds were taken in the form of TLR ligation screening which showed that 
the compounds do not interact with Toll-like receptors, suggesting a different 
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mechanism than those of CpG-ODN and MPLA. This is supported by the fact 
that compounds 1-3 do not induce TNF production at lower concentrations. 
The fourth and final chapter of this thesis expanded the concepts introduced in 
the two previous chapters. Methods for circumventing the intrinsic heterogeneity 
of many natural polysaccharides have been developed and well-defined natural 
polysaccharide mimics have been prepared by attaching various disaccharides to 
a highly homogenic linear polysaccharide. The interactions between the 
modified polysaccharides and a protein, human galectin-3, have been 
investigated by using NMR techniques. Furthermore, a commonly used protocol 
for convenient polysaccharide functionalization, copper(I)-catalyzed dipolar 
azide-alkyne cycloaddition, was found to be detrimental to the structural 
integrity of polysaccharides. The ability of the reaction conditions to degrade 
polysaccharides into smaller structures of regular size was investigated using 
industrially and biologically important polysaccharides. 
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Figure 5.3. The compounds used for functionalization of dextran in chapter 4. 
The binding studies showed that Gal-3 binds lactose-functionalized dextran in its 
canonical binding pocket as expected. Dextrans functionalized with β-(1→2) 
linked mannosides and maltose, however, were found to interact with a different 
part of the protein, on the opposite side of the CRD from the canonical binding 
site. This unusual binding could indicate that protein-carbohydrate interactions 
may have hitherto unknown impacts on biological systems. Furthermore, the 
degradation of polysaccharides under typical CuAAC conditions shows that 
great care should be taken and all available analytical methods should be used to 
verify the structures of prepared compounds. Conventional NMR spectroscopic 
methods might hide effects such as degradation of large heterogeneous 
molecules due to the severe overlapping in the spectra. This phenomenon could, 
however, be used for controlled depolymerization of polysaccharides into 
fragments with low polydispersities which could make it applicable for 
processing of biomass. 
To conclude, β-(1→2) linked mannosides analogous to those found in the cell 
wall of C. albicans and derivatives of these have been prepared and their 
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potential biological applications have been evaluated. The conformational 
behavior of the molecules in solution has been studied by NMR spectroscopic 
techniques combined with molecule modelling methods. Furthermore, methods 
for modifying polysaccharides and preparing structures that imitate natural 
polysaccharides have been developed. Throughout the thesis, particular attention 
has been focused on thorough characterization of prepared compounds, 
especially by NMR spectroscopic methods. A wide array of one and two 
dimensional methods has been used and quantum mechanical simulation has 
enabled the extraction of information from complex spectra. 
Carbohydrate chemistry dates back over a hundred years and many great 
discoveries have been made in this field. Even with the increasing knowledge of 
carbohydrates, many questions remain unanswered and scientific breakthroughs 
are to be expected in the future. The importance of carbohydrates cannot be 
denied and in the future their importance might be emphasized due to modern 
lifestyles contributing to an increase in allergies and antibiotic resistance. The 
applicability of carbohydrates as vaccines and other immunomodulators makes 
carbohydrate chemistry an attractive field for future research and the skills 
developed during the work of this thesis make a solid foundation for such. 
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